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ABSTRACT
The effects of protein-energy malnutrition on the concentrations 
of free amino acids, serotonin and norepinephrine in the brains of 
rats have been studied.
The concentrations'of glutamic acid, aspartic acid, GABA, 
glutamine and serotonin have been measured in the forebrain, cerebellum 
and brainstem of the rat between 7 and 120 days of age. DNA content 
was studied as a measure of cell number.
Maternal protein deficiency from the 5th day of gestation did not 
result in any significant changes in the concentrations of glutamic acid, 
aspartic acid, GABA, serotonin and norepinephrine in the whole brain of 
one day old rats. Pre- and post-natal maternal protein deficiency, 
on the other hand, resulted in an increase in the concentration of 
aspartic acid and a decrease in that of glutamic acid in the forebrain, 
and an increase in the concentration of aspartic acid and in that of 
GABA in the cerebellum of offspring at 21 d of age. The activity of the
enzyme glutamic acid decarboxylase was higher in the cerebellum of the
. ■ ik
malnourished rats at this age. The entry of U-G -D-glucose was depressed
in the forebrain and cerebellum in these animals. The free amino acid
concentration in the brain returned to normal after rehabilitation for
120 d whereas the DRA content and cholesterol concentration did not.
In male weanling rats fed a low protein diet for $6 days, the 
composition of the free amino acid was changed. There were differences 
between the different parts of the brain but the concentration of histidine 
and methionine were increased in each part studied. In rats fed a high 
protein diet of equal energy content, the free amino acid pool in the
3
three "brain parts -was also altered, hut not in the same way as in the 
animals that had eaten the low protein diet. The in vivo uptakes of
CT1"— methionine and H^-histidine were increased. The incorporation of
lh . . .  . . .C -methionine into brain protein was also increased.
Giving a low protein diet to weanling rats also depressed the
serotonin concentration in the forebrain and brainstem. The in vivo
3 . . .
uptake of H -tryptophan into the brain and its incorporation into brain
protein was depressed in rats on a low protein diet, but not in those
on a restricted high protein diet. Insulin injection enhanced the uptake
3 . . . . . . . .
of H -tryptophan and its incorporation into brain protein m  low protein
animals. *
The possible relevance of this work to brain function and to the 
malnourished child is discussed. ^
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Chapter I 
INTRODUCTION
11
A. INTRODUCTION 
*
Protein-energy malnutrition (P.E.M.) is an important nutritional 
problem affecting infant and young children in most developing countries 
. of the -world. It is probably the most widespread nutritional disorder 
in tropical and subtropical countries. It has been estimated that 
about 500 million children, under 5 years of age, suffer from mild to 
moderate forms of P.E.M. This represents 60% of the world’s children 
and 75$ of the children in developing countries. Moreover, the Science 
Advisory Committee Panel on the World Food Supply set up by the President 
of the United States of America estimated that in 1967 20% of the people 
in the developing countries, accounting for two thirds of the world's 
population, were malnourished with deficiencies of both protein and 
energy.
There are two distinguishible syndromes covered by the term 
’’malnutrition" (Hansen, 1961; Dean, 1965)* namely ’ marasmus * 'and 
’kwashiorkor’. The former is due to insufficient food and a diminished 
intake of energy, protein, vitamins and minerals, whereas the classical 
definition of the latter is that it is caused by deficiency of protein 
in a diet potentially adequate or containing an excess of energy. It is 
now recognised that the same diet deficient in all nutrients with adequate 
or inadequate energy may produce either condition (Gopalan, 1969)9 and 
it may well be that kwashiorkor is the condition produced by a failure, 
of the organism to adapt to a deficient diet (Waterlow, 1969)* However, 
there is often no clear dividing line between the two syndromes (Garrow, 
1966a) and the term marasmic kwashiorkor was introduced (Picou, Alleyne
12
and Seaking, 1965) to cover the complex intermediate syndrome. In an 
attempt to standardise the nomenclature of this complex syndrome, an 
international working party under the sponsorship of the Wellcome Foundation 
met in Jamaica, and proposed that the term marasmus should he applied
to children who were less than 60% of the body weight for age, based on
the 50th percentile of the Boston standards (Helson, 1959)5 and had no 
oedema. The term kwashiorkor on the other hand, should be applied to
t
those children who had oedema and were between 60% and 80% of the expected 
weight for age, whereas the term ’marasmic-kwashiorkor* should be applied, 
to those who were less than 60% of the expected weight for age but had 
oedema (Lancet, editorial, Aug. 8, 1970)•
Apart from P.E.M., there is a sizeable population of low birth
weight babies in more privileged societies who may also be at risk. This 
group may be divided into (a) the prematurely born; (b) those born near 
term but small due to slow intra-uterine growth (Gruenwald, 1963; 1966), 
and (c) babies with congenital structural defects, or with inborn metabolic 
errors which operate in utero. It has been shown that full-term babies 
with birth weights below 2.5 kg and especially those whose weight is less 
than 2 kg can be intellectually affected permanently (Weiner, Rider, Oppel, 
Fisher and Harper, 1965; Singer, Westphal and Niswander, 1968). Scarr 
(1969) studying the effect of birth weight on the later intelligence of 
twins, reported a low intellectual quotient (I.Q.) in lighter co-twins.
From studies in the rat, Chow, Sherwin, Hsuch, Blackwell and Blackwell 
(1967) have suggested that the protein content of the maternal diet may 
be an important factor in the aetiology of low birth weight.
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I Effect of P.E.M. on somatic growth
Extensive studies on the effect of malnutrition on the growth and 
development of experimental animals have been carried out in the past 
20 years or so. Lister and McCance (1965) gave a low protein diet to 
pregnant guinea pigs, and the same diet to their male offspring for one 
month after birth. They found that the malnourished offspring remained 
smaller after rehabilitation than their well nourished controls. It 
appeared that the finite growing time of the guinea pig did not give 
sufficient time for full growth to take place. In rats, undernutrition 
during the first three weeks of life affects the subsequent rate of 
growth and adult size (McCance and Fiddowson, 1962). Further work on 
rats showed that undernutrition of similar severity, and for the same 
length of time immediately after, rather than before, weaning, has a 
smaller effect on the prospect of successful rehabilitation, and the 
effects in the latter parts of the growth period are purely temporary 
(Fiddowson and McCance, 1963)* However, more severe undernutrition in 
the rat from weaning does have an apparently permanent effect growth 
potential (Dickerson, Hughes and McAnulty, 1972).
It is clear from these studies that the effects of malnutrition on 
growth are dependent upon the severity of the undernutrition and its 
timing in relation to the physiological development of the animal at the 
time of deprivation. This conclusion is further supported by the results 
of experiments in the pig. This animal: is horn in a much more mature 
physiological state than the rat and the ultimate size after rehabilitation 
of a previously undernourished animal is only affected by veiy severe 
undernutrition from birth (McCance, 1968).
lb
The timing of the nutritional deprivation affects the subsequent 
growth on rehabilitation of different organs and tissues to a different 
extent, and generally speaking, this is due to relationships of the 
period of deprivation to that of cell multiplication (Winick and Noble,
1966). When the deprivation occurs at a period when growth consists 
mainly of an increase in cell size, the effects will be reversible on 
restoration of normal nutrition. Growth and development varies from 
one species to another, and within each of the species depends on the 
timing of the insult and its severity.
Although it is believed largely on the basis of animal studies that
severe malnutrition in early human life may cause a permanent deficit in
body growth, there are several reports of long-term observations on the 
later growth of malnourished infants and children that are not in agreement 
with this hypothesis. .
Prader, Tanner and von Harnack (1963) in a study of five children 
deficient in size from a variety of causes, implied that there was an 
unlimited potential for "catch-up” growth. Their subjects, however, were
not as•severely deficient as those reported on by other workers.
Garrow and Pike (1967) reported that a series of malnourished children 
had equalled or surpassed the growth of "healthy" and other siblings from 
a similar population. Again, from their study one could conclude that 
their patients were only.a little more stunted than their siblings, or 
the average of the population from which they came.
Cabak and Naj dan vie ^ (1965) reported complete recovery in the height 
of a number of malnourished infants, when compared with others from the
15.
same population. These children were severely underweight at the time of 
the original studies, but the original height of these children was not
looked at. It is quite possible that their loss of weight had been recent
and that they may have had only minor defects in height.
Graham (l966; 1967)3 however, in a longitudinal study on the
subsequent growth of a group of 53 severely malnourished children, found 
that the earlier in life the deficit occurs., the more severe and permanent 
the stunting in height and head circumference. Furthermore, the older \ 
the infant when deprived, the longer the. period of undernourishment he 
can tolerate without permanent stunting. Subsequently, Graham (1968) 
in a long term observation: of malnourished infants suggested that severe 
energy deprivation during most of the first year of life is likely to 
cause permanent stigmata in height and head size, whereas severe protein 
deficiency, unless accompanied by prolonged and severe energy restriction, 
is much less likely to induce permanent defects.
II Effect of P.E.M. on the brain
Malnutrition appears to be invariably associated with disorders of 
the central nervous system (CNS) (Platt, 1961), and these effects are 
accentuated when malnutrition occurs at an early age. A considerable 
number of studies have been focussed on the effect of undernutrition on 
the brain, and this is not surprising since there might be a permanent 
effect on behavioural and intellectual performance.. .
The development and growth of the human brain resembles that of 
experimental animals , in many respects, and studies in experimental animals, 
principally the rat and pig, have yielded important information about the 
effects of malnutrition in the brain which probably has some relevance
16
to the effect of malnutrition on the growth and development of the human 
brain. One of the results of such studies is the recognition that there 
is a time during development when the brain is particularly vulnerable to 
changes in its environment and that this period coincides with its 
growth-spurt". This is the period when the brain is growing at its 
fastest rate, and varies in its timing with respect to birth in different 
species ' ' ' , (Dobbing, 1968).
a) The effect of P.E.M. on mental and behavioural performance
Stoch and Smythe (1963) reported that children who were underfed 
as infants had low intelligence quotients (I.Q.) as well as lower than 
normal weights, heights and head circumferences. Subsequently, they have 
published even longer follow-up data on the same children which show that 
at about 11 years of age, such deficits still persist (Stoch and Smythe,
1968). Cabak and Najdanvic (1965) also reported a substantially lower 
I.Q. in children of 7“1^  years of age that had been undernourished at an- 
early age. Cretvioto and Robles (1965) in a more detailed study showed 
that recovery from kwashiorkor, in children under 6 months of age, did not 
improve their mental age. Cravioto, de Licardie and Birch (1966) and 
Birch and Gussow (1970) have also reported retarded mental development in 
malnourished children as compared to more adequately nourished controls. 
Hertzig, Birch, Richardson and Tizard (1972) in more sophisticated studies 
have reported that previously undernourished children have grown up with a 
permanently lower I.Q. when compared both with better nourished siblings 
and with their school mates. In this study, the diminshed achievement of 
the previously malnourished children appeared to be asociated with 
malnutrition before the age of two years. This study provided evidence.
17
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therefore3 that the vulnerable period, as far as intelligence was concerned, 
was longer than the first 6 months reported earlier by Cravioto and Robles
(1965).
It is now reasonably certain that infantile undernutrition can be 
correlated with diminished adult stature, brain size and intellectual 
capacity. However, many other socio-economic, genetic and other factors 
are also associated (Fig. .1.1'), (Cravioto, Birch, de Licardie and Rosales,
1967)• To this effect there is some evidence that small stature is related 
to lower intelligence in young adults (Schreider, 1956; Scott, Illsley and 
Thomson, 1956) and that small birth weight is associated with small 
ultimate stature and with lower intelligence (Babson et al, I96H).. . These 
changes may be independent of race,‘maternal care and socio-economic class 
(Wiener et al, 1965).
Evidence concerning the effect of undernutrition on learning ability 
in experimental animals is fragmentary and inconclusive. Cowley and 
Griesel (1962) utilized the technique of foster-nursing young rats whose 
mothers were fed a low-protein diet; no significant effect on errors in a 
modified Hebb-Williams test, using escape from water as a reinforcement, 
was found in the foster-nursing progeny of rats fed the LP diet during 
gestation. In another study Cowley and Gri^.sel (1966) fed female rats 
a low-protein diet from weaning. At 75 days they were mated with normal 
males, and the mothers‘plus the progeny were retained on the low-protein 
diet until weaned at 35 days of age. The litters were divided into two 
groups. One group was fed a normal diet while the other continued on the 
low-protein diet. Physical and behavioural development studies were 
conducted upon these two groups and additional experimental groups were 
formed by mating the low-protein females and then either feeding the progeny
the normal diet and continuing this normal diet through an additional 
generation or continuing the low-protein diet through two generations.
They found significant differences in Hebb-Williams test scores of 
’’intelligence" between the control groups and either the first 
generation receiving the low-protein diet, or the second generation 
receiving the low-protein diet.
Raja£jCbkshmi 5 Gouindarajan and Ramakrishnan (1965) found 
significantly poorer visual discrimination learning ability in rats, 
aged 1 month, 6 months and 12 months, given a 9"U^ protein diet for 
k to 6 months. Later, they found no differences in visual discrimination 
or reversal learning in mature rats which had been subjected to under­
nutrition only during the suckling period. Barnes, Cunnold, Zimmerman, 
Simmons, MacLeod and Krook (1966), applying a more severe deprivation by 
nursing rats in large litters and weaning them to a diet containing 3*5$ 
protein, showed that male rats which had been undernourished for the first 
11 weeks of life and rehabilitated until 19 weeks of age made significantly 
more errors and took longer on a visual discrimination test than well-fed 
controls in a Y-water maze. They also made more errors than male rats 
undernourished either during suckling or from 3~11 weeks of age. No 
difference was found in the performance of female animals under the same 
conditions.
Similar results have been obtained by a number of workers on animals 
by measuring their behaviour and learning abilities (Caldwell and Churchill, 
1967; Baird, Widdowson and Cowley, 1971; Simmonson, Stephan, Hanson and 
.Chow, 1971)* These findings seem to indicate that undernutrition during 
early life may have an effect on learning capacity in mature animals 
which is. greater and more permanent than the effect of deprivation later 
in life. Furthermore, a low protein diet is apparently more detrimental
' ■ v ■■' 20 .
than a low energy diet (Baird et al,* 1971).
*>) Effects tbf P.E.M. on structural components of the brain
The morphological development of the brain can be studied by 
estimation of its structural components using chemical markers. Thus 
determinations of D M  gives a measure of cell number. Other markers 
used are myelin lipids, such as cholesterol or cerebrosides which give 
a measure of the degree of myelination. Gangliosides gives some indication 
of dendritic development and perhaps acetylcholinesterase for numbers of 
synapses. The ratio of protein:DNA gives a measure of cell size.
(i) Effect of P.E.M. on cell number (DNA)
Undernutrition during the first 3 weeks of postnatal life in 
the rat results in brains that contain a smaller amount of DNA 
(Winick and Noble, 1966). This is interpreted as an indication of 
a smaller cell number. Nutritional deprivation during gestation 
(Zamenhof, van Martheis and Margolis, 1968; Zeman and Stanbrough,
1969) or during gestation and lactation (Chow and Lee, I96U;
Dickerson and Jarvis, 19705 Dickerson and MacAnulty, 1972) also results 
in a permanently small amount of DNA in the brain. Undernutrition 
after 21 days of age does not lead to a smaller cell number in the 
whole brain as compared to that of well nourished controls of the 
same age (Winick and Noble, 19&6; Dickerson and Wafmsley, 19-68).■■ 
However, Dickerson et al,(l972) found that when increase in body 
weight w-as prevented by dietary restriction for four weeks following 
weaning, a permanent retardation of DNA deposition in the cerebellum 
occurred.
In the pig, severe undernutrition from 2 weeks of age up to one 
year resulted in a depression of cell replication, as measured by the
absolute amount of DNA, which was not fully corrected by 
rehabilitation (Dickerson, Dobbing and McCance, 1967). Winick 
and Rosso (1969) and Winick, Rosso and Waterlow (1970) found 
that the brains of children severely malnourished in the first 
year of life contained a smaller than normal amount of DNA.
These findings show that undernutrition at an early age in 
experimental animals and in humans results in a permanently lower 
DNA content of the brain.
(ii) Effect of P.E.M. on myelination
One of the important characteristics of the development of 
the nervous system is the development of the myelin shealth.
This process can be studied quantitatively by estimating lipid 
known to be present in. this membrancifcS? complex. The changes in 
myelin during brain maturation and development have been studied 
most extensively using .cholesterol as an index although only about 
70$ of brain cholesterol is in myelin (Cuzner, Davison and Gregson, 
1965). Studies of the effect of malnutrition on brain myelination 
have also included determination of other lipids, such as cerebrosides 
that are known to be present in the myelin shealth.
Culley and Mertz (1965) reported that the deposition of non­
lipid solids, cholesterol, phospholipids and cerebrosides into the 
brain was reduced by restriction of food intake of rats between 5 
and 20 d of age. Dobbing (1968) reported a significant permanent 
deficit of brain cholesterol concentration in animals undernourished 
from birth to 3 weeks and from birth to 11 weeks, despite the fact 
that these rats were rehabilitated to 28 weeks of age. Nutritional 
deprivation during the first 21 d o f 1 life in the rat also 
produces a decrease in total lipids and phospholipids (Benton, Moser,
Dodge and Carr, 1966). Undernutrition after weaning resulted, on
... 2 2
the contrary, in brains.that were smaller for age , but contained 
normal concentrations of cholesterol; on rehabilitation the brains 
returned to normal for age (Dobbing and Widdowson, 19&5; Dickerson 
and Walmsley, 1967). However, Dickerson et al (1972) reported 
that when increase in body weight was prevented by dietary 
restriction for four weeks subsequent to weaning, there was a 
permanent retardation of cholesterol deposition in the forebrain and 
brainstem.
In pigs, severe undernutrition from 2 weeks of age resulted 
in a lower cholesterol concentration in the brain, which was not 
fully corrected on rehabilitation (Dickerson et al, 1967)* In 
children, myelin lipids is lower in the brain of children under­
nourished from 2 to 22 months than in better nourished children of 
similar age (Fishman, Prensky and Dodge, 1969). However, it may not 
be low for the weight of the brain (Dickerson, 1973).
(iii) Effect of P.E.M. on dendritic development (ganglioside and 
microsocony).
Gangliosides, a class of sphingoglycolipids localised primarily 
in neurons, have been extensively studied in a number of neurological 
disorders. The present knowledge about the precise function of 
gangliosides in the brain is far from clear. However, a number of 
workers have considered them to be involved at the molecular level in 
learning behaviour.
Dickerson and Jarvis (1970) studied the brain of the weanling 
offspring of rats undernourished, from the 5th day of gestation and 
during lactation, and reported that the ganglioside concentration was
23
lew in the ‘brainstem, forebrain and cerebellum of the undernourished 
animals, the greatest differen.ee being in the brainstem and the 
smallest in the cerebellum.
Further studies (Dickerson, Merat, Stewart and Waterlow, in 
preparation)have shown that gangliosides are preferentially reduced in 
certain parts of the brain of severely malnourished rats, pigs and 
humans. Since gangliosides are primarily neuronal constituents 
(Wiegandt, 1967)5 a decrease in these constituents could be 
interpreted as an indication of delayed dentritic development.
Dickerson and Jarvis (1970) also reported that the specific 
activity of acetylcholinesterase was reduced in the brainstem of 
malnourished animals. In a histological study, Bass, Uetsky and 
Young (1972) have shown that malnutrition in the rat. reduces the 
dendritic development in the somato sensory area of the cortex.
Cragg (1972) by means of electron microscopy also showed that the 
number of synapses per neuron on average was reduced by 38 to k0% 
in the rat undernourished for the first three and seven weeks of life.
Ill Effect of P.E.M. on the metabolism of the brain
i) Energy
There is little information available pertaining to the effect 
of P.E.M. on the energy reserve of the brain. Thurston and Prensky 
(1971) reported that rats undernourished for the first nine days of 
postnatal life exhibited no decrease in the energy reserve, i.e., 
in the brain content of P-creatine, ATP, glucose and glycogen of the 
brain, although there was a reduction in the concentration of glutamic 
acid. It is possible that the nutritional insult applied on these
2k
animals was not severe enough-, as judged by the normal amount of 
DNA, RNA and protein found in the brains of the malnourished rats.
Agrawal, Fishman and Prensky (1971) reported that there might
be a block in the intermediary metabolism of glucose in the brains
. . Ikof undernourished rats that reduces the availability of 2-C carbon .
of glucose to the precursor pool used for protein and lipid
' synthesis.
ii) Protein
Nutritional alterations have a profound effect on the incorporation 
of labelled amino acids into protein in cell-free systems of liver 
and skeletal muscle (Von Der Decken, 1967; 1968 a,b; 1969 a,b; Von Der 
Decken and Omstedt, 1970). Agrawal, et al (1971)5 however, showed 
that \rtttS uncie-mouhishsd during the first 21 d of postnatal life did
. . , 1^  N .not change the.incorporation of (U-C )L-leucine into brain protein. 
Enwonwu and Glover (1973) obtained similar results in some studies on 
the protein of the brains of the 21 d old offspring from rats fed a 
5$ protein diet from the ll* d of gestation and throughout lactation 
period. .
Ogata, Kido, Furusawa and Satake (1968) reported that giving adult 
rats a protein-free diet for 7 days did not change the rate of
. plj.
incorporation of C -leucine into the total protein of brain slices 
of grey matter, and in a cell free S^-fraction, which consisted of
brain cortex microsomes and cell sap. Von der Decken (1970) also found
. . . . 1 1 *  . . .no difference m  the rate of incorporation of C -leucine 111 vitro,
in adult rats fed a protein free diet for four days. However, after six 
days on the protein free diet there was a significant decrease in the
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amount of C -leucine incorporated into the brain. These results 
are not comparable, since different incubation systems and different 
brain parts were used by the different workers. It seems possible 
that a more severe degree of malnutrition may have some effect on 
the synthesis of protein in the brain and further work is necessary 
to elucidate this aspect.
iii) Effect of P.E.M. on brain amines
There are three important amines — NE, serotonin and dopamine 
— that occur in the brain. It is now widely believed that these 
amines have a neurotransmitter function. Furthermore,NE and serotonin 
occur particularly in those parts of the brain concerned with emotion 
and higher control, learning, motivation and behaviour (Smythies,
1965).
Sereni, Prinicipi, Perletti and Serani (1966) reported a transient
decrease in serotonin and NE concentrations in the brains of rats 
Undernourished by increasing the litter size;. Shoemaker and Wurtman 
(197I) also found a lower content of NE in the brain of the 2k d old 
progeny from rats fed an Q% protein diet from the lU d of gestation 
and during the lactation period. The enzyme tyrosine hydroxylase in the 
brain of these undernourished rats, on the other hand, was increased.
Lee and Dubos (1972) reported a decrease in the concentration of NE 
and also in the activity of tyrosine hydroxylase in the brain of a 
progeny from rats which were fed a 20% gluten diet from the lUth day 
of gestation and during the lactation period. The rats were killed 
at 30 d of age having been transferred to a normal diet at 21 d of age. 
These studies were done on the whole brain and it is possible that
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different kinds of dietary restriction may have different effects 
on the brain' and that different parts of the brain may be affected 
to a different extent.
Wurtman and Fernstrom (1972) reported a decrease in tryptophan 
and serotonin concentrations in the whole brain of rats given a 
corn diet or a 6% casein diet for 5 weeks. They did not study the 
mechanism leading to these changes, the effects of rehabilitation, 
or regional variations in the concentration of these parameters 
among different parts of the brain.
iv) P.E.M. and brain free amino acids
In the C.N.S. the free amino acids are not only precursors of 
protein, but some of them appear to have either an actual or a potential . 
pharmacological activity. Th6S£ may be either precursors of amines 
believed to have pharmacological activity in the brain, or else may 
themselves have a direct action on the excitability of neurons. The 
effect of nutrition on the pattern of free amino acids in the 
developing brain has been studied under various nutritional conditions 
and in animals of different ages. Rajalakshmi, Ali and Ramakrishnan 
(1967) found no change in the concentrations of glutamic acid, 
aspartic acid, glutamine, GABA and alanine when they restricted the 
feeding time of rats for the first 21 d of life. Mourek, Agrawal,
Davis and Himwich (1970) reported a transient decrease in the amino 
acid concentrations in the cortex, subcortical parts and medulla 
oblongata of young rats starved for 10-12 hours a day from the 5tb 
to the 10th d of postnatal life. Enwonwu and Glover (1973) reported
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that the ratio of amino acids thought to have an excitatory function 
(glutamic acid, aspartic acid, asparagine and glutamine) to those thought 
to have an inhibitory function (GABA, taurine and glycine) was reduced 
by 30l in the cerebrum of the progeny of mother rats given a 7% protein 
diet from the lVth day of gestation and through a 21 d lactation period.
Lehr and Geyet (1966) found a decrease in the concentration of 
aspartic acid and an increase in that of glutamic acid in the cerebral 
cortex of adult rats fed a protein-free diet for 102 d. The concentration 
of GABA in the cortex of these animals remained unchanged. In this 
experiment, no appropriate age controls were employed. Mendle and 
Marks (1965)5 on the other hand, reported that the concentration of 
glutamic acid, aspartic acid and GABA in the brain (forebrain and 
cerebellum) was not affected by feeding a protein free diet for 3 to 
6 weeks. The same authors found an increase in the concentration of 
histidine, methionine and serine, and a decrease in phenylalanine 
concentration in the brains of adult rats fed a protein-free diet for 
the same period of time.
Rajalakshmi et_ al (1965) found a lower concentration of glutamic 
'acid, aspartic acid, GABA and alanine and decreased activities of 
several enzymes related to the metabolism of these amino acids in 
the cerebrum of rat aged 1 month, 6 months and 12 months, fed a 9% 
protein diet for ^-6 months.
Gordon (1967) pointed out that it is necessary to freeze the 
brain in liquid nitrogen immediately after decapitation to avoid 
post-mortem changes in the concentration of GABA in the brain. Most 
of the investigations on the effect of dietary restriction on brain 
free amino acids, with the.exception of that of Mendle and Marks (1965)
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did not, however, follow this procedure. This may probably account 
for the discrepancies reported by various workers, although differences 
in the methodology and in the diets given are also important factors. 
Furthermore, most of these studies were performed on the whole brain 
or a specific area of the brain, with very little attention being paid 
to different parts of the brain..
Baxter (1968) pointed out that the relationship between brain 
and plasma amino acids is determined by uptake, extrusion and exchange 
of amino acids between the plasma and brain. Roberts and Morelos 
(1965) showed that giving rats a diet deficient in particular amino 
acids (phenylalanine or tyrosine) led to an increase in the rate of 
movement of leucine between blood and brain.Although there was no 
net increase of free amino acids in the brain, there was an increase 
of flux of amino acid into the slowly metabolizable type of protein, 
thus indicating that deficiency of certain amino acids can increase 
the rate of flux without necessarily increasing the net movement in 
any one direction. Moreover, excess or deficiency of any one amino 
acid may influence the metabolism of other amino acids by competitive 
inhibition of transport or other mechanisms of interference such as the 
inhibition of enzymes. In view of the close relationship between 
plasma and brain free amino acid, it seems necessary to study the free 
amino acids in the plasma and brain simultaneously in the same animal.
Elevation of the ratio of non-essential to essential amino acids 
occurs in the plasma of malnourished children, rats, pigs and dogs 
(Whitehead, 1-965; Widdowson and Whitehead, T966;Heard, Kriegsman and 
Platt, 1968; Grimble and Whitehead, 1969) and it is not known whether 
these changes have any effect on the concentration of these amino acids 
in the brain.
B. THE FREE AMINO ACIDS OF THE BRAIN
•
One of the most familiar biochemical facts about the nervous system 
is the outstanding dependence upon the oxidation of glucose for energy 
(Sinclair3 1961). However, at any one time the brain contains relatively 
little carbohydrate. Amino acids on the other hand, in free or bound form 
or as proteins constitute over k0% of its dry weight. Furthermore, the 
brain contains a relatively high concentration of free amino acids. In 
the rat, the concentration is second only to that in the kidney(Freidberg 
and Greenberg, 19 7^)• Although the physiological significance of the high 
amino acid concentration in the brain is not clearly understood. Studies 
with isotopically labelled amino acid have shown that amino acids are 
rapidly incorporated into brain protein (Gaitonde and Richter, 1955;1956) 
thus indicating that protein is continuously synthesised and broken down 
in the brain. .
I Regional concentrations, distribution and developmental pattern of 
free amino acid in the brain
Brain amino acids and other brain-constituents are derived from the 
bloodstream. Amino acids, in general, exist in rat brain at a concentration 
six times higher than in the blood of the same animals. In human brain, 
the average value for free amino acids is about eight times that in blood 
and in both human (Robinson and Williams, 1965) and rat (Shaw and Heine, 
1965) brain, the concentrations of individual amino acids differs in 
different regions of the brain. The mammalian brain contains all the 
amino acids common to the tissues of the body with the exception of GABA and 
N-acetylaspartic acid with which the brain is greatly enriched.
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A remarkable constancy of distribution of free amino acids has been 
found in the whole brain at a particular stage of development in a given 
species and under normal conditions. These amino acids can be 
conveniently divided into three groups. A large number of amino acids 
are present in relatively low concentrations; these amino acids may be 
concerned primarily with tissue protein synthesis and breakdown which is 
constantly taking place during development. A second group consists 
of several related amino acids, namely, glutamic acid, glutamine, aspartic 
acid and GABA, which are present in relatively large concentrations and 
play an important role in intermediary metabolism, participate in protein 
synthesis and possibly act as neurotransmitters. The third group consists 
of generally unrelated amino acids and their derivatives which tend to 
decrease during the maturation process.
The blood may be regarded as a pool of amino acids outside the brain 
cells where individual amino acids are continuously being added and removed 
as a result of the metabolic activity of the brain. The movement of amino 
acids involves a number of complicated and interrelated processes which 
will be briefly discussed here.
II Movement of amino acids between the brain and its environment
i) Blood Brain-Barrier
It has been shown that In the intact adult mammalian brain the net 
entry of free amino acids from the blood into the brain is limited when 
compared with the entry into other tissues such as the liver, kidney and 
muscle (Friedberg and Greenberg, 19^ 7; Kamin and Handler, 1951; Purpura, 
Girado, Smith and Gomez, 1958; Lajtha and Toth, 1963; Dingman and Sporn, 
1959)* The administration of a given amino acid at doses sufficient to 
maintain a high concentration in the blood, results only in a slow rise 
in the concentration of the amino acid in the brain, reaching a peak value
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much later than that in the blood (Kuttner, Sims and Gordon, 1961;
Guroff and Udenfriend, 1962; Chirigos, Greengard and Udenfriend, i960)..
This suggestsa sluggish response of the brain to environmental levels 
in vivo. In the liver and kidney, on the other hand, the amino acid 
concentration rises rapidly above that in the blood (Kuttner et al, 1961).
The slow net uptake of amino acids into the intact brain in situ is 
in marked contrast to the uptake of amino acids by brain slices. Here, 
in most cases, a peak concentration is rapidly attained which is
■ i n ­
considerably higher than that of the surrounding medium. This phenomenon
indicates the existence of some sort of barrier to the net uptake of amino
acids by the intact brain, and this is usually referred to as the blood-
brain barrier.
In some cases interpretation of results in terms of a blood-brain 
barrier may be subject to considerable doubt. This is best exemplified 
by the uptake of lysine. In vivo, this amino acid enters the brain less 
readily than it enters the kidney (Friedberg and Greenberg, 19^ 7; Kanin 
and Handler, 1951; Lajtha and Furst, 1957j Lajtha, 1959) however, both the 
brain and kidney take up lysine to a lesser, but similar extent in vitro, 
when compared with the uptake of other amino acids. As a relative restriction 
of the uptake of lysine by brain is apparent both in vivo and in vitro, 
it would appear that factors in brain other than a blood-barrier are involved.
The whole question of the blood-brain barrier in relation to the 
transport mechanisms in the brain for amino acids is a very complex one. • 
There appear to be various transport mechanisms in the brain for free 
amino acids which can be saturated by overloading or by competition from 
other members of the group of compounds which share a common system.
Such an arrangement clearly confers a degree of selectivity in the rate 
and extent of acceptance of different amino acids, and if this is what
is meant by a ’barrier’ to.amino acids, then such a barrier exists.
However, it seems preferable to think of amino acid transport as a
• .
reflection of metabolic activity (including specific transport mechanisms) 
in the brains glial and other cells, rather, than to apply the general 
.term ’barrier’ to such a wide range of different phenomena (Dobbing, 1968).
Evidence has also been obtained indicating that in young and newborn 
animals entry of amino acids into the brain often seems to be less restricted 
than in the adult. After intravenous or intraperitoneal injection of 
amino acids into the young animal the brain concentration rises to somewhat 
higher levels than in the adult, although it is still well below the 
concentration in the blood (Kuttner et al, 1961; Lajtha, 1958; Lajtha and 
Toth, 1961).
However, it must be pointed out that low net uptake from blood is not 
in itself sufficient evidence of a blood-brain barrier; comparison must 
first be made with the uptake by other tissues, or by brain in vitro.
Further, there is no evidence that there exists a barrier to a two-way 
movement of amino acids between blood and brain, which is in fact rapid 
(Roberts, Flexner and Flexner, 1959; Lajtha, Berl, and Waelsch, 1959;
Lajtha and Toth , 1962).
Structurally, the blood-brain barrier is a mechanism which may involve 
astrocytes surrounding the blood vessels (Davison, 1965) thus causing amino 
acids to leave the brain almost as quickly as they enter. It may protect 
the brain against entry of harmful metabolites in the blood, i.e. , 
pharmacologically active amino acids, which might otherwise enter the brain 
in excessive amounts.
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The difference between developing and adult animals in the uptake of 
amino acids into the brain is also found with other constituents, such as 
cholesterol which enters the brain from the blood stream in the young animal 
but does not do so in the adult. On this and.other similar evidence,
Dobbing (1968) has interpreted the blood-brain barrier concept in terms of 
differing metabolic activity. .
ii) Net uptake of free amino acids by the brain
A large number of studies on the net movement of amino acids into 
brain tissues have been carried out on isolated brain slices rather than 
on the intact brain in situ. There are two main criticisms of the use 
of brain slices. Firstly, the behaviour of the tissue is often grossly 
altered in vitro, and secondly, that the medium in which they are 
suspended is not physiological. They do, however, give ’a simple means of 
studying transport processes in the brain and much useful information has 
been obtained from, their use'. With slices it is easy to maintain a 
relatively constant level of metabolite in the environment of the cells, 
or to produce a particular intracellular concentration (Neame and Smith,
1965; Smith, 1967). In intact animals, on the other hand, these
. \
conditions are much more difficult to establish.
Blasberg and Lajtha (1965) have shown in vitro, that brain tissue is 
able to "take up and concentrate a large number of amino acids by active 
transport. Other workers have shown that the uptake requires energy and 
is diminished in the absence of oxygen (Stern, Eggleston, Hems and Krebs,
19 9^; Neame, 1961; Abadom and Dcholefield, 1962) or glucose (Stern et al,
19 9^; Abadorn and Scholefield, 1962; Tsukada, Nagata, Hirano and Matsutani, 1963 
Neame, 196*1) , or in the presence of metabolic inhibitors (Guroff, King and 
Udenfriend, 1962; Tsukada et_ al, 1963; Neame, 196*1). Uptake often involves 
movement against a concentration gradient, and is subject to saturation
phenomena. In the latter, the rate of uptake reaches a limit with 
increase in the concentration of amino acid available owing to the 
saturation of carrier sites (Neame, 1961; Tsukada et al, 1963; Smith,
1967). In the case of neutral amino acids, the smaller molecules 
are concentrated in the tissue to a greater extent than the larger 
ones (Neame, 1962; Schanberg, 1963; Tsukada et al, 1963; Yoshida, Kanike 
and Namba, 1963; Blasberg and Lajtha, 1965)• Acidic amino acids are 
concentrated well in the tissue (Korey and Mitchel, 1951; Takagaki,
Hirano and Nagata, 1959; Tsukada et al, 1963; Blasberg and Lajtha, 1966), 
but large basic amino acids are concentrated relatively poorly (Neame, 1961; 
1962; Blasberg and Lajtha, 1965).
iii) Transport systems in the brain
There appear to be several transport systems or carriers for amino 
acids in the brain and each system preferentially transports a different 
type of amino acid (Blasberg and Lajtha, 1965; Neame, 1968). This 
conclusion has been derived from experiments involving competition between 
specific amino acids for a common carrier. If an amino acid shares the same 
transport system as a second amino acid, the uptake of each amino acid 
will be reduced by the presence of the second due to partial displacement 
from the carrier. This phenomenon is known as competitive inhibition, and 
can be influenced by altering the concentration of either amino acid. 
Non-competitive inhibition, on the other hand, does not necessarily involve 
a specific carrier.
Conclusions about the different transport systems in the brain appear 
to have been reached with only limited evidence that mutual inhibition 
between different types of amino acids is actually competitive. In brain, 
inhibition has, in most cases, been found to be competitive (Smith, 1963; 
Neame, 196**). .Fig. 1.2 shows an outline of the various transport systems
-lh one urmn. uver-Lappmg or groups indicated by regular indentations.
definite relationship between an amino acid and a given group is 
indicated by a patterned line.
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Note: Table of abbreviations of some amino acids 
presented in Fig.1.2.
Alanine 
3-Alanine 
Aminoadipate 
y-AminobUtyrate . 
a-Amino-n-butyrat e 
E-Aminocaproate 
a-Amino i s obuty r at e 
Arginine 
Asparagine 
Aspartate 
Cycloleucine 
(l-aminocyclo- 
pentane 
carboxylate) 
Cystine
ayy-Di ami nobutyr at e 
a93“Diaminoprop- 
rionate 
39^ -Dihydroxy- 
"phenylalanine 
Glutamate
Ala 
3~ Ala 
Aad 
GABA 
Abu 
-Acap 
AIB 
Arg 
Asn 
Asp
ACP.C
Cys
Dbu
Dpr
DOPA
Glu
Glutamine Gin
Glycine Gly
Histidine His
Hydroxyproline Hyp
5-Hydroxytryptophan _HTP 
Isoleucine lie
Leucine Leu
Lysine Lys
Methionine Met
Norleucine Nle
Norvaline Nva
Ornithine Orn
Phenylalanine Phe
Proline Pro
Tryptophan Trp, Try
Tyrosine Tyr
Valine . V
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which are believed to exist in the brain (Neames 1968).
With neutral amino acids as inhibitors, inhibition of uptake of 
both large and small neutral amino acids is greater the longer the carbon 
chain of the inhibitor (Blasberg and Lajtha, 1965). This suggets that 
the lipid solubility of the apolar side-chain plays a part in inhibition and 
hence in the transport of these amino acids. The effect on large basic 
amino acids is similar to that on neutral amino acids but the effect on 
acidic and W-amino acids is in the opposite direction, thus indicating 
both-similarities and differences in the nature of the transport of these 
various groups of amino acids. There is also evidence that neutralcK -amino 
acids are transported by two types of carrier, one primarily for the smaller 
amino acids and the other primarily for the larger ones (Blasberg and 
Lajtha, 1965; Neame,. 1966). Furthermore, the transport‘systems for neutral • 
amino acids arest'ereqpreferential in favour of the L-isomer (Neame, I96U, 
1966, 1968).
When basic amino acids are used as inhibitors (Neame, 196*1; Blasberg 
and Lajtha, 1965) there is more obvious discontinuity of pattern of effect 
between the large and the small molecules than is observed with neutral amino 
a.cidsindicating more prominently in the existence of two separate transport 
systems; one for large and one for small amino acids. Uptake of large amino 
acids - (.arginine, lysine) is inhibited by large basic amino acids (arginine, 
lysine, orninthine) but not by small basic amino acid (a, y-diaminobiityric 
acid, a-8“diaminopropionate) (Blasberg and Lajtha, 1965). In fact the latter 
amino acids cause an apparent stimulation, probably due to their own rapid 
uptake and resultant interference with the outward transport process (Levi, 
Blasberg and Lajtha, 1966). The transport of small neutral a and o)_amino 
acids (Blasberg and Lajtha, 1965) and histidine (Neame, 196*0 are inhibited
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"by small, but not by large basic amino acids, with marked effect in most 
cases by a, y-xLiaminobutyric acid, suggesting that the transport system 
involved here is preferential for the latter. The large basic amino acids, 
on the other hand, only inhibit uptake of each other (Blasberg and Lajtha,
1965). Such a difference in effect between large and small amino acids 
suggests the existence of two transport systems for basic amino acids.
Transport in brain for basic amino acids appears,as in the case of neutral 
amino acids, to be preferential for L-isomer (Blasberg and Lajtha, 1965)-'
When acidic amino acids are used as the added amino acid, the inhibitory 
effect is unrelated either, to chain length or to steroisomerism (Neame,
196^; Blasberg and Lajtha, 1965). This phenomenon has been regarded as . 
evidence in favour of a separate transport system for acidic amino acid 
(Neame, 196 )^. It could be that it is simply a reflection of the relationship 
between a negatively changed side-chain and the transport system for neutral 
amino acids. However, it is more likely, that in the brain acidic amino acids 
are transported primarily by a separate non-stereopreferential carrier 
system which is not influenced by the length of the carbon chain (Neame,
196*0.
iy) Influx and Efflux
In addition to the rapid uptake of amino acids into the brain, outward 
transport also occurs. If diversion to metabolism is ignored, the net 
uptake may be considered simply as composed of two components, influx and effli 
Either of these may be produced by diffusion (a passive process), active 
transport (requiring energy and often involving the movement of the substrate 
amino acid against a cone. gradient) or processes, such as facilitated 
diffusion (Christensen, 1962), which are intermediate. •
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Diffusion may also occur at the same time as active transport 
(Smith, 1963). In addition there may he a connection between the influx 
and efflux systems involving counter-transport (Wilbrandt and Rosenberg,
196l) or exchange diffusion (Heinz and Walsh, 1958; Johnstone and 
Scholefield, 1965) in which the movement of substrate in one direction 
causes movement at the same time in the opposite direction (Christensen,
3.962).
Metabolism and pharmacology of certain amino acids
Several amino acids appear to have potential or actual pharmacological 
activity. These include the precursors of amines thought to possess 
pharmacological activity in brain, and the amino'acids which themselves 
have a role in neuronal excitability. The first group includes 5 Hydroxy- 
tryptophan (5KTP), a precursor of serotonin; 3,ii-dihydroxyphenylalanine 
(DOPA), a precursor of dopamine and NE; and histidine, a precursor of 
histamine. The enzyme associated with the production of these amines have 
been found in most cases in certain localised areas of the brainstem and 
diencephalon. The second group includes diearb'OJfcylic acids, glutamic 
acid and aspartic acid, and the w-amino acids, 6“alanine and GABA. The 
distribution of these amino acids and of any enzymes involved in their 
metabolism is not localised in the same way. Their action on neuronal 
excitability may, at least in some cases, be considered to be merely side- 
effects without physiological function. Moreover, these amino acids are 
involved in certain metabolic processes which appear to be confined to the 
brain.
The metabolism and function of these amino acids and their relationship 
with other amino acids will be described.
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i) 5~Hydroxytryptophan (5HTP)
Metabolism (Fig. 1*3)
Tryptophan, an essential amino acid, is the precursor of 5HTP and 
serotonin. 5HTP is known to be pharmacologically active in peripheral 
tissues (Keele and Neil, 1965) and may probably have a neurotransmitter 
function in the brain. 5HTP can be converted to serotonin in the brain 
by the enzyme 5HT decarboxylase. An increase in the concentration of 
actively transported precursors of tryptophan (Guroff and Udenfriend,
1962; Smith, 1963; Schanberg, 1967)9 or of 5HTP (Udenfriend, Bogdanski 
and Weissbach, 1956; Green and Sawyer, 196 ;^ Eccleston, Ashcroft and 
Crawford, 1965) in blood results in an increase of 5HT in the brain.
Gal and Marshall (196U'). also found that tryptophan injected intracerebrally 
increased the concentration of serotonin in the brain. Entry of serotonin 
itself into the brain occurs only to a very small extent. The immediate 
precursor of 5HT, 5HTP, can be formed in the brain either by the hydroxylation 
of tryptophan (Gal, Poczik and Marshall, 1963; Gal, Armstrong and Ginsberg,
1966) or by transamination (Albers, Koval and Takoby, 1962; Fonnum, Haavaldsen 
and Tangen, 196 )^. It has recently been suggested that tryptophan assimilation 
and hydroxylation control the cerebral synthesis of serotonin (Grahame-Smith 
and Parfitt, 1970; Macow, Sokoloff and Glowinski, 1971)* The close 
relationship between 5HTP and serotonin is suggested by the presence of 
5HTP decarboxylase in some of the regions of the brain where the amine is 
also found (Gaddnm and Giarman, 1956; Bogdansi, Weissbach and Undenfriend,
1957; Mcllwain, 1966). The enzyme ’ 5.HTP decarboxylase is mainly found in 
phylogenetically older parts of the brain (Amin, Crawford and Gaddum, 195^; 
Bogdanski, et al, 1957; Bertler, 1961) and nerve endings (Whittaker, 196k).
The activity of the enzyme is also related to the concentration of the amine 
(Heller, Seiden, Porcher and Moore, 1966). Furthermore, Green and Sawyer 
(196 )^ and Palaic, Page and Khairallar (1967) reported that there may be two .
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metabolic pools for the synthesis of serotonin by decarboxylation. One of 
these pools is involved in endogenous 5HTP synthesis, and the other 
primarily with 5HTP derived from external sources.
b) Pharmacology
Evidence for suggesting that serotonin is a neurotransmitter came 
at first from studies on invertebrate systems.(Gerschenfeld and Stefani,
1968). In mammalian brain, the suggestion is' based on the relationship 
between the behavioural response of animals and the concentration of 
serotonin in the brain after the administration of 5HTP (Udenfriend, 
et al, 1956; Costa and Rinaldi, 1958; Aprison, Wolf, Poulos and Folkerth, 
1962). The behavioural response seems to depend on the dose of 5HTP, for 
a small dose causes depression and sedation, whilst larger doses produce less 
sedation or even excitation and other behavioural changes (Bogdanski et al, 
1958; Costa, Himwich, Godstein, Canham and Himwich, 1959; Aprison and 
Ferster, 1961).
The sedative response of animals to low doses of 5HTP is believed to 
be due to the production of serotonin, whereas'the excitation produced by 
larger doses could be the result of the release of catecholamines for it 
is similar to the response that follows the administration of large doses 
of serotonin (Brodie, Comer, Costa and Dlabac, 1966). Inhibition of the 
enzyme 5HTP decarboxylase by a-methyl DOPA results in a lowering of the 
concentration of serotonin in the brain but not in that of WE, and the animal 
shows a reduction of co-ordinate motor activity (Smith, i960).
The application of serotonin in physiological amounts to regions close 
to the hypothalamus raises the body temperature in some animals (Feldberg 
and %ers, 196 ;^ Feldberg, Hellron and Lotti, 1967; Giarman, Tanaka, Mooney
. h2
and Atkins, 1968). The changes in body temperature are brought about by
a number of factors, including vasodilation, vaso-constriction, alteration in
muscle tone and shivering. This is in accordance with the findings of
Toh (i960) who reported that extremes of heat and cold lowered the serotonin
content of the brain of rats.
ii) 3-V-Dihydroxyphenylalanine (DOPA)
)Metabolism (Fig.l.V)
DOPA can be formed in the brain by hydroxylation of tyrosine (Iyer,
McGeer and McGeer, 1963; Wagatsu, Levitt and Udenfriend, 19.610, an amino 
acid.which is able to enter the brain from the blood (Guroff and Udenfriend,
1962) and is also formed in the brain by transamination (Alber et al, 1962;
Fonnum et al, 196 )^. In the brain, DOPA can be converted to dopamine 
and WE (Dietreich, 1953; Udenfriend and Creveling, 1959; Gey and Pletscher, 
I96U). "Anton and Sayre (196 )^ showed that DOPA can pass from the blood 
to the brain but since its concentration in the blood is normally low it 
is likely that the DOPA in the brain is mainly derived from the hydroxylation 
of tyrosine in situ.
On the other hand, WE does not readily enter the brain. It has been 
shown, however, to penetrate to an appreciable extent in the region of the 
pituitary gland and hypothalamus (Weil-Malherbe, Whitby and Axelrod, 1961).
In vitno studies have shown that WE can be taken up by the cortex against 
a concentration gradient (Dengler, Spiegel and Titus, 1961; Dengler, Michaelson 
Spiegel and Titus, 1962), and it is therefore probable that the poor entry 
of WE in vivo is partly to be attributed to a ’blood-brain barrier' 
mechanism.
The enzymes associated with the production of WE are found mainly in . 
the brainstem and hypothalamus (Vogt 195*f; Kuntzman, Shore, Bogdanski and 
Brodie, 1961; Glowinski, Snyder and Axelrod, 1966) and are at much higher
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concentrations in the latter than in the former, (Kindwall and Weiner,
1966). NE is also associated wjLth nerve-endings (Bertler, Hillarp
and Rosengren, I96O; Glowinski et al, 1966). The localization of NE, and its 
intermediate metabolite, dopamine, and the enzymes involved in its synthesis 
•is somewhat different. Goldstein, Anagnoste, Owen and Battista (I967) 
reported that dopamine and the enzymes involved in its production are 
found mostly in areas of the brain which contain little NE, and it has 
been suggested that the two catecholamines, although related chemically, 
may have independent functions (Bertler and Rosengren, .1959)•
b) Pharmacology
Carlsson, Lindquist and Magnusson (1957) demonstrated that dopamine 
may play a role in the coordination of motor activity. The administration 
of DOPA to animals results-' in an increase of spontaneous movement 
(Bertler and Rosengren, 1959; Carlsson et al, 1957) and also reverses the 
sedative effect induced by reserpine (Blaschko and Chrusciel, I960;
Carlsson et_ al, 1957)* The latter is also accompanied by an increase in 
the concentration of dopamine in the catldate nucleus and in the hypothalamus 
(Bertler and Rosengren, 1959)* In the brain of patients suffering from 
Parkinson’s' disease, those parts that are normally rich in catecholamines 
have an unusually low dopamine content. The administration of L-DOPA 
ameliorates the condition, and also inhibits the activity of amine 
oxidase (Hornykiewicz, 196*1; Sourkes, 196^a).
NE, like serotonin, produces changes in body temperature (Feldberg 
and Myers, 196*0 5 and arousal (Kirshner, 1966) in the cat.
iii) Histidine •
Histidine is the precursor of histamine (White, 1959s I960) a 
compound which has been reported as having some specific function in 
the brain (Crosslan, I960; Green, 196*1-). The uptake of histidine by 
the brain in vitro can proceed to a considerable extent (Neame, 1961,
1962, 196*+), whereas its net entry in vivo is poor (Kamin and Handler,
1951-)* Histidine can enter the brain from the blood, particularly 
in the hypothalamic region, where it is decarboxylated to form histamine 
(White, 1959; Adam, Hye and Waton, 196*0. On the contrary, histamine 
itself does not enter the hypothalamic region or other parts of the 
brain from the blood in vivo (Adam et al, 196*1; Schayer and Reilley, 1970) 
nor is it taken up against a concentration gradient by brain in vitro 
(Neame, 196*0. However, it can enter the anterior lobe of the hypophysis 
from the blood (Adam et al, 196*0*
The function of histamine in the brain is not clear. The fact that 
it may have some specific function in the brain is suggested by the 
localization of both histamine and the enzymes involved in its synthesis 
in certain regions of the brain. It is normally found in the brain mainly 
in the hypophysial and hypothalamic regions (Adam, 1961). This localization 
is common to other amines which are associated with nerve endings (Synder, 
Gloninski and Axelrod, 1966).
iv) Glutamic acid, aspartic acid, glutamine and y-aminobutyric acid 
(GABA) ‘
a) Metabolism (Fig.l.5)
The-metabolic relationships in the brain between glutamic acid, 
aspartic acid, glutamine and GABA, and their relationships with alanine, 
the tricarboxylic acid cycle and glucose are shown in Fig. 1.5. The
concentration of glutamic acid is relatively high in brain (Waelsch, 1957)
fee
and the rate at which it can/oxidized is also reported to be relatively 
high (Schepartz, 1961). Glutamic acid appears to occupy a central 
position in view of the many reactions in which it can be involved. The 
close relationship between glutamic acid.and the tricarboxylic acid 
cycle by way of a -oxoglutarate is shown in Fig.1.5.
Reaction 1. The synthesis of glutamic acid can be carried out by 
reversible transamination of a-oxoglutarate with alanine, together with 
pyruvate (Cohen and Hekhuis, 19^ 1; Haslam and Krebs, 1963).
Reaction 2. The synthesis of glutamic acid can be carried out by 
reversible transamination of a-oxoglutarate with aspartic acid, together 
with oxaloacetate (Cohen and Hekhuis, 19^ -1; Bessman, 1952; Haslam and
Krebs, 1963).
Reaction 3. Glutamic acid can be synthesised by a reversible reaction 
between a-oxoglutarate and the ammonium ion by the enzyme glutamic acid • 
dehydrogenase (Weil-Malherbe, 1936; Tsukada, 1966).
Reaction U. Glutamic acid can be transaminated directly with 
a-oxoglutarate, each metabolite being converted into the other (Balazs and 
Haslam, 1965)•
Reaction 5. Glutamic acid can be transaminated directly with a-oxoglutarate 
and GABA, the latter being converted to succinic semialdehyde by GABA 
transferase (Bessman, Rossen and Layne, 1953; Baxter and Roberts, 1961; 
Roberts, 1963). Theoretically, this reaction is reversible as with other 
transaminations. The irreversibility of the formation of GABA from glutamic 
acid (as in reaction 8 below) would, in the normal cell, tend-to revert 
the reaction to a one-way one.
■ -Vf ■
Reaction 6. Glutamic acid can be combined with ammonium ion by the 
enzyme glutamine synthetase to fora; glutamine (Lajtha, Mela and 
Waelsch, 1953;.Bu' Ruisseau, Greenstein, Winitz and Birnbaum, 1957)»
This reaction is found to be a one-way reaction towards the formation 
of glutamine in brain (Strecker, 1957) and it is ATP dependent (Krebs,
1935; Elliott, 19 8^; Sellinger,, Cantanzaro, Chain and Pocchiari, 1962; 
Tsukada, 1966). The reaction is important for the removal of ammonia, 
a product which is released by the metabolic activity of the brain 
(Richter and Dawson, 19^ -8).
Reaction 7. The conversion of glutamine to glutamic acid is catalysed 
by glutaminase. This reaction is the opposite to Reaction 6, but is 
carried out by a different enzyme.
Reaction 8. GABA can be formed from glutamic acid with the release of 
COr> *y ^he enzyme glutamate decarboxylase (Awapar, Landua, Fuerst and 
Seale, 1950; Roberts and Frankel, 1950; Berl et al, 1961; Sellinger et al,
1962). Following its formation from glutamic acid, GABA transaminates 
with a-oxoglutarate to form succinic semialdehyde together with glutamic 
acid. The succinic semialdehyde is then converted to succinate, which 
provides a pathway for the entry of GABA into the tricarboxylic acid cycle 
(Roberts, Rothstein and Baxter, 1958)* In theory, GABA could be formed 
not only from glutamic acid but also from succinic semialdehyde, but this 
does not seem to be the case (Roberts, 1962). These reactions can provide 
an alternative route for the part of the tricarboxylic acid cycle between 
or oxoglutarate and succinate. Elliott (1965) and Haslam and Krebs (1963) 
reported that approximately 10 to k0% of the croxoglutarate of the cycle 
may be diverted through such a pathway. Moreover, McKhann and Tower (1961) 
found that the proportion involved was inversely related to the amount of 
a-oxoglutarate present. It has also been shown that the shunt involving
kQ
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GABA, as well as the presence of significant amounts of GABA, are unique 
to brain (Waelsch, 1957; Roberts and Eidelberg,1960; Roberts, 1962).
The close relationship between glutamic acid and a-oxoglutarate suggests 
that glutamic acid is closely related to the tricarboxylic acid cycle, 
and therefore also with pyruvate and glucose (Fig.1.5). Experiments have 
shown that glucose, pyruvate and carbondioxide can contribute to the 
formation of dicarboxylic acids and other amino acids in the brain by way 
of the cycle (Beloff-Chain, Cat-anzaro. Chain, Masi and Pocchiari, 1955;
Busch, 1955; Gaitonde, Dahl and Elliott, 1965; O'Neal, Koeppe and Williams,
1966). Cremer (196 )^ and Tsukada (1966) reported that after the peripheral 
administration of isotopically-labelled glucose 80$ of the radioactivity 
was found in the free amino acids in the brain. ~ Glutamic acid is always 
the most heavily labelled, aspartic acid and glutamine are labelled to 
about half the extent of glutamic acid,and GABA either to an intermediate 
degree, or to an extent comparable with either of the other three amino 
acids.
The close relationship between glucose and amino acids in the brain 
contributes to a large extent to the oxidation processes. Glutamic acid 
and aspartic acid are readily oxidised to carbondioxide; glutamic acid 
has also been shown to increase oxygen uptake (Salvador and Albers, 1959)* 
Chain, Cohen and Pocchiari (1962) also reported that glutamic acid and 
aspartic acid can be oxidised in preference to glucose, and are able 
to produce about 35$ of the brain respiratory carbon dioxide. Moreover, 
Richter (1965) suggested that brain, which has little reserve of glycogen, 
is especially adapted to the use of amino acids and protein for energy 
purposes.
50
b) Compartmentation of metabolism
It is evident that certain metabolic processes in the brain are 
contained in different compartments and that each compartment may have 
different characteristics for the entry and metabolism of various 
compounds (Waelsch, 1961; Weil-Maherbe. 1962; Lajtha, I96U). To this 
effect there appear to be two main metabolic compartments for the 
processes in Fig.1.6 (Waelsch, 1961; Garfinkel, 1966).
. One compartment seems to contain a larger proportion of the 
glutamic acid present in the brain and is shown as the ’large pool’ in Fig. 
1.6. The other contains a smaller proportion of the glutamic acid present, 
is referred to as the ’small pool'. Evidence for the existence of the 
two separate pools has been demonstrated by the appearance of different 
amounts of glutamic acid and related amino acids in the brain of 
experimental animals according to the kind of metabolite administered. 
Several reports have shown that in spite of the large amount of glutamic 
acid normally found in the. brain, more glutamine than glutamic acid 
appears in brain .after the injection of glutamic acid, glutamine, acetate, 
ammonium ion, bicarbonate ion or butyrate (La.jtha et al, 1959$ Waelsch,
1961; Berl, Lajtha and Waelsch, 1961; Berl, Takagaki, Clarke and Waelsch, 
1962; O’Neal and Koeppe, 1966). This suggests that there is a compartment 
in which rapid glutamic acid metabolism can occur without involving 
the main pool i.e. the ’large pool’ of glutamic acid.
On the contrary, glutamic acid is labelled more heavily than glutamine
. . . il* ll* lU
after administration of C -glucose, C-glycerol or C -lactate (O’Neal
and Koeppe, 1966; O’Neal, Koeppe and Williams, 1966) and more glutamic
acid is formed from glucose than is derived from glutamic acid in the
blood (Roberts et al, 1959)* Moreover, the metabolism of these compounds
51 :
occurs mainly in the major reservoir of glutamic acid in the brain. 
Furthermore, the results also’ indicate that the small pool is relatively 
impermeable to glucose, glycerol and lactate, whilst the large pool 
is relatively impermeable to acetate, the ammonium ion, bicarbonate, 
butyrate, glutamic acid and glutamine. Both pools, however, contain 
enzymes involved in the TCA cycle.
It must be pointed out that there is no definite evidence as to 
the true physical size of the two pools. The representation in Fig.1.6 
must therefore be considered as diagrammatic. The concept of difference 
in size of the two pools is based on the apparent size of the glutamic 
acid reservoir in each pool. It is possible that the apparent size in each 
case may be altered more by metabolic reaction rates than by actual 
dimensions. •
There seems to be a regional difference in the development of 
compartmentation and it does not seem to be well developed in very young 
animals (Berl and Purpura, 1966).
) Pharmacology
Many workers have shown that aspartic acid and glutamic acid stimulate 
electrical activity in various types of neurons, while 3“alanine and GABA 
have a depressant action (Curtis, Phillis and Walkins, 1959j Curtis and 
Watkins, I960, 1965). In intact brain, it has been found that leakage 
of GABA and glutamic acid from the cortex on to the cortical surface of the 
brain is related to the arousal state. More GABA appears to leak out when 
the EEG shows a ’sleep’ pattern than when it shows an ’arousal’ pattern, 
a relationship which is the reverse of that found with glutamic acid 
(Jasper, Khan and Elliott, 1965)* GABA is released on local super fusion 
of monkey brain (DeFeudis, Delgado and Roth, 1970) into fluids in contact
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with the neocortex (Mitchell and Scrimvasan, 1969) cats. A decreased 
concentration of GABA induces seizures in the brain in the presence of 
certain drugs (Killam, 1957; Killam and Bain, 1957)9 whereas an increased 
concentration can be correlated with reduced electrical activity 
(Purpura et al, 1958; Eidelberg, Baxter, Roberts, Saldias and French, 1959)* 
This effect has been shown to vary from one region of the brain to another 
(Baxter, Roberts and Eidelberg, i960).
The release of glutamic acid from striatal tissues is increased on 
stimulation (Katz, Chase and Kopin, 1969), and this occurs also in 
synaptosomal preparations from the cerebral cortex (Bradford, 1970).
Graham and Aprison (1969)showed a differential localization of glutamic 
acid in the spinal cord and interpreted their results as supporting the 
notion that glutamic acid may act'as an excitatory neurotransmitter. 
Moreover, localised liberation of small quantities of glutamic acid in 
the hypothalamus of adult unaesthetized rats evoked quite complex 
behavioural responses which were similar to those produced by electrical' 
stimulation of the same sites (Brody, Cho, Stefano and Gessa, 1969).
Evidence in favour of a transmitter function for these amino acids 
derived from their localisation and that of the associated enzymes is not 
very strong. The enzymes associated with GABA metabolism and GABA 
itself are found mainly in the grey matter (Roberts, Harman and Frankel, 
1951; Hirsch and Robins, 1962), whereas the enzymes associated with 
glutamic acid, glutamic acid decarboxylase,<Zr®-mainly associated with 
nuclei of the extra-pyramidal system (Lowe, Robins and Eyerman, 1958;
Miiller and Langemann, 1962) and with nerve-ending particles (BalUzs,
Dhal and Harwood, 1966). GABA-glutamic acid aminotransferase is also found 
in mitochondria (BAlazs et al, 1966).
\  : ■ ■ 5^
IV. Incorporation of amino acids into proteins
It used to be thought that brain proteins are in an inert metabolic
state with little renewal of amino acids (Greenberg and Winnick, 19 8^;
Levington and Meister, 195^ 0* More recently it has been found that the
constituent amino acids of brain protein are continually being replaced
(Gaitonde and Richter, 1953; Lajtha, 196 ;^ Lajtha and Marks, 1965).
Several amino acids are incorporated into the protein of the brain, in vivo.
In adult animals, the incorporation of leucine, phenylalanine, methionine,
glutamic acid and lysine has been shown to occur. Thus, after administering
labelled amino acids intracerebrally or intravenously and extracting other
materials, the protein residue has been shown to contain labelled in
peptide linkages. Relations between the specific activity of the free
cerebral amino acids, and those of the protein sampled at the same time,
can be expressed with some reservations, as turnover rates in terms of the
35half-life of the isotope. Gaitonde and Richter (1955) reported when S
methionine is injected intraperitoneally the protein of the brain.is
labelled less than the protein of other tissues thus indicating a slow entry
of the amino acid into the brain from the blood due to the blood-brain
barrier. Gaitonde and Richter (1956) on the other hand, reported that 
35when S-methionine is injected intracerebrally (a route which by-passes the 
blood-brain barrier), the labelling of brain protein is of a similar order 
to that of other tissues, thus suggesting that the rate of metabolic reactions 
involved in the incorporation of amino acids into protein in the brain may 
be of a similar order to that in other tissues. The rate of turnover <?f 
leucine and lysine in brain protein has, in fact, been shown to be of a 
similar order to that in skeletal muscle, but slower than that in liver 
(Lajtha and Furst, 1957; Lajtha, Furst and Waelsch, 1957; Lajtha, 1959)*
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Furst et al (1958) showed that the biological half-life of leucine,
•lysine and methionine in whole brain protein ranges between 5 and lUo 
minutes. In view of the lack of homogeneity of protein in different 
metabolic compartments, whether regional or intracellular, and also the 
variation of experimental period, the interpretation of results for the 
apparent half-life in various tissues is very difficult. In brain protein 
the turnover of lysine is most rapid in the corpus callosum (half-life 
k to 9 days), followed by the thalamus, hypothalamus and cortex (half- 
life 5 to- 17- days). The slowest turnover was found in the spinal cord 
(half-life 10-19 days). The half-life of certain brain microsomal proteins 
within the cell is very rapid (50 - 100 mins.) and, moverover, different 
proteins derived from the microsomes have different half-lives (Clouet 
and Richter, 1959)•
Considering the existence of separate pools or compartments, for the 
metabolism of a given amino acid, it is likely that the results of experiments 
involving incorporation of amino acids are distorted by the existence of 
such pools, particularly as the rate of synthesis and degradation of 
protein is probably related to the concentration of amino acids in a 
particular pool. Such a relationship has been shown in liver (Hanking 
and Roberts, 1965). There is a possibility that turnover rates might be 
distorted by the reincorporation of labelled amino acids from the free 
amino acid pool of the brain.
Protein synthesis in the brain may follow a similar process to that 
in other tissues and it is likely that the immediate precursors of protein 
synthesis are amino acids rather than peptides (Lajtha, 196U). Briefly, 
amino acids would first of all be activated by an amino acid-specific 
activating enzyme, using energy derived from ATP. The resulting compound
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known as amino acid adenylate, would remain attached to the enzyme.
Amino acid adenylate would then catalyse the union of amino acid and 
an amino acid specific transfer-RNA, with the release of adenosine 
monophosphate (AMP) and the enzyme. The amino acid-transfer RNA complex 
would become attached to a ribosomer-messenger RNA complex, the latter 
being involved directly with the formation of the protein or polypeptide 
molecule but the sequential application of the appropriate amino acid- 
transfer RNA complexes with attachment of the amino acid to the. newly 
synthesised end of a growing protein molecule. Subsequent complexes 
would be brought into appropriate position, and then, when completed, 
the protein or polypeptide molecule would be released from the ribosomes 
(Lajtha, 196U; Crick, 1966).
The rate of protein breakdown in brain in vivo has been studied
. • . . lUby following overall rates of disappearance of protein-bound C after
’ il| . .
• labelling by the inclusion of C-lysme m  the diet. The average half-
life of the cerebral protein was close to lU days, and is comparable to 
the time calculated from studies of rates of amino acid incorporation 
into proteins in the brain. The calculations of rates of protein 
breakdown indicate that approximately 90% of the total protein of the tissue 
had a turnover time of between 10 and 20 days (Lajtha and Toth, 1966).
The process of protein breakdown is not clear. Proteolytic enzymes 
are quite active in cerebral preparations. Work has been initiated to 
classify and locate proteinase in the brain (Lajtha and Marks, 19&5; Marks 
and Lajtha, 1965). Briefly, the protein molecule would be split into 
various peptides some of which might be reincorporated into brain protein 
as such, but most of the peptides would be broken down.into individual 
amino acids.
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Conclusions and plan of present studies
From the review of the literature, it was concluded that although 
there have been a number of investigations of the development of 
the pattern of free amino acids and serotonin in the brain, few studies 
have included an investigation of the pattern in different parts of the 
brain. In one particular study in which different parts of the brain 
were studied, that of Murick at al (1969)5 there is some doubt about 
the results since the brain were not frozen in.liquid nitrogen immediately 
after death. This procedure has been shown to be essential if post-mortem 
changes in some of the amino acids are to be avoided.
Previous studies of the effect of protein energy malnutrition on the 
free amino acid pattern and that of the amines, have been mostly concerned 
with the effect of acute deprivation in adult animals, arid here again 
little work has been done on different parts of the brain. Furthermore, 
the design of some of the experiments is open to criticism because of 
differences, other than those of specific nutrients, in the diets given 
to the experimental and control animals. It is also well known that 
animals given diets deficient in protein become anorexic, and few studies 
have included pair-fed controls.
No previous study has been found in which an attempt has been made to 
elucidate the mechanisms whereby changes in the free amino acid patterns 
in the brain are brought about in malnourished animals.
In the light of these conclusions it was decided to study the 
developmental pattern of free amino acids and serotonin in three easily 
dissectable parts of the brain of the rats. The study was extended to 
include the effects of dietary restriction at different periods of life 
and the effects of subsequent rehabilitation. These studies also include
investigations of the uptake of labelled amino acids and their 
incorporation into protein. Since the endocrine status of an animal is 
known to he affected by protein-energy malnutrition, the effects on brain 
amino acids after giving corticosterone and insulin have also been 
investigated.
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Chapter II 
Materials and Methods
A. ANIMALS AND DIETS
1. Animals
Wistar albino rats which had originated from a Medical Research 
Council strain were used throughout. These rats have been r a n d o m l y  
inbred for about 25 generations in the University Animal House under 
normal lighting and heating conditions. Both sexes were used up to 
21 days of age when the rats were weaned, and after 21 days, only 
males were used. These rats were all free from specific pathogens.
The mother rats were littered on hard wood chippings and the young 
reared to weaning (3 weeks) on the same bedding in polyethylene cages 
with zinc plated tops before being transferred on to ’Steralite* 
bedding in similar cages (U.P. Usher Ltd.). More details of animals 
and caging systems have been mentioned elsewhere in the thesis.
2. Experimental diets
Stock diet (Spillers, 21% protein) in pellet form was given to the 
control weanling rats unless otherwise stated. The 7$ protein diet was 
made from the same stock diet in powder form by diluting it with potato 
starch. Vitamins, minerals and fat were added to the low protein diet 
in order to replenish them to approximately the same level as those in 
the original stock diet. The composition of stock diet and the 7$ 
protein diets are shown in Tables 2.1 and 2.2 respectively. The 
composition of the 25$ casein (purified) diet and the 3% casein diet 
are shown in Tables 2.3 and 2.b respectively. The composition of the
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Table 2.1. Composition of the stock (Spillers) diet
Moisture 8.5$
Oil 5*1$ in the pellet diet (2.0$ in the
powder diet)
Protein 21$
Fibre ’ 2.7$
Ash 5.1$
Calcium 0.9$
Phosphorus 0.8$
Vitamin A 11.0 I.U./g.
Vitamin 2.k I.U./g.
Choline 520 mg/g.
Tocopherol 2k mg/g.
Thiamine 1+ mg/g.
Riboflavin ' 7 mg/g.
Nicotinic acid 80 mg/g.
Vitamin 0.015 mg/g.
Folic acid 0.16 mg/g.
Iron II4O p.p.m.
Starch accounted for the rest of the percentage of the ingredients.
Table 2.2 • Composition of the 7$ protein diet
Spillers powder (21$ protein) 33.3$
Starch (from potato) 59*3$
Vitamin mixture 3.3$
Mineral mixture 2.6$ ‘
Corn oil 1.3$
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Table 2.3 Composition of the 25% Caseine diet
%
Casein (with 0.2% methionine) 25
Starch (from potato) 56
Vitamin mixture . • 5
Mineral mixture ^
Corn oil 10
Table 2.h Composition of the 3% Caseine diet
■ . % '
Casein-, (with 0.2% methionine) 3 *
Starch (from potato) J8
Vitamin mixture 5
Mineral mixture . k
Com oil 10
Table 2.5 Composition of the mineral mixture
Gm ;
Sodium chloride 50
Calcium phosphate ^00
Iron citrate 35
Potassium iodide - r - 1
Magnesium sulphate 80
Acid sodium phosphate 105
Potassium chloride 250
Sodium fluoride 0.0^
Manganese sulphate 0.20
Table 2.6 Composition of the vitamin mixture
content/kg
Vitamin A 1,000,000 I.U' s
Vitamin D 100,000 I.U's
Vitamin E 10.0 gms
Vitamin 1. 0 gm
Nicotinic acid 4.0 gms
Calcium pantothenate 3.0 gms
Folic acid 0.1 gm
Vitamin C 40.0 gms
Inositol 10.0 gms
Vitamin Bg 1.0 gm
Vitamin 1.0 gm
Biotin 0.02gm
Vitamin B^ 2.0 mgs
Choline chloride 100.0 gms
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mineral mixture (Nutritional Laboratories, Cambridge) and the vitamin 
mixture used in formulating the low protein and casein diets are shown 
in Tables 2.5 and 2.6. Further details of the experimental diets are 
described at appropriate places in the text.
B. ANALYTICAL PROCEDURES
1. Chemicals
The chemicals used in the various analytical procedures were as 
follows
a) Standards: L-Glutamic acid, L-glutamine, Y-aminobutyric acid 
"(GABA),"L-aspartic acid, L-alanine, L-tryptophan, L-tyrosine,
isoleucine, norleucine, .D-glucose(analar), cholesterol and 
-calf thymus DNA were all obtained from British Drug Houses 
(BDH)j a standard solution of amino acids for the amino acid 
autoanalyser were obtained from Technicon and CalBiochem.
A standard solution of GABA was prepared and run separately;
5 Hydroxytryptamine(serotonin),,5~Hydroxyindolacetic acid 
(5HIAA),L-norepinephrine(NE) and cortisone were all obtained 
from Sigma; bovine serum albumin was obtained from Koch-Light.
The human insulin standard (KU076), anti-insulin serum 
(^273) and guinea pig normal serum (GPNS) (CT/02) were from 
Wellcome Ltd. ...
li* 3
The C and H toluene standards were obtained from Packard.
b) Enzymes: Glucose oxidase (Activity approx. 139000-l8,000 EU/g)
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c) Buffers: 0.5 M sodium carbonate buffer pH 9»9“10
O.U M Potassium phosphate buffer pH 6.^ .
0.5 M Phosphate buffer pH T.O.
d) Solvents: All solvents were of analar grade and were obtained
from BDH.
e) Radioactive chemicals: U -C ^-D-glucose (285 mCi/mmol);
l-ri-^ -L-methionine(^ 6mCi/mmol); H^-L-Histidine (58yCi/mmol);
G-H^-L-Tryptophan (2.8 Ci/mmol); T^^-insulin (50p.Ci/yg). 
These radioactive chemicals were all obtained from the 
Radiochemical Centre at Amersham.
f) Liquid Scintillators: The composition of the liquid
scintillator for the radioisotope studies was made up as 
follows:-
2:5-'diphenyloxazole (PPO), 1 g l, -^Bis-2'-(U-methyl-5_phenyl- 
oxazolyl)-bensene (P0P0P). 500 ml methanol, 100 ml ethylene
glycol and 0^0 g cab-o-sel, and made up to 5 litres with 
dioxan.
Toluene Scintillator: U.O g POP and 0.1 g P0P0P in a litre 
of toluene.
Toluene scintillator with 0.5$ Nuclear Chicago solubilizer:
1*.0 g POP, 0.1 g P0P0P and 5 nil of Nuclear Chicago solubilizer 
and made up to 1 litre with toluene.
2. Analytical Methods
a) Removal and dissection of the brain
All animals were killed by decapitation at approximately the same 
time of the day i.e. lU.OO + 1 hr. Possible interfering effects of 
diurnal variations in plasma amino acid levels (Fernstrom, Larin and 
Wurtman, 1971)9 serotonin level in the brain (Quay, 19659 1968) and 
uptake of U-C^-D-glucose into the brains (Defeudis and Black, 1972)
were eliminated or minimised by killing the animals at this short time 
span. The head was quickly placed into liquid nitrogen. The brain was 
removed from the frozen skull, and dissected into forebrain, cerebellum 
and brainstem (Dickerson and McAnulty, 1972). In some one-day old. rats 
the whole brain was used. The brain samples were weighed and analysed 
immediately or stored' at -1+5° • Blood samples were collected from the 
decapitated body into heparinised tubes. The samples were centrifuged 
at 2000 r.p.m. for 20 min. and the separated plasma stored at -1+5°.
b) Quantitative determination of free amino acids by paper chromatography
A known weight of brain tissue was homogenised with 10 volumes of 
cold 80$ alcohol. The homogenate was centrifuged at 1000 r.p.m. in 
a refrigerated centrifuge. The extraction was repeated twice, and the 
supernatants pooled and evaporated to dryness at U0° on a water bath.
The residue was dissolved in a known volume of water (l ml per 0.5 g-Gf 
brain tissue)and centrifuged. The clear supernatant was used for 
determination of amino acids. . ■ . •
Amino acids were separated by two dimensional chromatography on 
Whatman No. 1 paper b-6 x 57 cm. Samples equivalent to 20-1+0 mg of 
original tissue were applied to the paper in duplicate. The papers 
were run for 20-22 hours in butanol-acetic acid and water (100:2^:20) 
as the first phase and phenol-water (80:20) as the second.
Amino acids were located by dipping the paper in 0.25$ ninhydrin 
in acetone, drying and heating for three minutes in an oven at 100°.. 
After five minutes the chromatograms were sprayed with copper nitrite 
solution (l ml saturated copper nitrite solution and 0.1+ ml 10$ HNO^ 
in 100 ml of absolute alcohol)and dried under a stream of cold air.
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The spots were cut out and extracted with 1| ml of absolute methanol 
for 1 hr. The absorption of this solution was measured at 509 nm in 
a spectrophotometer (Unicam SP600) against a methanol blank. Standard 
solutions of the corresponding amino acids were spotted, located and 
extracted in the same way as the tissue extract. Recovery of 10-20 yg 
of individual amino acids from test mixtures was 95-103$ of the expected 
value.
c)Determination of free amino acids by amino acid autoanalyser (Thomas, 1970)
Weighed samples of brain tissue were transferred whilst still cold 
to a chilled all-glass Potter-Elvehjen homogeniser containing ice-cold 
perchloric acid (PCA). The brain was extracted twice with ten volumes 
of cold PCA. The precipitate was removed by centrifugation and the 
supernatants combined. A volume of extract equivalent to 100 mg tissue 
was passed through a column- of zeocarb 225 (0.2 x 10 cm) resin in the 
chloride form in order to absorb the amino acids. The column was washed 
with distilled water until the PCA was completely removed and the amino 
acids were then eluted with 2 N ammonia solution. The eluate was 
evaporated to dryness over a water bath-at 37° C under a stream of cold . 
air. The residue was dissolved in a known volume of 0.05 N HC1 containing 
0.5 ymo3§/ml. of norleucine as internal standard. The amino acid content 
was measured on an autoanalyser.
Plasma free amino acids were separated by deproteinising 0.5 ml 
of plasma with 0.2 ml of 16$ sulphosalicylic acid. Norleucine (0.1 ml 
of a solution containing 1 ymole/ml in 0.025 N HCl) was added as 
internal standard. The precipitated protein was removed by centrifugation 
at 2,000 r.p.m. and the supernatant was used directly for amino acid 
determination as described above. A standard amino acid chromatogram
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is shown in Fig.2.1. The reproducibility of tryptophan estimation 
in brain and plasma extracts by spectrophotometry (Thomas, 1970) was 
found to be unreliable. A sensitive spectrofluorimetric method was, 
therefore,used instead.
d) Determination of free amino acids by amino acid autoanalyser
at University College, North Wales.
Weighed samples of brain tissues were homogenised with 5 volumes 
of cold k% sulphosalicylic acids containing 0.05 lJmole-per ml norleucine 
as internal standard. The homogenate was centrifuged at 2,000 r.p.m. 
for 30 min. at U°. The clear supernatant was used for the amino acid 
analysis.
Plasma samples were deproteinised with 16% sulphosalicylic acid 
containing 0.15 mole per ml of norleucine as internal standard. Three 
volumes of plasma were added to one volume of sulphosalicylic acid 
solution. The tubes were centrifuged at 2,000 r.p.m. for 20 min. and the 
supernatant was analysed on an amino acid analyser similar in design 
to that described by Thomas (1970) a "but differing in the method of handling 
the output. The transmittance values were recorded on a dotting 
recorder and also through a retransmitting slide wire, and digital 
voltmeter, on paper tape. ■ The latter was used as input to the computer 
to produce the printed output of peak areas . A typical amino acids 
chromatogram- is shown in Fig.2.2.
e) Determination of tyrosine in the brain
The method is essentially a modification of that described by 
Waalkes and Udenfriend (1956).
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Reagents: l-Nitroso-2-naphthol: 0.1% l-nitroso-2-naphthol (BDH)
dissolved in 95% alcohol.
Nitric acid reagent2h.5 ml of 1:5 nitric acid mixed with 0.5 ml 
of 2.5$ NaN02.
Ethylene dichloride (analar) was obtained from BDH.
Procedure: Brain tissue was homogenised with 5 volumes of 6% TCA.
To 2 ml of the deproteinised brain homogenate, in a glass-stoppered 
centrifuge tube was added 1 ml of the nitrosonaphthOl reagent and 
1 ml of the nitric acid reagent. The tube was stoppered, shaken and 
placed in a water bath at 55° f°r 30 minutes. After cooling, 10 ml 
of ethylene dichloride was added, and the tubes were centrifuged, the 
supernatant aqueous layer was transferred to a'cuvette. Fluorescence 
was measured in a Baird-Atomic spectrophotofluorimeter. Activation 
and emission were set at ii60 nm and 570 nm respectively. The recovery
of tyrosine from the tissues by this procedure was 90“95%« The standard 
curve for tyrosine is shown in Fig. 2.3.
f) Determination of serotonin and NE in the brain
Brain serotonin and NE were measured by the method described by 
Michael et al (1968). Individual or pooled brain parts were 
homogenised in 10 volumes of cold acidified n-butanol (0.85 ml concentrated 
HC1 in 1 litre n-butyl alcohol) in a glass Potter Elvejhem homogeniser.
The homogenates were transferred to a centrifuge tube and centrifuged 
for 5 min. at 2,000 r.p.m. Aliquots (2.5 ml) of butanol were transferred 
to a stoppered tube containing 5 ml of n-heptane and 0.1+ ml of 0.1 N-HC1. 
After being shaken for 5 minutes on a mechanical shaker, the tubes were 
again centrifuged for 5 minutes at 2,000 r.p.m. The organic phase was 
then transferred to 10 x 75 mm test tubes for the determination of 
serotonin and NE as described below.
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Serotonin determination:
Reagents: 0-phthalafi4€f{tjCf6 (OPT) (analar) was obtained from BDH.
To test tubes containing 0.1 ml of acid phase 
were added 0.6 ml of. a freshly prepared solution of OPT (1+ mg/100 ml) 
in 10 N HC1. After mixing, the tubes were heated in a boiling water 
bath for 15 minutes, then cooled under tap water. Fluorescence was 
measured in a Baird-Atomic spectrophotofluorimeter using 1 cm micro 
quartz cuvettes. Activation and emission wavelengths were set at 
360nm. and l*70nm respectively. The standard curve is shown in Fig.2.U.
NE determination: To test tubes containing 0.1 ml of acid phase were
added 0.2 ml of 1 M sodium acetate (pH 7*0) containing 0.1 M EDTA.
The tubes were mixed and 0.1 ml of 0.1 N iodine, in absolute ethanol 
added. After mixing, the tubes were allowed to stand .for exactly two 
minutes at room temperature, and 0.2 ml of a freshly prepared alkaline 
sulfite solution (2.5 g of anhydrous Na^SO^in 1 ml of water and 9 ml 
of 5N NaOH.) was added to each tube. The tubes were mixed again, then 
after exactly 1.5 minutes, 0.2 ml of 5N acetic acid was added and 
the tubes heated in a boiling water bath for 2 minutes. After cooling 
under tap water, the fluorescence was read at 38511131 and U8513331 activation 
and emission respectively. Standard curve for the fluorescence is shown 
in Fig.2.6.
g) Determination of serotonin and 5HIAA in the brain
In some experiments serotonin and 5HIAA were determined in the . 
brain by the method of Curzon and Green (1970)* The initial procedure
was essentially that of Maickel et al (1968).
\
Reagents:0PT and L-cysteine (BDH).
Procedure: Brain tissue was homogenised in 10 volumes of cold acidified
n-butanol in a glass Pott er-Elvej hem homogeniser. The homo gen ate was
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transferred to a centrifuge tube and centrifuged for 5 minutes at 2,000 
r.p.m. An aliquot (2.5 ml) of supernatant was transferred to a 25 ml 
glass stoppered tube and shaken mechanically for 5 minutes with 5 ml 
of n-heptane and O.lj- ml 0.1 N HC1 containing 0.1% L-cysteine. The 
phases were separated by centrifugation and 5 ml of the organic phase 
used for the 5H1AA determination.
Serotonin determination: To 0.1 ml samples of the aqueous phase
was added 0.6 ml of 0.00k% OPT in 10 N HC1. After mixing and heating 
in a boiling water bath for 15 minutes the tubes were cooled under tap 
water and fluorescence, measured in nicro-cuvettes using a Baird-Atomic 
spectrophotofluorimeter. Activation and fluorescent wavelengths were 
360.nm and U70 nm (both uncorrected) respectively. Blanks were prepared 
by reacting 0.6 ml of the OPT solution with 0.1 ml N HC1 plus cysteine 
solution only. Standards were prepared in deionized water (60pg/ml), 
diluted 1:100 for use with 0.1 N HC1 containing 0.1% cysteine and 
0.1 ml reacted with 0.6 ml of the 0.00^% OPT in HC1 solution.
5H1AA determination: The 5 ml of organic phase remaining after 
the extract of serotonin was pipetted into a 25 ml glass stoppered tube 
containing 0.6 ml 0.5 M phosphate buffer (pH 7*0) and shaken mechanically 
for 10 minutes. After centrifuging for 3 minutes at 39000 r.p.m. two 
0.2 ml portions of the aqueous phase were pipetted into two test tubes,
A and B. To A was added 0.02 ml 1% cysteine solution and to B 0.02 ml 
of 0.02% sodium periodate solution. Then O.k ml concentrated HC1 was 
added to both A and B. After this 0.02 ml of OPT solution (0.1% in 
methanol) and 0.02 ml periodate solution was added to tube A. After 
30 minutes, 0.02 ml of the cysteine and OPT solution were added to tube B
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Standard curve for 5H1AA determination
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The standard curve for determination of norepinephrine
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The tubes were placed in the boiling water bath for 10 minutes,' cooled 
under tap water and the activation and fluorescence were read at 360 nm 
and i+70 nm respectively (both uneorrected). The blahk reading (Tube B)
.was substracted from the test reading (tube A). Standards were prepared 
as 15 yg per ml solution and were diluted 1:100 in the pH 7*0 to 0..5 M 
phosphate buffer for use, 0.2 ml being added to tubes A and B. The 
standard curve for 5H1AA is shown in Fig. 2.5*.
h) Determination of tryptophan (Denkla and Dewey, 1967).
Reagents: the reagents were HCl/FeCl^ : 0.3 mM FeCl^ in 0.1 mM HC1;
75$ TCA (v/v); 10% TCA (w/v); and formaldehyde: 1.8% (V/v) aqueous 
formaldehyde; tryptophan stock solution: 250 nmoles per ml of O'.IN NH^OH; 
norharman stock solution: 250 nmoles per ml 0.25$ TCA (W/v). Non incubated 
norharman (5nmoles) in 2 ml of 0.1 N NaOH was used as fluorescence standard 
to read between samples.
Procedure: Fresh brain tissue was homogenised in 7“10 volumes of 0.9$
saline. The 0.0l* ml of homogenate was pipetted into a plastic centrifuge 
tube followed by 1.8 ml of HCl/FeCl3. After mixing, 0.2 ml of 75$ TCA 
was added and the precipitated protein was separated by centrifugation . 
at 20,000 r.p.m. for 10 minutes. The supernatant was transferred into a 
stoppered tube graduated for 2 ml and 0.2 ml formaldehyde was added.
The stoppered tubes were placed in a boiling water bath for 1 hour.
The temperature was not allowed to fall below 97° •. The tubes were cooled 
to room temperature and the volume of each tube brought back to 2 ml 
with 10% TCA. The fluorescence was then measured at excitation and 
emission wavelengths of 373 and k 2^ nm respectively in 1 cm cuvettes. 
Plasma: Heparinised plasma (0.02 ml) was pipetted into a 3*0 ini
polyethylene centrifuge tube using Hamilton micro-syringes (Hamilton Co.
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Inc., Whittier, Calif.) and 1.8 ml of TCA/FeCi^ was added, mixed, and the 
mixture spun at 20,000 r.p.m. for 10 minutes. The supernatant was 
decanted completely into a 3.0 ml glass stoppered tube (calibrated for 
2.0 ml) and 0.2 ml of formaldehyde was added. The stoppered tubes were 
placed in boiling water bath for 1 hour. The tubes were cooled to room 
temperature and 10% TCA was used to replenish to the 2 ml mark the 
fluid lost during incubation. The fluorescence of the product was read 
at excitation and emission wavelengths of 373 and ^52 nm respectively, in 
a Baird-Atomic spectrophotofluorimeter. The standard curve for the 
determination of tryptophan is shown in Fig.2.7*
i) Determination of brain cholesterol (Hanel and Dam,. 1955)
Reagent: Glacial acetic acid, acetyl chloride and zinc chloride
anhydrous sticks were all of analar grade and were obtained from BDH.
Weighed brain samples were homogenised in 20 volumes of chloroform:methanol 
(2:1,V/v) and passed through filter paper. 10 volumes of chloroform: • 
methanol, with the reverse ratio (1:2,V/v) was added to the residue and 
again homogenised and filtered. The extracts were combined and chloroform 
added to restore the chloroform-methanol ratio to 2:1. A measured volume 
of sample was pipetted into 5 ml stoppered tubes and evaporated to dryness.
The residue was dissolved in 2 ml chloroform and then 1 ml of ZnCl^
and 1 ml of acetyl chloride was added, mixed and incubated at 65° for
exactly 15 minutes. The tubes were cooled and made up to 5 ml with chloroform,
mixed and read at 528 m in a Unicam SP600 Spectrophotometer. Known amounts
of cholesterol stnadards (cholesterol in chloroform) solutions were run
in the same manner as the test samples. The standard curve for the cholesterol
is shown in Fig. 2.8.
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j) Determination of total plasma 11-hydroxycorticosterone ■ .
This is essentially a modification of the method of Mattingly 
(1962). was extracted from plasma by shaking with methylene
chloride. The extract was mixed with a sulphuric acid ethanol mixture 
(7 volumes of sulphuric acid to 3 volumes of ethanol; fluorescence 
reagent) to develop the fluorescence. The fluorescent product is 
unstable and therefore the timing of the fluorescence reading was 
important.
Prbcedure: Heparinised plasma (0.5 ml) "was pipetted into a glass
stoppered tube. Distilled water (0.5 ml) and k.O ml of purified 
methylene chloride were added. The contents of the tube were mixed 
for 10 minutes on a rotary shaker. Methylene chloride extract (3-0 ml) 
was transferred to a 5 ml glass stoppered tube, and 1.5 ml of fluorescence 
reagent added and mixed by vigorous shaking for exactly 30 seconds.
The acid layer (lower) was transferred to a fluorimeter cell and the 
fluorescence was measured at Vf5 nm and 515 nm activation and emission 
respectively at exactly 25 minutes after the fluorescence reagent was 
added. A blank using 0.5 ml of distilled water and standards (corticosterone 
in ethyl alcohol) were prepared and carried through the same procedure.
The standard curve for determination of cortisol is shown in Fig.2.9*
k) Determination of plasma insulin
Plasma insulin was measured by a double antibody radioimmunoassay 
procedure which is a modification of the method described by Salmols 
and Belkus (196V). Blood samples were collected into heparinised 
’ micro-centrifuge tubes (Gelman-Hawdesly) and kept on ice. After 
centrifugation at 2,000 r.p.m. at U°C for 15 minutes, the tubes were 
stored at -^5°C until they were assayed. The portion of the tube
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which contained plasma was cut off just prior to analysis.
Reagents: Barbitone-acetate buffer for electrophoresis ionic strength
0.1 (VER),(0X0ID), pH 8.6:16.5 gm of the powder dissolved in 100 ml
distilled water. Human albumin was added to it to minimise insulin
125 . . .adsorption to glassware; I insulin was obtained from the Radiochemical
Centre, Amersham, in batches of 10 Ci/inl (50yCi/yg). The volume was 
distributed in aliquots of 500 yl in vials and stored at -20°C until use.
An aliquot was diluted with 11+.5 ml of barbitone-acetate buffer just before 
use- This solution (100 yl) was added to each tube; Human insulin 
standard (Wellcome Ltd., Kl+076)): The freeze dried preparation (2.8 m ) 
was dissolved in 2 ml of barbitone-acetate buffer and stored at -20° 
in aliquots of approximately 300 yl. When needed an aliquot was left 
to thaw, then diluted 1:1  ^in barbitone-acetate buffer to give a 
concentration of 100 yu/ml; Anti-insulin serum (Wellcome Ltd., $+273): 
Freeze dried guinea pig serum (0.5 ml of 1:1000 dilution) was further 
diluted (1:1+0) with barbitone acetate buffer to give a final concentration 
of 1:1+0,000 dilution. To each tube 50 yl of this solution was added;
Guinea pig normal serum (Wellcome Ltd., CT/02) (GPNS): freeze dried 
preserved GPNS was dissolved in 7 nil of distilled water to give an 
equivalent of 1:10 dilution of GPNS in isotonic saline. This was stored 
in aliquots of 1 ml at -20° until use. When used further dilution 
to 1:25 was done using barbitone-acetate buffer. To each tube 50 yl 
of this solution was added; precipitating serum; gamma-globulin antibody, 
(Wellcome Ltd). Rabbit anti-guinea pig gamma-globulin serum was used 
at a dilution of 1:5 with barbitone-acetate buffer. 50 yl of this 
solution was added to each tube.
Procedures: Duplicated tubes (Luckham Ltd.,) for each of the unknown
samples and standards were set up in metal racks and maintained at 1+°.
The following solutions were added to each tube using Hamilton micro- 
syringes (Hamilton Co. Inc., Whitter, Calif.). To 25 yl of plasma,
325 Pi of barbitone acetate buffer ionic strength 0.1 (VER), (0X0ID),
125
pH 8.6, 100 yl of I insulin and 50 yl guinea pig anti-insulin serum 
were added, mixed and incubated at k° overnight. After the incubation 
50 yl of carrier GPNS and 100 lil antibody-globulin antibody were added, 
mixed and incubated again overnight at 1+°. The tubes were centrifuged 
for 30 minutes at 2,000 r.p.m. at 1+° in a Mistral ‘6L centrifuge. The 
supernatant was discarded and the content of the tubes dried, and Y-radiation 
was counted for 5 minutes in a ’Wallac* Auto-gamma Counter.
Human insulin standards 0-1+00 lyU/ml in barbitone acetate buffer 
pH 8.6 were included and run parallel to the tests for each determination.
A standard curve for determination of plasma insulin is shown in Fig. 210.
l) Determination of plasma glucose (o-Dianisidine method)(Hackett, 1962) 
Reagent: The combined enzyme-acceptor reagent consisted of a mixture
of:-
a) Peroxidase (1+ mg) and glucose oxidase (25 mg) dissolved 
in 100 ml, 0.25 M, pH 7*0 phosphate buffer.
b) 1 ml of 1% o-dianisidine in ethanol.
This combined mixture was prepared on the day of use.
Procedure: Plasma (0.10 ml) was pipetted into 0.1+0 ml of water in a
centrifuge tube. Then 0.50 ml of 6% PCA was added, mixed and tubes were
centrifuged at 2,000 r.p.m. in a Mistral 6L centriduge at 1+°. To 0.5 ml
of the PCA supernatant 5*0 of combined enzyme-acceptor reagent was 
added, mixed and incubated at 37° for 20 minutes. Sulphuric acid
" 8 6
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Fig. 2.10 Standard curve for determination of plasma 
insulin using Human insulin as standards
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(25$? V/v) (2 ml) was then added to each tube, mixed and the colour 
read at 525 nm in a Unicam SP600 spectrophotometer. A blank (0.5 ml 
3% PCA) and standards (0.5 ml 3% PCA containing glucose for 20 to 
200^g) was carried out through the same procedure. The standard curve 
for determination of glucose is shown in Fig.2.11.
m) Determination of brain protein
Total brain protein was determined by the method of Lowry et al 
(1951)* A suitable dilution of fresh brain homogenate was prepared 
(200 mg/10 ml 0.5 N NaOH). To a measured volume of aliquots of these 
solutions 10 ml of freshly prepared reagent (100 parts 2% Na^CO^ in
0.1 N UaOH, 1 part of 1% CuSO^  5^0 and 1 part 2% sodium potassium 
tartrate) was added and mixed. After 10 minutes 0.5 ml of folin- 
ciocaAteU^ reagent (1:1 dilution) was added and immediately mixed.
After incubation for 30 minutes at room temperature the developed 
colour was measured at 720 nm using a Unicam SP 600 spectrophotometer.'
A reagent blank with water and standards of bovine serum albumin were
also rim through the same procedure. The standard ciirve for determination
of albumin is shown in Fig. 2.12.
In chapter  ^the Kj eldahl method was used to determine the nitrogen 
(N) content and crude protein content was calculated as total K x 6.25.
n) Determination of DNA 
Extraction of brain DNA.
About 0.1 - 0.2 g of brain tissue was homogenised in 8 ml of cold 
6% PCA and left for 30 minutes with occasional shaking. It was then 
centrifuged at 2,000 r.p.m. for 20 minutes and the supernatant discarded.
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Standard curve for determination of protein
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The lipids were extracted by addition of 5 ml of cold 96% ethanol.
The precipitate was rehomogenised, left for 15 minutes and then centrifuged 
at 2,000 r.p.m. for 15 minutes. After discarding the supernatant, the 
alcohol extraction was repeated. Of the 6%> PCA (5 ml) was then added 
to the precipitate and the mixture stirred with a glass rod. The mixture 
was heated for 20 min; in a water bath at 90°C and the extract separated 
by centrifugation at 2,000 r.p.m. for 20 min. The supernatant was 
decanted and the extraction repeated with another 2 ml of 6% PCA.
The supernatants were combined and the volume was made up to 10 ml by 
the addition of 6% PCA solution.
Measurement of DNA >
Diphenylamine reagent: This solution was prepared by dissolving 
1.5 g of recrystallised diphenylamine (Analar grade, BDH) in 100 ml of 
glacial acetic acid and the addition of 1.5 ml of concentrated sulphuric 
acid and 0.1 ml of 0.16$ acetaldehyde solution. The reagent was prepared 
just before use.
The diphenylamine reagent (if ml) was added to each of the tubes 
containing 2 ml of DNA extract from the brain tissue. The tubes were 
kept in an oven at 28°C to 30°C for a period of U5 hours, which has 
shown to give maximum colour, development. The optical density was 
measured at 600 nm using a Unicam SP 600 spectrophotometer. A standard 
curve was prepared using DNA from calf thymus (Fig 2.13).
. il|. lif
o) Determination of uptake of C -atom of U-C -D-glucose into the
brain tissues and its incorporation into brain free amino acids 
Dissected brain parts were weighed and homogenised in. 5volumes of 
ice-cold 80% ethanol (V/v). The radioactivity of the whole homogenate 
and extracts of the three brain parts were estimated:by taking 0.5 ml 
of the homogenate or extracts and counting them in a dioxan gel
91 .
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Fig. 2.13
Standard curve for determination of DNA
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scintillator. The efficiency of this counting system was 90$.
An aliquot of the homogenate was extracted twice with 80$ ethanol 
(V/v), the supernatants were pooled together and evaporated to dryness 
under cold air, and made up to volume (0.5 g homogenate per ml) with 
water. The free amino acids were then separated by two-dimensional 
descending paper chromatography. Amino acids were located by the spark 
chamber technique and the radioactivity of each amino acid was determined 
by cutting the area of the individual spot and counting it in 10 ml of 
toluene scintillator.
ll^ 3 . . .
p) Determination of uptake and incorporation of C -methionine, H -histidine
and H -tryptophan into brain tissue and brain protein.
•Animals were injected intraperitoneally with (l) 0.05 yCi/g body 
weight of C -methionine, (2) 0.10 yCi/g body weight of H -histidine, and 
(3) 0.10 yCi/g body weight of H -tryptophan and killed after 10 and 30 min.
The brains were quickly frozen in. liquid nitrogen, weighed, dissected and
, v . lU . .homogenised (1:7) with 0.1 N NaOH, and analyzed. C -methionine,
3 . . .  3 .
H -histidine and H -tryptophan uptake by the three brain parts was
estimated by taking 0.5 ml of the homogenate and counting it in a dioxan 
Gel Scintillator. Radioactivity was determined in a Packard 3200 liquid 
scintillation counter and expressed as cpm/mg of brain tissue.
ill 3 . 3
The incorporation of C -methionine, ' H -histidine and H -tryptophan
into brain protein was determined by a modification of the method of Flexner
and Flexner (1965). The protein in 0.5 ml aliquot of brain homogenate was
precipitated with 3 ml of ice cold 12$ (W/v) trichloroacetic acid (TCA)
and the precipitate transferred with suction on to glass fibre paper
(Whatman, GF/A).
93
The precipitate was washed twice with 12$ ice cold TCA, twice 
with 6$ TCA, three times with cold water and twice with dry acetone.
The plated protein was dried and placed in a glass counting vial.
10 ml of toluene counting solution with 0.5$ of NCS (Nuclear Chicago 
solubilizer) were added and the radioactivity determined and expressed 
as count/10 min./mg brain protein.
q) Determination of glutamic acid decarboxylase(h-glutamate 1-carboxylase,
I.U.B. k.1.1.15) (GAD)
Reagents: Ninhydrin reagent: Ninhydrin, l^f mM, made up in 0.5 M- 
sodium carbonate buffer, pH 9*9 to 10.0; standard solution of GABA, 2 and 
 ^mM; pyridoxalphosphate, 50 mM; potassium phosphate buffer, O.k M, pH 6.if. 
Glutamic acid, 100 mM, neutralised to pH 6.5 to 7»0; TCA, 10$; copper 
tartrate reagent: 1.6 g Na^ CO^, 329 mg tartaric acid, and 300 mg of 
CuSO^.513^ 0 were dissolved in 1 litre of water. The complete buffer- 
substrate vp the enzyme assay in homogenates was made up just before 
use by combining 10 ml of 0.if M-phosphate buffer and 10 ml of 100 mM 
glutamic acid with O.if ml of 50 mM pyridoxal phosphate.
Measurement: The GAD activity was determined by the fluorimetric method
as described by Lowe, Robins and Eyerman (1958). Brain tissue was 
homogenised in water (l g= 10 ml) in an electrically driven Potter 
hoinogeniser. An aliquot of the homogenate (0.1 ml) was incubated 
with 1:1 buffer substrate solution (0.1 ml) at 38° for 60 min. in a 
shaking water bath (30 cycle per min.). Reaction was terminated by 
placing the tubes in an ice bath and 10$ (V/v) TCA (0.1 ml) was added.
Tubes were then centrifuged for 10 min. at 3,000 r.p.m.in a Mistral 6L 
centrifuge at If0°. Aliquots of the supernatant (0.1 ml) were mixed 
with ninhydrin reagent (0.2 ml) and the stoppered tubes were incubated 
at 60° for 30 min. in a water bath. Copper tartrate reagent (5 ml) 
was added and fluorescence was read 15 min. later at 375 nm and if85 nm
activation and excitation respectively. Substrates and reagent 
blanks and standards (0.1-0.3. pinole) were carried through the 
same procedure.
Statistics
All results are expressed as average _+ S.E.M. and means 
were compared by student’s t test. To obtain the value of P a 
degree of freedom - 2 was assumed in all calculations.
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Chapter III
THE EFFECT OF DEVELOPMENT ON THE PATTERN OF CERTAIN FREE 
AMINO ACIDS AND OF SEROTONIN IN THE RAT BRAIN
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INTRODUCTION
The development and maturation of the pattern of free amino acids 
in the brain tissue of animals has been the topic of many reports in 
recent years. It is agreed that amino acid gontent, especially that c f 
of glutamic acid, aspartic acid, glutamine and GABA, in the brain 
increases during maturation. A progressive increase in the concentration 
of these amino acids has also been reported to occur concomitantly with 
post-natal development of the neurophii and the appearance of myelin in 
the brain of rats, cats and rabbits (Schade and Baxter, I960; Vernadakis 
and Woodbury, 1962; Berl and Purpura, 1963; Mihailovic and Kozalic, I96U). 
The quantitative increase is probably related to the development of brain 
structure and function, as well as to energy metabolism although the 
physiological significance of these findings is still not clearly 
understood.
The development and maturation of serotonin metabolism in the brain 
of experimental animals has also been the focus of a number of 
investigations in recent years (Pletscher, 1956; Wiegand and Perry,
1961; Baker and Quay, 1969; Loizou and Salt, 1970, Renson, 1971; Baker 
and Hoff, 1972). Most of these investigations have been carried out 
upon whole brain, with little attention being given to regional patterns 
of maturation for serotonin and its associated enzymes.
The primary interest of this study was the investigation of maternal 
protein restriction on the certain free amino acids and monoamines in 
the brain of the offspring. Since it is known that the different parts 
of the brain grow and develop at different rates (Dickerson et al, 1967) 
it seemed important to study the developmental pattern in different parts
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of the rat hrain. This chapter describes the developmental pattern 
of glutamic acid9 aspartic acid9 GABA9 glutamine and serotonin in 
the forebrain9 cerebellum and brainstem of the rat.
98
Animals and diets
Eats were maintained on a stock pellet diet (Table 2.1), and 
water ad libitum unless otherwise stated. Pregnant animals were 
caged individually. After birth, the litter size was maintained at 
eight pups throughout the suckling period. Animals were weaned 
at 21 days, separated by sex, and maintained in groups of six to 
eight animals. Up to 21 days of age animals of both sexes were used. 
Pups were kept with their mother for as long as possible to avoid 
exposure to the cold before being killed.
Animals were weighed and killed by decapitation at intervals 
between 1 and 120 d of age and the brain dissected as previously 
described. Free glutamic acid, aspartic acid, glutamine and GABA 
in the forebrain, cerebellum arid brainstem were quantitatively 
determined by paper chromatography. Serotonin was determined by 
the method described by Maickel. et al (1968).
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RESULTS
The forebrain weight increased rapidly during the first lU d 
after "birth, more slowly up to 21 d with little subsequent change 
up to 120 d of age (Fig. 3.1). The cerebellum and brainstem gained
weight more gradually from birth to 21 d of age and continued to 
increase until 120 d of age. The gain in body weight on the other 
hand rose slowly during the first 1^-d.of life and then rose more 
rapidly up to 120 d.
The DRA content increased very rapidly during the first 1^ d after 
birth in each brain part (Table 3.1). The DRA content of the forebrain, 
cerebellum and brainstem did not, however, change significantly between 
Ik and 21 d of age but doubled between 21 and 50 d, .. and further 
increased between 90 and 120 d. The greatest increase between 90 and 
120 d appeared to be in the cerebellum, forebrain and brainstem in that 
order (Table 3.1).
There was a progressive rise in the concentrations of GABA (Fig.3.2a, 
2b), aspartic acid (Fig. 3.3a, 3b), glutamine (Fig. 3.Ua, ;Ub) and glutamic
acid. (Fig. 3.5a, 5b) in the forebrain, cerebellum and brainstem up to 90 d 
of age.
The rise in the concentrations of GABA in the forebrain was most 
rapid between lU and 21 d whereas in the cerebellum and brainstem the 
concentration of GABA increased gradually from 7 d up to 35 <3. (Fig. 3.2a, 
2b; Table 3.2). The adult concentration of GABA was attained in all 
three parts at approximately 35 d and remained constant up to 120 d 
of age.
The concentration of aspartic acid in the forebrain and cerebellum 
increased significantly between 7 and 1^  d whereas it did not change
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significantly in the brainstem. The adult level of aspartic acid 
in the three brain parts was reached at 90 d (Figs. 3.3a* 3b;
Table 3.3). The concentration of glutamine in each three brain 
parts fell between 7 and ih d of age and increased between 1*+ and 21 d 
(Figs. 3.J+a, Vb; Table 3.^ ). The adult level of glutamine was 
reached at 21 d of age in the forebrain and brainstem whereas in the 
cerebellum it continued to rise until 35 d of age and then fell 
progressively up. to 120 d.
The concentration.of glutamic acid in the cerebellum and brainstem 
increased only slightly between 7 and Ik d of age but rose to almost 
mature levels by 21 d. In the forebrain, on the other hand, the 
concentration fell between 7 and lV d , rose rapidly between ll+ and 
21 d and continued to rise slowly but progressively up to 120 d 
(Figs. 3.5a, 5b; Table 3.5)'.
The concentration of serotonin was highest in the brainstem at 
each age (Figs. 3.6a, 6b; Table 3.6). There was a similar pattern 
of changes in the concentration of serotonin in the forebrain and 
brainstem. The concentration in these two parts rose to an adult level 
at 35 d of age. The concentration in cerebellum, however, decreased 
from the 1st to lUth day after birth and rose to attain a mature value 
at 70 d with no subsequent change up to 120 d of age.
The values of the parameters measured in this investigation, unless 
otherwise stated, are expressed as percentage of the corresponding values 
at 120, d of age. The latter is assumed as representing normal mature 
values of the parameters measured in rat brain, under the conditions of 
the investigation.
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TABLE 3.1 D M  CONTENT (yg/BRAIN PART) OF THE FOREBRAIN 
CEREBELLUM AND BRAINSTEM AT VARIOUS AGESIN RATS
Description 1 7
AGE IN DAYS 
Ik 21 50 90 120
Forebrain 630+B 918+12 1301+15 1368+15 29 0^+llfO 3110+200 iilOO+220
Cerebellum Ij-O.9+6 297+3 12i+0+2 1250+13 2810+50 3300+120 5200+130
Brainstem 97*8+^ 165+6 238+6 256+5 6ko±ko 7 0^+10 950+120
Each value represents the average ±  S.E.M. of determinations on five rats.
TABLE 3.2 GABA CONCENTRATION (ymole/g wet brain tissue)
IN THE FOREBRAIN, CEREBELLUM AND BRAINSTEM IN 
DEVELOPING RAT BRAIN
Description 7 lU
AGE IN DAYS 
21 35 50 90 ' 120
Forebrain 2.0+0.08 2.6+0.05 2.9+0.03 2.8+0.27 2.9+0.03 2.9+O.OU 2.8+0.03
Cerebellum 1.2+0. Oil- I.5+O.IO 2.1+0.03 2.0+0.05 2.I5+O.O5 2.U+0.10 2.5+O.O5
Brainstem 0/8+0.03 1.05+0.09 2.8+0.Oil- 2.5+O.OU 2.i++0.07 2.5+0.20 2.6+0.02
Each value represents average + S.E.M. of determinations on five rats.
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Fig. 3 .2(a) Effect of age on the GABA concentration ( p  m oles/g wet 
brain w eight) in forebrain, cerebellum and brain stem  
in Rats
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Fig. 3 .2(b) Effect of age on the GABA concentration ( p  m oles/ 
g wet brain weight ) in the forebrain, cerebellum and 
brainstem in the Rat. Values are expressed as 
. percentage of normal adult values at 120 d of age 
( For details see t e x t )
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Fig. 3 .3(a) Effect of Age on the Aspartic Acid Concentration ( \i mole/brain wet tissue) 
in the forebrain, cerebellum and brainstem in rats
100 -
50 -
Fig. 3. 3(b) Effect of age on the aspartic acid concentration 
( ji m oles/g wet brain w eight) in the forebrain, 
cerebellum and brainstem in the Rat. Values 
. are expressed as percentage of normal adult 
values at 120 d of age ( For details see text )•
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TABLE 3.3 ASPARTIC CONCENTRATION^mole/g wet brain tissue) 
IN THE FOREBRAIN, CEREBELLUM AND BRAINSTEM OF 
DEVELOPING RAT BRAIN
Description 7 Ik
AGE
21
IN DAYS 
35 50 90 120
Forebrain 0.8+0.11 1.1+40.03 1.1+5+0.12 1.6+0.11+ 1.540.13 2.0+0.12 2.1+0.11+
Cerebellum 1.1+0.12 1.5+0.09 1.60+0.11+ 1.50+0.12 1.80+0.15 1.940.11+ 1.8+0.12
Brainstem 1.9+0.l*i 2.1+0.11 2.1++p.ll+ 2.1++0.11 2.5+0.21+ 3.0+0.21 2.9+0.1!+
Each value represents average _+ S.E.M. determinations on five rats.
TABLE 3.1+ GLUTAMINE CONCENTRATION (ymole/g wet brain tissue) 
IN THE FOREBRAIN, CEREBELLUM'AND BRAINSTEM IN 
DEVELOPING RAT BRAIN -
Description 7 ll+
AGE
21
IN DAYS 
35 50 9° -120
Forebrain 3.1+0.10 1.9+0.05 1+.2+0.11+ 1+.1+0.05 1+.0+0.13 I+.2+O.O7 1+.1+0.21
Cerebellum 2.6+0.07 1.8+0.11 3.1+0.13 5.O+O.O7 1+.5+0.12 3.9+0.08 3.8+0.07
Brainstem 3.3+0.08 2.0+0.13 2.8+0.10 2.1++0.11 2.6+0.11 2.8+0.05 2.7+0.05
Each value represents average _+ S.E.M. of determinations on five rats.
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Fig. 3.4(a) Effect of Age on.the Glutamine Concentration (11 m oles/g wet brain 
weight) in the forebrain, cerebellum and brainstem in rats
100
7 14 21 35 50 90 120 Days
Fig. 3 .4(b) Effect of Age on the Glutamine Concentration 
(p. m oles/g wet brain weight) in the forebrain, 
cerebellum and brainstem in the rat. Values 
are expressed as percentage of normal adult 
values at 120d of age, (for details see text)
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[ Fig. 3. 5(a) Effect of age on the Glutamic Acid concentration ( jumole/
j g wet brain tissue ) in forebrain, cerebellum and forebrain
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Fig. 3.5(b) Effect of age on the Glutamic Acid concentration 
( jumole/g wet brain weight) in the forebrain, 
cerebellum and brainstem in the rat. Values are 
expressed as percentage of normal adult values 
at 120 d of age ( For details see te x t )
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Fig. 3. 6(a) Effect of age on the Serotonin concentration ( iu m oles/g wet brain 
tissue ) in the forebrain, cerebellum and brainstem of the Rat
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Fig. 3. 6(b) Effect of age on the serotonin concentration
( ju m oles/g wet brain w eight) in the forebrain, 
cerebellum and brainstem in the Rat. Values 
are expressed as percentage of normal adult 
values at 120 d of age ( For details see te x t ) no
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DISCUSSION
The present results show a progressive rise in the concentrations 
of glutamic acid9 aspartic acid, GABA and glutamine from f d up to 
90 days of age. Different amino acids attained their peaks of 
development at different times and they differed in the three brain 
parts studied.
Waelsfcfo. (1951) reported that the concentrations of glutamic acid 
in rat brain rose during development whilst that of glutamine changed 
to a much smaller extent. Agrawal, Davis and Himwich (1965) found 
a similar progressive rise in glutamic, aspartic acid and in GABA, 
during maturation. The adult concentration of glutamic acid was attained 
at 21 d, whereas the concentration of GABA and aspartic acid was reached 
at about 30 d. In the brain cortex and subcortical parts of the rat 
brain, Mourek et al (1969) found the greatest increase in'GABA, glutamic 
acid in that order and the smallest in aspartic acid. In the medulla 
oblongata, they found a surprising increase in aspartic acid. They 
also found a gradual increase with age in glutamic acid, aspartic acid, 
GABA and glutamine in the three parts of the brain included in their 
study.
The study of Dravid and Himwich (I96U) showed a similar progressive
increase in glutamic acid, and aspartic acid with maturation in the dog
brain. The levels of glutamic acid, GABA and aspartic acid in the brain
of one-day old rat are higher than those in newborn pupies (Dravid,
Himwich and Davis, 1965)9 and the adult levels of these amino acids are
also attained earlier in the rat than in the dog. These patterns are
related to differences in the rate of development of neuronal elements
in the two species and reflect the differences observed in the maturation
and ontogeny of behaviour. These results, especially those of glutamic
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acid are in agreement -with the accepted fact that the young rat develops 
faster than the developing dog.
Glutamine, an amide usually in dynamic relation with glutamic acid, 
was at a high level at 7 d. The concentration fell from 7 d to l^l d of age,
and then increased up to 35 days. The present data agrees with those of
Mourek et al (19T0) who found a decrease in the concentration of glutamine 
in the subcorticol parts and medulla oblongata from 5th d of age to 1  ^d and 
a steady increase from 21 to 35 d of age. A similar pattern for glutamine 
was reported by Dravid and Himwich (I96U) in the dog brain during 
development. The curve for the dog, however, is smoother than that in 
the rat which reflects perhaps the shorter span over which maturation
occurs in the latter species. Agrawal et al (1966) on the contrary,
reported a decrease in glutamine in the whole brain of rat from birth to 
seventh day and then showed a steady increase up to 90 days. The 
discrepancy could be due to the different techniques and to the different 
strain of rat.
It is well known that GABA is essentially formed in the CHS by 
decarboxylation of glutamic acid, a reaction catalysed by glutamic acid 
decarboxylase. The concentration of GABA increased progressively with 
age up to 35 d after birth in the cerebellum and brainstem whereas in 
the forebrain the adult value was attained at 21 d. The progressive 
increase in GABA with age may be the result of the increase in glutamic 
acid since the glutamic acid concentration in the three brain parts 
showed a major increase at the same period. To that effect Bayer and 
McMurray (1966) found that the content of GABA and the activity of 
glutamic acid decarboxylase followed similar courses during post­
natal development. The maxima were reached by 25 days of age.
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Baxter, Schade and Roberts (i960) correlated the content of 
GABA and other amino acids with histological changes in certain areas 
of rabbit brain cortex and they found that the largest increase in GABA 
appeared to be related to the increase in volume of the average nerve 
cell. The largest increase in GABA in the three brain parts appeared 
to be at Ik - 21 days. The whole picture of changes in these amino 
acids is complex, being affected by the increase in cell volume and 
that of the neurophil, as well as that of the growth of the brain.
Th.e picture is also affected by a decrease in cell density and in 
that of water content consequent upon the increase in lipids.
Development of brain serotonin
There was a marked increase in the concentration of serotonin in 
the brainstem between 7 and 21 d of age. The mature value, however, 
t?as attained at 35 d. In the forebrain, the increase in serotonin concn. 
was gradual with a maximum rate of increase between lU and 21 d. In 
the cerebellum, there was a fall in the concentration between the 1st 
and the Ik d with a slow increase up to 35 .d. Thus there were distinct 
regional differences in the developmental pattern of serotonin 
concentration in the three brain parts studied. A number of studies 
on the regional maturation of brain serotonin and its associated 
enzymes have been reported (Himwich, Pscheidt and Schweigerdt, I96O;
Pepeu and Giarman, 1962; Shimizu and Morikawa, 1965). It has been 
shown that regional changes in the serotonin synthetic pathways are highly 
varied and it is difficult to relate them to the serotonin pattern 
of the - developing brain as a whole.
Tryptophan hydroxylase (EC. l.llf.3.2) is generally considered to be 
theJLimiting step in the rate of serotonin synthesis (Grahame-Smith',1967)
■ 11^  V
and Bennett and Giarman (1965) consider it to be the development ally 
limiting step in the pathway in immature rat brain. This view is 
supported by the developmental pattern of tryptophan hydroxylase 
maturation in the whole brain obtained by Schimidt and Sanders-Bush 
(19T1)* They found minimal enzyme activity just before birth and 
for the first week after birth, followed by a rapid increase during 
the next three weeks. It would clearly be of interest to study the 
developmental pattern of tryptophan hydroxylase in the three brain 
parts studied in this investigation.
The high concentration of serotonin found in the brainstem of 
the developing rat is in agreement with the known adult concentration 
and localization of serotonin in this part of the brain. Both 
biochemical (Bogdanski, Weissbach and Udenfriend, 1957) and histochemical 
(DahlstrBm and Fuxe, 196k) methods of localization have shown that adult 
rat brain had the highest density of serotonin-containing neurons in the 
brain stem, with the greatest aggregation being in the raphie nuclei. 
Histochemical study of maturing rat brain has shown a similar 
distribution of serotonin-containing neurons after birth with neurons . 
apparently containing serotonin and terminals essentially free of 
serotonin. As maturity progressed the serotonin content of the neurons 
increased, and so did the number of serotonin-containing terminals 
(Loizou, 1969).
The biochemical and anatomical differences between mature and 
immature animals are associated with differences in the physiology of the 
serotonin-system.TyCe5 Flock and Owen (1961) found a lower blood-brain 
barrier to tryptophan, a precursor of serotonin, in immature brain.
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Other workers' showed variations in the amount of ’hound’ serotonin 
in the brain during early postnatal life (Karki, Kuntzman and Brodie,
1962; Bennett and Giarman, 1965; Haber and Kamano, 1966) and differences 
between the newborn and the adult brain in drug and irradiation effects 
on serotonin (Palak and Supek, 1966). At present, the available 
information on regional serotonin metabolism in the brain is too 
sparse and scattered to warrant any generalization.
By using the data obtained previously in this laboratory from 
the same strain of rat, we can obtain an integrated picture of 
changes in total DHA cholesterol and gangliosides and those of 
free amino acids and serotonin to illustrate the relationship between 
these constituents and brain development. Fig 3.7 shows the developmental 
pattern of these parameters from birth" to 120 days of age in the forebrain. 
It can be seen that the absolute amount of gangliosides attained its 
first peak at 21 d of age, and the total cell number, as indicated by 
DNA content, also increased very rapidly during this period. The rise 
in gangliosides at this time was attributed in part to an increase in 
the density of cell membranes (Merat and Dickerson, 1972). Since 
gangliosides were considered to be primarily located in neurons, and 
particularly in nerve endings (Derry and Wolfe, 1967) and synaptic 
membranes (Lapetina, Solo and De Hobertis, 1967), the increase could 
reflect an increase in dendritic arborization of the brain. It is 
interesting to note that the increase in serotoninconcn. ,a putative neuro­
transmitter known to be localized in the neurons and released at synaptic 
endings coincided with this peak andso did the increase in GABA, a 
possible inhibitory neurotransmitter. Furthermore, most of these
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Fig. 3. 8 Effect of age on the concentrations of glutamic acid, GABA, aspartic 
acid, glutamine ( jumole/g wet brain w eight), serotonin ( jug/g wet 
brain weight ) and absolute amount of DNA ( jug/brain p art) and 
ganglioside ( NANA/brain p art) in the cerebellum. Values are 
expressed as percentage of normal adult values at 120 d of age
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constituents appeared to attain their peak of development between 
21 and 35 <3. of age which is coincident in time with the neuro- 
anat.omical changes occurring during maturation (Schade and Baxter, 
I960; Eayrs and Goodhead, 1959; Legrand, Kriegel and Jost, 1961; 
Schade/, van Backer and Colon, I96U) and with the development of 
spontaneous electrical activity (Schade, 1959; Bradley, Earys and 
Schmalbach, i960).
In the cerebellum (Fig. 3.8), a similar pattern was found 
except that the peak period was somewhat later than in the forebrain. 
This is in accordance with the findings that different areas of the 
brain develop and mature at a different rate (Dickerson and Dobbing, 
1967).
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Chapter IV
THE EFFECT OF PRE- AND POSTNATAL MATERNAL PROTEIN DEFICIENCY 
ON THE FREE AMINO ACIDS AND AMINES IN RAT BRAIN
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INTRODUCTION
The brain of- the rat at birth contains mainly neurons and the 
multiplication of glial cells starts after(Angevine and Sidman9196l;
Brize and Vogt, 19&3; . Berry, Rogers & Eayrs, I96U; Altman aftd Das,
1966). It is well known that early postnatal undernutrition in the 
rat retards brain development and that different parts of the brain 
are retarded in different ways (Fish and Winnick,19&9; Dickerson and 
McAnulty, 1972). The effects of prenatal malnutrition on brain cell 
number and cell size have also been studied (Zemenhbf, Matheus and Margolis 
' 1968;.Zeman and-Stanborough,.1969)• Shoemaker and Wurtman (1971) 
reported a lower content of norepinephrine and dopamine in the brains 
of the 2*1 day old offspring of mothers fed an Q% protein diet from 
the fourteenth day of gestation. Perinatal malnutrition which stunts 
physical growth has been shown in experimental animals to produce 
subsequent impairment in behaviour, memory and learning ability 
(Scrimshaw, 1967; Dobbing, 1968 ; Baird, Widdowson and Cowley, 1971) .
The concentrations of free amino acids and amines are known to play 
a role in normal brain function. The present investigation was 
undertaken to study the effects of maternal protein restriction on the 
brains of the offspring at birth, and on different brain parts of the 
brain at 21 days of age, with respect to certain free amino acids and 
amines.
It is well known that there exists in each species of animal a 
critical period of brain growth and development during which severe 
malnutrition can produce irreversible damage (Dobbing, 1968; Chase 
et al, 197l)» It was therefore also of interest to study the effect
120
of rehabilitation on the concentrations of free amino acids in the 
brain of the malnourished offspring.
The metabolism of the brain is characterized by a rapid incorporation
1  ^ . . il|
of C into free amino acid, after the administration of U-C glucose
in vivo in the cat (Gaitonde, Marchiand Richter, I96U) and in the rat
(Cremer, I90U; ■ Gaitonde-, .Dahland Elliott,1965), or after the administration
of 2-C^ glucose in vivo in the rat (O’Neal and Koeppe, 19^3, 1966).
Roberts (i960) pointed out that the most significant changes in free
amino acid pool of the cerebral cortex resulted from experiments ■which,
directly or indirectly, affected the integrity of the enzyme mechanism of the
tricarboxylic acid'cycle. Since the brain depends on oxidation of
glucose for energy (Sinclair, 1961) and that it is exceptional in its
high rate of conversion of glucose into glutamic acid and aspartic acid^the
Ik llf . . .in vivo uptake of C of U-C -D-glucose into the brain and its incorporation
into certain free amino acids was therefore also studied.
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Animal and diets'
Pregnant rats of known mating date were divided into two groups
on the fifth day after copulation. The animals were given free access to
water and to either a stock pellet diet (Spillers) containing 21%
protein, or a powdered form of this diet diluted with starch, with
appropriate additions of minerals ahd vitamins, to contain 7% protein
(Table 2.2). • At birth the litters were adjusted to eight pups in the
7% protein group and to six pups in the control. Animals were killed
and the train dissected as previously described. Free amino acids were
quantitatively determined by paper chromatography and tyrosine was
measured as described by Waalkes and Udenfriend (1956). The protein
and DNA content were measured as described by Lowry et al (1951) and
Burton (1956) respectively. Serotonin and NE were measured by the
method described by Maickel. et al (1968) and cholesterol was determined
according to Hanel and Dam (1958)* Plasma was obtained by centrifuging
the blood samples at 2,000 r.p.m.for 20 minutes at U° on a Mistral 6l
centrifuge, and plasma glucose was determined by glucose oxidase method 
(Hackett, 1962).
Rehabilitation
In order to study whether the effect of maternal restriction oh the 
free amino acid concentration in the brain of the malnourished offspring is 
of a permanent nature , a further group of malnourished offspring were 
weaned at 21 days and they were given free access of 21% protein diet from 
weaning for 120 days. Free amino acids, DNA and cholesterol were determined 
as already described.
II4 1I4. .
Uptake of C - of iX-C -D-glucose into brain and brain free ahnno acid
In order to study the possible mechanism of the changes leading to 
alteration of free amino acids in the brain of malnourished offspring,
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a further group of animals was reared as described above and were
injected subcutaneously with O.lyci/g body weight of labelled
ll* 1  ^ lUU-C -D glucose at 21 days and the uptake of C - of U-C -D-glucose
into the brain and brain free amino acid were determined as previously 
described.
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RESULTS
The "body weight and brain weight of the newborn offspring of 
malnourished mothers were approximately 20$ and 15$ lower than those 
of well-nourished mothers respectively (Table .^l). The absolute 
amount of protein and DNA per brain was also lower, and so too was 
the concentration of cholesterol. The concentrations of NE and serotonin 
(Table 1*.1) and those of GABA, glutamic acid, alanine and aspartic acid 
were not significantly changed in the brains of the offspring of the 
malnouri shed rats.
At 21 days of age the body weight of the malnourished rats was about 
80$ lower than that of the controls (Table h.2). The weight of each 
of the three brain parts was also significantly lower, the largest 
difference being in the cerebellum (U0$) and the smallest in the brainstem 
(20$). The concentration of DNA was significantly lower in the cerebellum, 
but not in the forebrain and brainstem. The total DNA content was, however, 
lower in all three brain parts due to the reduction in brain weight.
The concentration of tyrosine was significantly higher in each part 
of the brain of the malnourished animals (Table .U. 3) • The increase was 
of the same order in each of the three brain parts. The concentration 
of GABA was increased in the cerebellum only. The specific activity of 
GAD was also significantly higher in the cerebellum of the malnourished 
animals (10.09 ± 0.26 units and 8.50\+ 0.21 units, respectively P< 0.001) 
compared with that of the controls. The concentration of aspartic acid 
was significantly increased in the cerebellum and also in the forebrain 
but not in the brainstem. Glutamic acid concentration was significantly 
decreased in the forebrain only. The concentrations of serotonin and NE
12l|
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■were not significantly different in any of the brain parts (Table 1+.3).
The total amount of serotonin and NE were lower as compared to the controls 
due again to the differences in brain weight. Studies of the brains of 
malnourished rats at 7 <3. of age showed that there was a transient fall in 
the concentration of serotonin in the forebrain and brainstem at this age, 
but not in the cerebellum (Fig. l*.l).,
ill il| . .
The uptake of C from U-C -D-glucose into the forebram and
cerebellum was significantly lower at 21 d of age in the offspring of
malnourished mothers than in the controls (Table h.k) whereas the uptake
ill . . . . ...
of C into free aspartic acid was significantly higher in these two
brain parts (Table 5) •
Rehabilitation
The body weight and brain weight of the previously malnourished 
animals rehabilitated to 120 d of age did not attain those of the controls 
(Table U.6). The absolute amount of DNA was lower in the forebrain and - 
cerebellum. The concentration of cholesterol was lower in the forebrain 
and also in the brainstem as compared to the controls (Table .^T)«
The concentrations of glutamic acid, GABA, glutamine and aspartic acid 
on the other hand, were within the normal range in each part of the brain 
(Table 1^ .8). The entry of U-C^-D-glucose into the homogenate and extract 
of the three brain parts was also not significantly different from the 
controls (Table U.9)•
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TABLE 1+.1+ EFFECT OF MATERNAL PROTEIN RESTRICTION ON THE
llf llf
INCORPORATION OF C OF U-C -D GLUCOSE INTO
.THE FOREBRAIN , CEREBELLUM AND BRAINSTEM OF
OFFSPRING AT 21 DAYS OF AGE.
ll+ . .Radioactive C -glucose wccSt administered subcutaneously m  doses
of 0.1 yCi/g body wt., and animals were sacrificed 30 min. after '
injections.
All rats were fasted 8-10 hr. before experiments.
Each value represents mean + S.E.M. of determinations on four rats.
FOREBRAIN dpm/g x 10~3
Control Malnourished
Homogenate Extract Homogenate Extract
3^8.03 + 9.10 (1+) 321.06 + 7-58 (1+) 292.63 + i M  (1+) 273.06 + 12.81 (1+)
CEREBELLUM
Extract Homogenate Extract
* ## 
260.1*0 + 6.1+6 (1*) 21+9.00 +10.96 (U) 228.03 + 9.12 (1+)
BRAINSTEM
Homogenate Extract Homogenate Extract
167.86 + 10.80(1+) 152.5 + 10.75 (1+) ll+8.93 +12.30 (1+) 133.7 +10.75 (1+)
Significance of differences between malnourished and controls shown 
** where p < 0.01, * where p < 0.05
Homogenate 
286.23 + 8.59 (1+)
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TABLE h.6 BODY WEIGHT AND WEIGHT OF FOREBRAIN,
CEREBELLUM AND BRAINSTEM OF PREVIOUSLY
MALNOURISHED RATS REHABILITATED FOR 120 D. 
Each value represents average _+ S.E.M. of determination on six rats.
CONTROL REHABILITATED
Body weight (g) ^35+1^ 335 ± 10
Forebrain (g) 1.19 + 0.03 1.06 + 0.01**
Cerebellum (g) 0.28 + 0.01 0.23 + 0.01**
Brainstem (g) 0.1*0 + 0.01 ' 0.33 + 0.01**
Significance of differences between malnourished and controls shown 
** where P < 0.01, ***. where P < 0.001.
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TABLE If.7 EFFECT OF REHABILITATION FOR 120 DAYS ON THE DNA
(yg/brain part) AND CHOLESTEROL (ymole/g tissue) 
OF THE FOREBRAIN, CEREBELLUM AND BRAINSTEM.
Each value represents average ± S.E.M. of determinations on six rats.
DNA CONTENT (yg/brain part)
CONTROL REHABILITATED
Forebrain kkOO + 200 3k60 + 200
Cerebellum 5200+250 3500 + 300
Brainstem 950 + 90 880 + 70
CHOLESTEROL (ymole/g tissue)
CONTROL REHABILITATED
Forebrain 53.2+2.5 k6.2 + 1.7
Cerebellum U2.5 + U.7 40.5 ± 3.2
Brainstem 91.5 ± 3. b ..81.3 + 2.5*
Significance of differences between malnourished and controls shown 
* where P < 0.059 **'where P < 0.01, *** where P < 0.001.
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TABLE k.9 INCORPORATION OF C1  ^OF U-C^-D-GLUCOSE
INTO THE'FOREBRAIN, CEREBELLUM AND BRAINSTEM 
• OF PREVIOUSLY MALNOURISHED RATS REHABILITATED 
FOR 120 D.
Each value represents average + S.E.M. of determination on six rats.
CONTROL (cpm/g brain wt) REHABILITATED (cum/g brain
wt)
Homogenate Extract ' \ Homogenate Extract
Forebrain 587.62+1*9.05 558.18+1*3.25 5^.69+58.01 529.27+1*9.83
Cerebellum 279-1*0+22.65 273.23+22.89 21*2.10+13.90 21*0.75+13.63
Brainstem 23l*.ll*+19.52 225.1*l*+17.l8 219.26+19-7^ 2.3.1*3+18.28
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DISCUSSION
In agreement with previous work, maternal dietary protein 
restriction resulted in a lower body weight and a lighter brain in 
the offspring at birth. The degree of retardation became more 
pronounced when the malnutrition was continued throughout the suckling 
period. The absolute amount of DNA was lower in the forebrain, cerebellum 
and brainstem at 21 d and also in the whole brain within the first 
10 hrs after birth. The greatest retardation in weight was found in 
the cerebellum, with the forebrain and brainstem showing progressively 
less'retardation. The DNA content followed a closely similar pattern.
These findings are in accordance with those of other workers 
(Zamenhof et al, I968; Chow and Lee, l$6h; Dickerson and McAnult'y, 1972).
Lower cholesterol concentrations have been reported (Dobbing, 1968; 
Dickerson and McAnulty ,1972) at 21 days in the brains of malnourished rats 
and thought to be due to a deficiency in the degree of myelination. The 
process of myelination in the rat brain commences at about 10 days after 
birth (Dobbing, 1968). Thus, the lower concentration of brain cholesterol 
found in the offspring of malnourished mothers at birth suggeststhat 
membranes other than the myelin may be affected at this age.
Rajalakshmi, Ali and Ramakrishnan (1967) found no change in the 
concentrations of glutamic acid GABA, aspartic acid, glutamine and 
alanine in the cerebrum of rats undernourished during the suckling 
period by removing them from the mother for different periods of time. 
Mourek et al (1970) on the other hand, reported a transient decrease in 
glutamic acid, GABA, aspartic acid, glutamine and alanine concentrations 
at 10 and 21 days in the cortex, subcortical parts and medulla oblongata 
of young rats starved for 10-12hr every day from 5 to 10 d of postnatal 
life. The brain cortex and medulla oblongata of starved animals did not 
show any differences at 35 d, whilst in the subcortical tissue a decrease
. 1 3 6  :
was still evident at the 35th day. The present result however, showed 
an increase in concentration of aspartic acid, a decrease in 
glutamic acid concentration in the forebrain , and an increase in 
concentrations of aspartic acid and GABA in the cerebellum. The higher 
concentration of the GABA can be explained by the concommitant raised 
specific activity of the enzyme GAD, in this part of the brain. The 
difference between the result of the previous investigations and the 
present one may, in part, be due to the different timing and kind of 
nutritional deprivation. Other uncontrolled stress factors may also 
be involved for the young animals were taken from their mother and 
handled twice every day. -
More recently,Enwonwu and Glover(1973) reported that the ratio of 
the sum of glutamic acid, aspartic acid, asparagine and glutamine to 
the sum of GABA, taurine and glycine in perinatal malnourished rats was 
30$ lower than a similar ratio for the cerebrum of control animals 
at weaning. In view of the suggestions (Curtis, 1970; Lajtha an<^  Piccoli, 
19715 Johnson, 1972) that‘aspartic acid and glutamic acid participate 
as excitatory transmitters at many synapses throughout the mammalian 
CNS whereas GABA has many properties expected of inhibitory transmitters,the 
changes in the concentration in these amino acids in the forebrain and 
cerebellum of the malnourished offspring at weaning may have important 
physiological significance.
The increase in concentration of aspartic acid in the forebrain 
and cerebellum of the offspring of mothers fed a protein-deficient 
diet is of interest because of its connection with the 
tricarboxylic acid (TCA) cycle. Robert (i960) considered that the 
most significant changes in the free amino acids of brain resulted 
from experimental procedures which could directly or indirectly affect
!37 *
the integrity of this cycle. Dawson (1953) showed that in rats 
subjected to insulin hypoglycaemia, the cerebral free aspartic acid 
content rose, whereas the glutamic acid concentration decreased and 
the concentration of GABA did not change. Measurements of blood 
.glucose in malnourished and control, rats at 21 d of age showed that the 
concentration was lower in the malnourished rats (85 + 6.h mg per
100 ml) compared with the controls (103',+ 5*0 mg per 100 ml,P< .0.001). There
. . . . lk .was also a significant decrease m  the entry of C -glucose into
forebrain and cerebellum in our malnourished rats. Thus, a decreased 
entry of glucose into the brain may result in a lower level of acetyl 
CoA which in turn may decrease the rate of condensation of acetyl CoA 
with oxaloacetate to form isocitrate. This, in effect, would increase 
the rate of transamination of glutamate and oxaloacetate, thus resulting 
in higher concentrations of aspartate and cj-oxoglutarate in the brain 
(Robert, i960).
The concentration of serotonin in the brains of rats malnourished 
prenatally and in the three brain parts of pre- and postnatally
malnourished rats at 21 day of age were found to be unchanged. Further
studies, however, showed a transient decrease in serotonin in the forebrain 
and brainstem of malnourished rats at J d. This is in accordance with 
the findings of Sereni, Principi, Peletti and Seieni (1966) who showed a 
transient decrease in serotonin concentration in the brain of under­
nourished suckling rats at the 6th and ll*th day of age.
The concentration of NE in the brain tissue may be regulated at many 
sites. These include the sensitivity of receptor, control mechanisms in 
the release and uptake system, and the relative rates of biosynthesis and 
degradation of enzymes involved.in NE metabolism (Molinoff and Axelrod,
1971). Sergni et al (1966) showed a transient decrease in NE
concentration in the brain of rats that had been malnourished postnatally
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by giving 16 or more pups to one lactating mother. Shoemaker and 
: Wurtman (1971) found a decrease NE and Dopamine content in the 
brains of offspring at 2k d raised from mothers fed an 8$ protein diet 
from the lU d of gestation. These differences were due entirely 
to the lower brain weight, for the difference is insignificant if 
the results are expressed in terms of concentration. More recently, Lee 
.and . Dubos (1972) reported a. lower concentration of NE and Dopamine tVfc* 
the brains of the offspring of mothers fed a diet containing 20$ 
wheat gluten from the ll*d of gestation. The offspring were weaned 
on to a normal pellet diet and killed at 3 months of age.
The present results show no change in NE in the brain of offspring 
at. the first day . of age and of the three brain parts at 21 d.
Thus, two different methods of maternal dietary deprivation, namely 
poor quality protein (wheat gluten) and quantitative restriction of 
diet, has different metabolic effects. Moreover, the timing of the 
insult and age of the animals may also be very important.
Rehabilitation •
When the malnourished offspring were rehabilitated for 120 d, the 
concentrations of glutamic acid, GABA aspartic acid and glutamine returned 
to normal in the three brain parts. This indicates that the changes 
in brain free amino acid in the malnourished offspring was a transient 
effect related to the diet during the period of malnutrition. The
ill .
entry of U-C -D-glucose into the three brain parts was also normal - 
as compared to the control indicating that intermediary energy metabolism 
was not permanently affected if rehabilitation takes place soon after 
weaning.
The DNA content in the forebrain and cerebellum, on the other hand,
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remained lower after the period of rehabilitation indicating that 
the cell number was affected up to 120 d ?y i-5 by the pre-postnatal 
maternal protein deficiency. The cholesterol concentration of the fore­
brain and brainstem of the rehabilitated animals were also significantly 
lower as compared to the controls and this may be due to delayed 
myelination in these two brain parts. Both these observations are 
in agreement with previous reports (Dobbing, 196 ;^ Winick and Noble,
1966; Dickerson and McAnulty, 1972).
In conclusion, this study adds another dimension to the effects 
of perinatal malnutrition on the developing brain. Previous work 
has largely attempted to elucidate the effects on structural constituents, 
cell number and myelination (Dickerson and McAnulty, 1972) and synaptic 
development (Merat and Dickerson, 1973). It seems likely that any 
abnormalities in brain function at the time of malnutrition are to be 
attributed to the combined effects of structural deficiencies and an 
imbalance of metabolically active constituents.
Chapter V
Effect of low protein and restricted high protein diet 
of equal energy content on the free amino acids3 serotonin 
and norepinephrine in the "brain of weanling rats.
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Chapter 5
INTRODUCTION
A large number of studies have shown that protein-energy 
malnutrition before weaning in the rat results in peimanent growth 
restriction, and an associated under-development of certain 
structures in the brain (Dobbing, 1968; Dickerson and McAnulty,
1972). Comparatively few studies have been made, however, of the effects 
on‘brain growth and development of a period of malnutrition after weaning. 
Indeed, earlier work suggested that the growth and development of the 
brain with respect to cholesterol, phospholipids, deoxyribonucleic 
acid (DNA) and protein is not permanently retarded by under nutrition 
at this time of life (Dobbing and Widdowson, 1965; Winick and Noble,
1966; Dickerson and Walmsley, 1967)* However, Dickerson, Hughes and 
McAnulty (1972) found that when increase in body weight was prevented 
for four weeks from weaning by dietary restriction there was a „ 
peimanent retardation of cholesterol deposition in the forebrain and 
brain stem, and of DNA in the cerebellum.
This study has now been extended by a study of the effects of 
malnutrition at this time of life on the free amino acids, serotonin 
and norepinephrine of the brain. Since it was found that the 
concentrations of histidine and methionine were raised, the entry of 
these amino acids into the brain was studied with radioactively 
labelled compounds.
It was also of interest to try to assess the sensitivity of 
the amino acid pool to dietary changes which, though producing some 
retardation in body weight, would have little effect on the growth
' lk2 7
of the brain. Experimental diets were chosen that differed in respect 
of the amount of protein they contained but which yielded the same 
amount of energy.
Since there is little information available on the effect of . 
rehabilitation on the free amino acid pool in the brain of animals 
subjected to protein energy malnutrition, the effect of rehabilitation 
on these animals was studied. Furthermore, the effect on the free amino 
acid pool in the brain after giving a low protein diet for a prolonged 
period was also investigated.
Animals and diets
Hats were reared in litters'of eight pups and weaned at 21 d.
At 2k d of age, male rats of similar body weight were divided into 
three groups by random sampling. They were caged individually, and 
each group was given one of the following three diets: low-protein (LP) 
(30 g/kg casein with 2 g/kg methionine and J80 g/kg starch); an amount of 
equal energy of a 250 g/kg casein diet,(with 2 g/kg methionine) and 
560 g/kg starch (RHP); or high protein diet ad lib. (HP). Animals 
were given free access to water. .The animals were killed after 56 d 
and plasma and brain free amino acids were determined by the method 
as described by Thomas (1970). Serotonin and NE in the brain were 
determined according to the method of Maickel, et al (1968).
Influence of Corticoisterone
Since plasma corticosterone concentrations have been found to be 
elevated in protein-energy malnourished rats, a further group of ten 
animals were given free access to the HP diet from 2U.d'of a'ge for 56 d.
1^3
Five were injected intraperitoneally with 8 mg/100 g body weight of 
corticoisterone 1+ hours before killing, and the other five were injected 
with saline and used as controls. The animals were killed and forebrain 
and plasma free amino acids were determined by the method described 
by Thomas (1970).
llj. . 3 . .
Uptake of C -methionine and H -histidine into the brain and their
subsequent incorporation into brain protein.
Further groups of animals were fed one of the LP, HP and RHP
diets for 56 d. They were then injected with 0j05yci/g body weight
lk . . . . 3 . . . •
of C -methionine or 0.1 Pci/g body weight of H -histidine. The
uptake of these amino acids into the brain and their subsequent 
incorporation into brain protein was also studied by the method 
as described previously.
Rehabilitation and prolonged protein restriction.
In order to . study .the permanency of the changes in free amino acids 
in the plasma and in the brain of malnourished rats, a further group 
of rats was reared as described above for 56 d. and given free access 
to HP diet for a further 120 d. In the same experiment, a group of 
animals was maintained on the LP diet throughout the entire period of 
the experiment. At the end of the experiment all the animals were 
killed by decapitation and plasma and brain free amino acids were 
determined on an autoanalyser at the University of Wales, Bangor.
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RESULTS
The animals on the restricted amount of the high protein diet 
(RHP) -weighed 30$ less than the controls (Table 5*1) but there was 
no significant difference in brain weight. The animals on the low 
protein diet (LP), however, weighed 75$ less than the controls, 
and each part of the brain also weighed less. The amount of D M  
in each paid; of the brain was practically the same in each group, whereas 
the amount of protein was lower in each part of the brain of the LP 
animals and hence the protein:DNA ratio was also lower.
The differences with respect to the controls in the concentration 
of free amino acids differ in the three brain parts in the.same animals 
and do not follow the same pattern in response to the two kinds of 
dietary restrictions. Thus, the concentrations of lysine were lower 
in the forebrains of the LP animals, whereas those of glycine and 
alanine were lower in those of the RHP animals (Table 5*2). The 
concentrations of histidine, methionine and glycine, on the other 
hand, were raised in the forebrains of the LP animals.
In the cerebellum (Table 5-3) the concentrations of glycine, 
methionine and histidine were raised in the LP animals but 'not 
in' the RHP animals. However, in the RHP animals, glycine and lysine 
were lower whereas they were - >inot in the LP animals. In the 
brainstem, (Table 5.k) the concentrations of histidine, methionine and 
phenylalanine were significantly raised in the animals on the LP diet 
but not in those on the RHP diet. In the RHP group the concentrations 
of alanine and leucine were significantly lower whereas they were not 
changed in the LP animals.
^5
TABLE 5-1 EFFECT OF A LOW PROTEIN AND RESTRICTED HIGH PROTEIN 
DIET ON THE BODY WEIGHT, BRAIN WEIGHT, PROTEIN AND DNA 
CONTENT OF DEVELOPING RAT
Description Control LP RHP
ffei£ht_J(g).
Body wt. 300 + 13
***
73 + 5 209 +
***
10
Forebrain 1.20 _+ 0.03 1.05 + 0.01** 1.16 4- 0.01
Cerebellum 0.32 _+ 0.01
***
0.25 + 0.01 0.29 _+ 0.01
Brainstem 0.38 + 0.01
***
0.31 + 0.01 0.1*0 Hh 0.01
Whole brain 1.96 + 0.03
■ ■ *** 
1.62 + 0.03 1.86 4- 0.02
Total protein (mg)
Forebrain 129.78 _+ 5.78 108.85 + 0.72 - 127.80 + 6.53
Cerebellum 3 .^92 _+ 1.1*9 28.20 + 0.95 32.3 4- 1.18.'
Brainstem lf3.50 + 2.26 31+.65 + 0.85* 39.00 _+ 1.27
Whole brain 208.20 1*. 50 173.85 + 1.77*** 196.12 _+ 5.01
Forebrain 
Cerebellum 
Brainstem 
Whole brain
Total DNA (mg)
1.85 +0.08 1.75 + 0.1k
2.03+0.01 2.01 + 0.0k
0.1*2 + 0.03 0.1*3 + 0.02
1*. 30 + 0.05 h.19 + 0.08
1.80 + 0.13 
2.05 + 0.08 
0.1*2 + 0.01 
.1**27 + 0.07
Each value represents the average + S.E.M. of determinations of five rats 
Statistical significance of differences between experimental and controls 
shown * where p < 0.01, ** where p < 0.002, *** where p < 0.001.
TABLE 5.2
EFFECT OF A LOW PROTEIN AND RESTRICTED HIGH 
PROTEIN DIET ON THE FREE AMINO ACIDS OF THE 
RAT FOREBRAIN (FOR DETAILS SEE TEXT).
Amino Acid RESTRICTED
pmole/g wt CONTROL LOW PROTEIN HIGH PROTEIN
tissue
Aspartic Acid 2.70+0.13 2.90 + 0.01 3.0 jf 0.6
Glutamic Acid 12.80 + 0.73 11.90 +0.63 10.50 + 0.1*7
Gab a 2.60+0.03 2.60 + 0.05 2.50 +0.05
Glycine 0.79 + 0.001 1.01 + 0.01 0.65+0.01
Alanine 0.70 + 0.02 0.70 + 0.02
***
0.1*8 + 0.003 '
Methionine 0.033+ 0.005 0.0U5+ 0.001* 0.010+ 0.006
Leucine 0.065+ 0.009 0.0U1+ O.OO7 O.O87+ 0.006
Tyrosine 0.053+ 0.001 0.051+ 0.001 0.060+ 0.003
Phenylalanine 0.033+ 0.001* 0.0U3+ 0.003 0.038+ 0.003
Histidine 0.053+ o.ook 0.18+0.011* 0.055+ 0.005
Lysine 0.150+ 0.005 0 . 083+ o.ooi*** O.I60+ 0.021
Each value represents the average +_ S.E.M. of determinations on five rats.
Statiscal significance of differences between experimental animals and 
controls shown * where P < 0.05, ** where P < 0.02, *** where P < 0.001.
TABLE 5.3
EFFECT OF A LOW PROTEIN AND RESTRICTED 
HIGH PROTEIN DIET ON FREE AMINO ACIDS OF THE
RAT CEREBELLUM. (FOR DETAILS SEE TEXT).
Amino Acid RESTRICTED
ymole/g wet CONTROL LOW PROTEIN HIGH PROTEIN
tissue
Aspartic Acid 2 .5 0  + 0 .2 0 2 A 1 + 0 A 0 2 A 0  + 0.2*1
Glutamic Acid 7 .0 0  + 0 .2 1 6 .9 0  + o.UU 7 A 0  + 0.2k
Gaba 2 .5 0  +  .0 .08 2 .5 0  +  0 .0 9 2 .2 0  + 0 .1 2
Glycine 1 .1 0  + 0 .0 5 1 .3 0  + 0 .0 8
***
0.5** + 0 .0 5
Alanine 0 .8 6  + 0 .0 2 0 .8 8  + 0 .0 3 0 .8 7  + 0 .0 2
Methionine O .3V + 0 .0 3
***
O .5 2 + O . O 8 0 . 2 8 + 0 . 0 5
Leucine . 0 . 0U2+ 0 .0 0 1 0 . 0*16+ 0 .0 0 7 0 . 0lf0+ 0 .0 0 6
Tyrosine 0 .0 5 ^+  0 .005 0 . 063+ 0 .012 0 . 050+ 0 .0 0 6
Phenylalanine 0 . 050+' 0.001+ 0.0**5± 0 .0 0 3 0.01*7+ 0.00U
Histidine 0 .0 8 5 + 0 .0 1 8 0 .3 0  + 0 .0 2 0.0^6+0.007
Lysine 0.37 ± 0 .0 2 0 .3 6  + 0 . 0U
***
0 .2 1  + 0 .0 2
Each value represents the average S.E.M. of determinations on five rats.
Statistical significance of differences between experimental animals 
and controls shown ** where P < 0.01 ,-.*** where P < 0.001.
TABLE 5.U
EFFECT OF A LOW PROTEIN AND RESTRICTED 
HIGH PROTEIN DIET OF FREE AMINO ACIDS OF 
THE RAT BRAINSTEM. (FOR DETAILS SEE TEXT)
Amino Acid RESTRICTED
ymole/g wet CONTROL LOW PROTEIN HIGH PROTEIN
tissue
Aspartic Acid 2 .2 0  + 0 .3 3 2 .5 0  + 0.1+3 2 .7 0  + 0.1+2
Glutamic Acid 8 .3 0  + 0 .Ik 8.00  + 0 .2 6 7 .5 0  + 0 . 1+0
Gaba 2.1+0 + 0 .0  6 2.U+ + 0 .1 2 2 . 0 9 + 0 . 0 9 * *
Glycine 4-. 10. + 0 .5 2 1+.30 + 0 . 3 5 3 . 3 0 + 0 . 1 2 -
Alanine 0 .6 8  + 0 . 0 2 0 . 7 0 + 0 . 3 5
***
0 .3 5  + 0 . 0 5
Methionine 0 . 029+ 0 .0 0 1 0.061+  0 .012* 0 .0 3 6 +  0 .0 0 8
Leucine 0.210+  0 .0 0 3 0.221+  0 .009 0 .1 7 0 +  0 .013**
Tyrosine 0 .310+  0 .0 1 3 0 . 302+ o.oii+ 0 . 25^+ 0 .0 2 8
Phenylalanine 0.01+6+ 0 .002 0 . 066+ 0 . 001+* • 0.01+7+ 0 .0 0 3
Histidine 0.01+7+ 0 .005 0 .2 0 0 + 0 .0 2 0.01+2+ 0 .0 0 2
Lysine 0 .3 3  + 0 .0 3 0 . 3 1 + 0 . 0 5 0.21+ + 0.01+
Each value represents the average + S.E.M. of determinations on five rats.
Statistical significance of differences between experimental animals
and controls shown * where'P < 0.05, ** where P < 0.02, ***where P < 0.001.
The plasma concentrations of aspartic acid, glycine, alanine 
and histidine were significantly increased whereas concentrations of 
valine, isoleucine and tyrosinewere decreased (Tahle 5*5) in the LP 
animals. In the RHP animals, plasma free amino acid concentration 
remained unchanged when compared to that of the controls.-
Tahle 5*6 shows the differences in the concentration of free 
amino acids in the plasma and brain of the LP animals expressed as 
a percentage of the values in the controls. In the plasma, the 
concentration of alanine was higher and that of tyrosine lower but in 
the brain the concentration of these amino acids was not changed 
significantly. In the case of methionine, the concentration was 
not changed in the plasma but was significantly higher in the brain.
The concentration of histidine was higher in both plasma and brain.
The concentration o'f phenylalanine was'higher only in the brainstem 
whilst that of lysine was lower only in the forebrain. 'On the RHP 
diet the concentration of glycine was lower in all three parts of 
the brain (Table 5*6) whereas that of alanine was lower only in the 
forebrain and brainstem and that of lysine only in the cerebellum.
Effect of corticO-Sterone on free amino acids in the plasma and forebrain
The concentrations of free amino acids in the plasma and forebrain 
of control rats injected with corticoisterone are shown in Table 5*7 
and Table 5.8 respectively. The plasma concentrations of glycine and 
alanine was significantly higher as compared to the controls whereas 
the concentration of tyrosine was significantly lower. The concentrations 
of GAB A and tyrosine were significantly lower in the forebrain of the 
control animals injected with corticoisterone.
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TABLE 5.5
EFFECT OF A LOW PROTEIN AND RESTRICTED HIGH PROTEIN 
DIET ON PLASMA FREE AMINO ACIDS IN THE RAT
Amino Acid 
Nmole/ml plasma CONTROL LOW PROTEIN
RESTRICTED 
HIGH PROTEIN
Aspartic Acid 0 . 02*1 jf 0 .0 0 1 0.0*17 + 0 .0 0 8 0 . 3 9 0 + 0 .0 0 8
Glutamic Acid O.lkO + 0 .0 0 6 O.lkO + 0 .016
Glycine 0 .0 8 2 + 0 .0 0 5 0 .2 6 0
**
+ 0 .0 1 7 0 .0 9 2  + 0 .0 0 5
Alanine 0 .2 3 4- 0 .0 1 0 .3 6
*
+ 0 .0 5 0.2k + 0 .0 1 3
Valine 0 .1 1 0 + 0 .0 1 3 0 .0 5 9
**
+ 0 .002 0 .1 3  + 0 .0 0 5
Methionine 0 .0 1 7 4^ 0 .0 0 2 0 .015
-V000 + 1 0 .0 1 2  + 0 .0 0 3
Isoleucine O.Obj _+ 0 .005 0 .0 3 1 + 0.00*t* 0 • 0 £r —4 1 
+ 0 .0 0 6
Leucine 0.06*1 + 0 .005 0 .0 5 3 + 0 .0 0 3 0 .0 9 7  + 0 .0 0 8
Tyrosine O.OI15 +_0 .0 0 3 0 .0 3 2 + o.ooU* O.O5I  + 0.00*t
Phenylalanine 0 .032 .Hh 0 .0 0 2 0 .0 3 0 + 0 .002 0 .0 3 6  + 0 .0 0 6
Histidine 0 .0 3 5 jh 0 .001 0 .1 0 5  + 0 .0 0 9 0 .0 3 9  + 0 .0 0 1
Lysine 0 .0 7 9 4- 0 .0 0 3 0 .0 5 6 + 0 .00U 0 .0 6 9  + 0 .0 0 1
Each -value represents the average +_ S.E.M. of determinations on five rats.
Statistical significance of differences between experimental and controls 
shown * where P < 0.05s ** where P < 0.01, *** where P < 0.001.
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TABLE 5.7 EFFECT OF CORTICOSTERONE ON THE PLASMA
. FREE AMINO ACID IN THE RAT
y mole/ml plasma CONTROL CORTISOL TREATED
Aspartic acid 0.024 + 0.001 0.027 _+ 0.001
Glutamic acid 0.14 + 0.006 0.13 + 0.001
Glycine 0.082 + 0.005 0.120 +_
**
0.005
Alanine 0.230 + 0.010 0.310 +
**
0.001
Valine 0.110 + 0.013 0.097 jf 0.013
Methionine 0.017+0.002 0.018 0.001
Isoleucine 0.047+0.005 0.046 + 0.006
Leucine 0.064 +.0.005 0.066 + 0.009
Tyrosine 0.045 ± 0.003 0.033 + 0.002*
Phenylalanine 0.032+0.002 0.040 _+ 0.002
Histidine 0.035 +0.001 0.038 + 0.003
Lysine 0.079 ± 0.003 0.095 + 0.005
Each value represents average _+ S.E.M. of determinations on five animals. 
Statistical significance of differences Between the control and the experimental 
show * where p < 0.023 where p < 0.001.
153
TABLE 5.8 EFFECT OF CORTICOSTERONE ON THE FREE AMINO
ACIDS IN RAT FOREBRAIN
Amino Acid CONTROL CORTICOSTERONE TREATED
ymole/g. wt.
Aspartic acid 2.70 Hh 0.13 2.50 + 0.03
Glutamic acid 12.80 + 0.73 11.50 0.53
GABA 2.60 + 0.03 2.30 +_0.12*
Glycine 0.791 + 0.001 0.765 j f 0.063: v
Alanine 0.70 Hh 0.02 0.56 + 0.06
Methionine 0.033 j f 0.005 . 0.026 Hh 0.003
Leucine 0.065 + 0.009 0.07U ± 0.018
Tyrosine 0.053 _+ 0.001 '  0.039 +_ 0.005**
Phenylalanine 0.033 + o.ooil 0.036 Hh 0.011
Histidine 0.053 + 0.00U 0.01*0 + 0.006
Lysine • 0.15 Hh 0.001 0.11 _+ 0.02
Each value represents the average + S.E.M. of determinations on five rats.
Statistical significance of differences between controls and the experimental 
shown * where p < 0.05, ** where P < 0.01.
1^
1 4  .  3  .  . .  .
Uptake of C -methionine and H -histidine into the brain and their
incorporation into brain proteins.
3 . . . .
The uptake of H -histidine into the three brain parts was
significantly higher in the LP animals, at 10 and 30 minutes and also 
at 30 minutes in the RHP animals. The incorporation of this amino 
acid into brain protein was not affected by the two dietary regimes 
(Table 5-9).
ll . . .  .The uptake of C -methionine into the three brain parts was
significantly raised at 30 minutes (Table 5.10); the incorporation of 
this amino acid into the protein of three brain parts followed a 
similar pattern. .
Effect of low protein and restricted high protein diet of equal energy 
content on brain serotonin and norepinephrine
The concentration of serotonin was significantly lower in the
forebrain and brainstem of animals fed a LP diet, but was not in the
cerebellum. In the RHP group the concentration of serotonin remained
unchanged (Fig. 5*1) • The concentration of NE in the three brain parts
was not affected by the two dietary regimes.
Rehabilitation of rats malnourished from weaning.
• During rehabilitation, the gain in body weight of the low protein 
animal and restricted high protein animals occurred at a very rapid rate. 
After a period of 80 d the body weight of the rehabilitated animals 
was close to that of the controls (Fig. 5*2). At 200 d of age the body 
weight ‘and the weight of the three brain parts of the rehabilitated low 
protein and restricted high protein animals were not significantly 
different from that of the controls (Table 5*11). The concentrations
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Fig. 5.1 Effect of Low protein and restricted high protein 
diet of equal energy content on the concentrations 
of serotonin and norepinephrine in the forebrain, 
cerebellum and brainstem in Rats
Statiscal significance of differences between the 
controls and experimental shown where***P < 0.001 
Each value represents the average ±  S. E.M. of 
five determinations
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TABLE 5.11
EFFECT OF REHABILITATION ON THE BODY WEIGHT 
AND BRAIN WEIGHT OF RATS PREVIOUSLY FED A 
LOW PROTEIN AND RESTRICTED HIGH PROTEIN DIET 
(FOR DETAILS SEE TEXT)_____ ________
CONTROL (k)
LOW PROTEIN 
REHABILITATED 
(3)
RESTRICTED HIGH 
PROTEIN REHABILITATE
(b)
Body wt (g) 
Forebrain (g) 
Cerebellum (g) 
Brainstem
368 + 15 
1.18 + 0.0*1 
0 . 321+ 0 .0 1  
0 .1*1* + 0 .0 1
358 + 6 
1 .1 6  + 0 .0 2
0.33 + O.Ol 
0 . 1*7 + 0 .0 1
3b3 + 10 
1.2U+ 0.03 
0.33 + O.Ol 
0 .1*6 + 0 .0 1
The number of animals used is indicated in the parentheses.
TABLE 5.16
EFFECT OF PROLONGED FEEDING OF A LOW PROTEIN 
DIET ON THE BODY WEIGHT AND BRAIN WEIGHT IN 
THE RAT
CONTROL (1*) PROLONGED LOW PROTEIN (1*)
Body wt.(g)' 368 _+ 15 97 + 8
Forebrain (g) 1.18 + 0.03 1.07 +
*
0.02
Cerebellum (g) 0.32 +_ 0.01 0.28 +
**
0.01
Brainstem (g) 0.1*1* _+ 0.01. 0.38 + 0.01
The number of animals used is indicated in the parentheses.
Statistical significance of differences between experimental and controls 
shown * where P < 0.05 9 ** where P < 0.02, *** where P < 0.001.
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TABLE 5.12
EFFECT OF REHABILITATION ON THE PLASMA 
FREE AMINO ACIDS OF. RATS PREVIOUSLY FED 
A LOW PROTEIN OR RESTRICTED HIGH PROTEIN 
DIET (FOR DETAILS SEE TEXT)._____ __
Amino Acid 
Umole/ml plasma CONTROL (4)
LOW PROTEIN 
REHABILITATED 
(3)
RESTRICTED 
HIGH PROTEIN 
REHABILITATED (4)
Taurine 
+ Urea
0 .1 3 . + O.O57 0 .1 9  + 0 .036 0 .1 9  ± 0 .0 1 4
Glycine 0 .1 2 0  + 0 .0 1 3 0.121 + 0 .0 1 0 .1 2 3  ± 0 .0 0 7
Alanine 0.190 + 0 .0 6 2 0 .271  + 0 .024 0.29Q + 0 .2 2
Cystine '0 .0 0 9  + 0 .001 0 .0 1 3  + 0 .001 0 .0 1 5  + 0 .0 0 2
Valine 0.1T0 + 0.01 o.m>± 0.006 0 .1 7 2  + 0 .0 1 1
Methionine 0 .024  + 0 .0 0  4 0 .0 3 1  + 0 .001 0 .0 3 3  + 0 .0 0 3
Isoleucine . 0 .0 7 1  + 0 .004 0 .0 6 1  + 0 .004 0 . 0 7 2 + 0 .0 0 4
Leucine 0.111 + 0 .0 0 6 0 .094  + 0 .008 0 .1 1 2  + 0 .0 0 6
lyrosine 0 .055  + 0 .0 0 3 0 .0 5 3  + 0 .001 0 .0 5 3  + 0 .0 0 7
Phenylalanine 0 .0 4 7  + 0 .025 0 .5 5 0  + 0 .001 0 .0 5 1  + 0 .0 0 6
Histidine 0 .0 8 7  ± 0 .0 0 3 0 .0 8  + 0 .006 0 .0 8 2  ± 0 .0 0 4
Ornithine’ 0 .1 1 2  + 0 .0 1 0 0 .0 7 9  + 0 .006 0 .0 5 6  + 0 .0 0 4
Lysine 0 .2 4 4  + 0 .030 0 .2 5 2  + 0 .025 0 .2 8 0  + 0 .0 3 1
Arginine 0 .0 7 8  + 0 .0 1 0 0 .094  + 0 .011 0 .1 0 2  + 0 .0 0 9
The number of animals used is indicated in the parentheses.
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of free amino acids in the plasma (Table 5»12) and also in the 
forebrain (Table 5*13)5 cerebellum (Table 5»l4) and brainstem 
(Table 5*15) bad returned to normal after 120 d of rehabilitation.
Low protein diet for 120 d.
After 120 d on the low protein diet, the body weight of the 
experimental animals was 20$ of that of the controls and the weight 
of the three brain parts was also lower (Table 5*16). The 
concentration of glycine remained higher in the forebrain (Table 5*17) 
and cerebellum (Table 5*18) as it was found in 56 d of protein 
restriction so too was the concentration of histidine in the three • 
brain parts. The concentration of tyrosine in the forebrain and 
brainstem (Table 5*19) yas on the'other hand, markedly decreased 
after a prolonged protein restriction, a change which was not seen in 
56 d of protein restriction.
The increase in concentrations of methionine in the three brain • 
parts, phenylalanine in the forebrain and lysine in the brainstem 
observed in 56 d of protein restriction (Tables 5-2, 5*3 and 5*4) 
was not found after 120 d of protein restriction.
The plasma concentrations of glycine, alanine and histidine were 
significantly increased whereas concentrations of valine, leucine, \ 
isoleucine and tyrosine were significantly decreased (Table 5*20).
These changes are consistent with the finding of plasma free amino acids 
in 56 d of protein restriction.
Table 5*21 shows the differences in the concentrations of free 
amino acids in the plasma and the brain of LP animals expressed as a 
percentage of the values of the controls. It can be seen that histidine
162 '
was raised both in plasma and in the three brain parts. The 
concentration of glycine was increased in plasma and also in the 
forebrain and cerebellum. The concentration of tyrosine in the plasma 
forebrain and brainstem remained lower than that of the controls.
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TABLE 5.13
EFFECT OF REHABILITATION ON THE FREE AMINO ACIDS IN THE
♦
FOREBRAIN- OF RATS PREVIOUSLY FED A LOW PROTEIN OR HIGH 
PROTEIN RESTRICTED DIET (FOR DETAIL SEE TEXT).
Amino Acid 
ymole/g wt tissue CONTROL (1*)
L P
Rehabilitated(3)
R H P  
Rehabilitated (1*)
Taurine + Urea 5.30 + O.27 1*.80 + 0.16 1*.15 + 0.35
Glycine 0.790 _+ o.oi* 0.871 + O.O67 0.860 j+ 0.050
Alanine 0.730 + 0.030 0.71*1 +0.021 0.712 + 0.01*8
Cystine 0.008 + 0.002 0.007 + 0.002 0.008 _+ 0.002
Valine 0.092 :<+ 0.003 0.090 + 0.002 0.080 + 0.009
Methionine O.OUl + 0.011 0.036 + 0.01 0.311 + 0.001
Isoleucine 0.022 +_O.OOl* 0.029 + 0.002 0.029 _+ 0.002
Leucine 0.051 + 0.006 0.062 + 0.001 0.065 _+ 0.005
Tyrosine o.oi*i + 0.006 0.063 +0.031 0.036 + 0.003
Phenylalanine 0.076 +_0.008 0.01*8 + 0.008 0.01*8 _+ 0.026
GABA 2.00 ■+0.06 1.90 + 0.17; 1.90 _+ 0.01
Histidine 0.162 + 0.005 0.l6l + 0.005 0.180 + 0.018
Ornin 0.076 + 0.005 0.076 + O.OO5 0.093 + 0.012
Lysine 0.210 + 0.011 0.302 + 0.051 0.211 + 0.005
Arginine 0.072 + 0.001* 0.078 ± 0.003 0.075 + 0.001*
The number of animals used is indicated in the parentheses.
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TABLE 5»ll*
EFFECT OF REHABILITATION ON THE FREE AMINO ACIDS IN THE CEREBELLUM 
OF RATS PREVIOUSLY FED A LOW PROTEIN OR HIGH PROTEIN RESTRICTED DIET
(FOR DETAILS SEE TEXT)
Amino Acid 
ymole/g vet vt. CONTROL (*0
L P
rehabilitated(3)
R H P  
rehabilitated (1*)
Taurine + Urea 1*.70 _+ 0.32 1*.00 + 0.05 3.90 4- 0.16
Glycine 1.10 _+ 0.03. 1.10 + O.O3 1.10 _+ 0.05
Alanine 0.760 4- 0.019 0.632 + 0.016 O.761 4- O.O55
Cystine 0.019 _+ O.OO6 - 0.026 +_0.003
Valine 0.087 + CT.005 0.078 ± O.OOl* 0.080 + 0.005
Methionine 0.033 4- 0.002 0.038 + 0.002 0.01*1 + 0.005
Isoleucine 0.031+ + 0.002 0.03b + O.OOl* O.OM* 0.006
Leucine 0.085 jf 0.002 . 0.070 + 0.003 0.077 _+ O.OOl*
Tyrosine O.OkQ + 0.005 O.OVf + 0.008 0.0l*5 4b 0.010
Phenylalanine 0.130 + 0.013 0.070 + 0.016 0.081 + 0.011
GABA 2.2b + 0.06 2.bo + 0.06 2.20 +_O.ll*
Histidine 0.190 + 0.013 0.192 + 0.028 0.20 _+ 0.013
Ornithine 0.121 + 0.009 0*133.i 0.002 0.12 4- 0.011
Lysine 0.300 _+ 0.021 0.31*2 + 0.032 0.35 +_o.oil*
Arginine 0.330 + 0.023 0.362 + 0.050 0.22 + 0.056
The number of animals used is indicated in the parentheses.
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TABLE 5.15
EFFECT OF REHABILITATION ON THE FREE AMINO ACIDS. 
IN THE BRAINSTEM OF RATS PREVIOUSLY FED A LOW 
PROTEIN OR HIGH PROTEIN RESTRICTED DIET (FOR 
DETAILS SEE TEXT).
Amino Acid 
pinole g/wet 
tissue
CONTROL -(h)
Low Protein 
Rehabilitated (3)
Restricted High 
Protein
Rehabilitated (1*)
Taurine 
+ Urea 1.50 + 0.19 1.50 + 0.113 1.60 + 0.08
Glycine 2.50 + O.Ol* 2.1*0 + 0.03 2.50 + 0.09
Alanine 0.1*10 + 0.030 0.1*70 + 0.015 0.1*6 _+ 0.010
Cystine 0.015 + 0.001 0.015 + O.OOl* 0.013 + 0.003
Valine 0.091 + 0.001 0.095 + 0.002 0.093 + O.OOl*
Methionine 0.078 + 0.012 0.067 + 0.006 O.069 + O.OOl*
Isoleucine 0.01*6 + 0.001 0.01*6 + 0.003 - 0.0l*6 + O.OOl*
Leucine 0.098 + 0.007 0.110 + 0.001 0.110 + 0.005
Tyrosine 0.053 + 0.010 0.051 + O.OOl* 0.01*3 + 0.002
Phenylalanine 0.085 + 0.022 0.088 + 0.013 ‘ 0.102+ 0.011
Gaba 2.97 + 0.33 2.5l* 0.15 2.6 + 0.18
Histidine 0.190 + 0.032 0 • H 00 O + 0.007 0.172 + 0.009
Ornithine 0.120 + 0.016 0.101 4- 0.005 0.099 ± O.OOl*
Lysine 0.260+ 0.077
0CO•0 + 0.033 0.382 + 0.021 •
Arginine 0.390 + 0.021* . 0.1*11 + O.O58 0.1*37 + 0.01*9
The number of animals is indicated in parentheses.
166
TABLE 5.17
EFFECT OF PROLONGED FEEDING OF A LOW PROTEIN DIET FOR 
120D ON THE FREE AMINO ACIDS OF RAT FOREBRAIN
Amino Acid
ymole/g wt CONTROL LOW PROTEIN
tissue
Taurin e + Ure a 5-3 + 0.22
+ 
1
H• 0.28
Glycine 0.79 + O.Oli 1.02 + 0.085
Alanine 0.73 ± 0.03 0.72 + 0.02:
Cystine 0.008 + 0.002 0.007+ 0.001
Valine 0.092 + 0.003 0.07 + 0.005
Methionine O.Oll + 0.011 * 0.019+ O.OOl
Isoleucine 0.022 + 0.00U 0.028+ 0.005
Leucine 0.051 + 0.006 0.037+ 0.007
Tyrosine 0.0U1 + 0.006 0.020+
**
0.002
Phenylalanine 0.076 + 0.008 0.0I2+ 0.008*
Gaba 2.00 + 0.06. 1.70 + 0.09
Histidine 0.160 4^ 0.005 0.151+
***
0.011
Ornithine 0.076 + 0.005 0.083+ 0.008
Lysine 0.212 + 0.011 0.210+ 0.01
Arginine 0.072 + O.OOl 0.076+ 0.002
Each value represents the average _+ S.E.M. of determinations of four rats.
Statistical significance of difference between exterimental animals and 
controls shown * where P < 0.059 ** where P < 0.02, *** where P < 0.001.
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TABLE 5.18 .
EFFECT OF PROLONGED FEEDING OF A LOW PROTEIN DIET 
ON THE FREE AMINO ACIDS OF THE RAT CEREBELLUM 
(FOR DETAIL SEE TEXT)
Amino Acid
pmole/g wet . CONTROL LOW PROTEIN
tissue
Taurine + Urea 1*.70 + 0.32 3.20 + 0. lij-
Glycine 1.10 + 0.03 1..U0 -_+
**
0.0H
Alanine 0.760 + 0.019 0.572 +
***
0.018
Cystine 0.019 ± 0.006 0.015 O.OOl}-
Valine 0.087 ± 0.005 0.081 0.013
Methionine 0.033 + 0.002 0.022 + 0.002
Isoleucine 0.03^ + 0.002 O.OltO + 0.008
Leucine 0.085 ± 0.002 0 0 —"3 L° _+ 0.00U
Tyrosine 1 0.0l}8 + 0.005 0.060 _+ 0.003
Phenylalanine ' 0.13 + 0.013 0.089 jh O.Oll}
Gaba 2 . 2 o  + 0.065 2.b0 + 0.16
Hisitidine 0.191 ± 0.013 O.I15O +
, *** 
O.Oll}-
Ominthine 0.120 + 0.009
CM•
O + 0.017
Lysine 0.302+ 0.021 0.312 + 0.006
Arginine 0.330+ 0.023 "O.kkl + 0.06
Each value represents the average + S.E.M. of determinations of four rats.
Statistical significance of differences between experimental animals and 
controls shown ** where P < O.Ol, *** where P < 0.001.
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TABLE 5.19
EFFECT OF PROLONGED FEEDING OF A LOW PROTEIN DIET FOR 
120D ON THE FREE AMINO ACID OF RAT BRAINSTEM
Amino Acid 
ymole/g wet 
tissue
CONTROL LOW PROTEIN .
Taurine + Urea 1.50 + 0.19 0.93 _+ 0.02
Glycine ,2.50 + 0.01+ 2.70 + 0.1+3
Alanine o.ia 4- 0.03 0.38 4- 0.01
Cystine 0.015 0.001 0.018 + 0.002
Valine 0.091 _+ 0.001 O.O65 _+ 0.005
Methionine 0.078 4- 0.012 0.051 4- 0.005
Isoleucine 0.01+6 +' 0.001 . 0.027 + 0.003
Leucine 0.098 _+ 0.007 0.078 jf 0.005
Tyrosine 0.053 Hh 0.001 0.025 4- 0.001+*
Phenylalanine O.O85 + 0.022 0.066 4- 0.021
Gaba 2.97 0.33 2.61 4h 0.09
Histidine 0.190 + 0.032 O.292 4-
***
0.019
Ornithine 0.120 Hh 0.016 0.112 +_ 0.012
Lysine 0.260 4- O.O77 0.271 _+ 0.027
Arginine 0.392 Hh 0.021+ 0.281+ jh 0.027
Each value represents the average ± S.E.M. of determinations of four rats.
Statistical significance of differences between experimental animals and 
controls shown * where P < 0.059 *** where P < 0.001.
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TABLE 5.20
EFFECT OF PROLONGED FEEDING OF A LOW PROTEIN DIET FOR 
120D ON THE PLASMA FREE AMINO ACIDS IN THE RAT
Amino Acid 
pinole/ml plasma Control
Prolonged 
Low Protein
Taurine + Urea 0.130 i 0.057 0.029 + 0.009
Glycine 0.121 + 0.013 0.291+ 4- 0.026
Alanine 0.19 § + 0.062 0.1+61+ 4-
*
0.025
Cystine 0.009 + 0.001 0.006 + 0.001
Valine 0.172 + 0.01 0.070 +
***
0.003
Methionine 0.02b +_ 0.001+ 0.015 4- 0.003
Isoleucine 0.071 Hh 0.001+ 0.033 + 0.005
Leucine 0.110 0.006 O.Ol+l Hh
***
0.005
Tyrosine 0.055 +_ 0.003 0.021+ +
***
0.001+
Phenylalanine 0.01+7 _+ 0.025 0.035 + 0.003
Histidine 0.087 + 0.003 0.181+ 4*
***
0.012-
Ornithine 0.110 + 0.01 0.01+5 + 0.001
Lysine 0.21+2 4* 0.03 0.21+0 4* 0.001
Arginine O.O78 +_ 0.01 0.085 0.003
Each value represents the average + S.E.M. of determinations on four rats.
Statistical significance of differences between experimental and controls 
shown * where P < 0.01, ** where P < 0.002, *** where P < 0.001
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TABLE 5.21
FREE AMINO ACID CONCENTRATIONS IN PLASMA AND BRAIN 
PARTS OF WEANLING RATS GIVEN A LOW PROTEIN DIET FOR 
120 DAYS EXPRESSED AS A PERCENTAGE OF THOSE IN CONTROL 
ANIMALS.
Values are means of values for h animals of each kind
Plasma Forebrain Cerebellum Brainstem
Glycine ini**** 131* 125** * 107 —
Tyrosine 1*8** 106 55*
Histidine 285**** 2^0*** * *
Statistical significance of differences "between experimental and 
controls shown * where p < 0.05; ** where p < 0.02; *** where p < 0.01; 
**** w^here p 0.001.
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DISCUSSION
The weight of forebrain, cerebellum and brainstem of rats fed 
the low protein diet was lower than that of the controls. The largest 
difference was found in the cerebellum and the smallest in the forebrain. 
No weight changes were noted in the corresponding brain parts in animals 
fed the RHP diet despite a significant retardation in body weight . The 
amounts of DNA per brain part showed that neither dietary regime changed 
the cell number, whereas the low protein diet did retard the normal 
increase in cell size as judged by the Tower protein:DNA ratio. These 
findings are similar to those obtained by Winick and Noble (1966) in 
the whole brain. The free amino acid pool in all three parts and on 
both restricted dietary regimes did, however, differ from that of the 
controls. Determination of the macroconstituents alone may not therefore 
be sufficient to elucidate the underlying biochemical changes. Thus, 
whereas high concentrations of methionine and histidine occurred in the 
forebrain, cerebellum and brainstem of the LP animals, they did not 
occur in the RHP animals. Conversely, low concentrations of glycine 
and alanine were found in the forebrain of animals fed the RHP diet but 
not in that of animals fed the LP diet. Thus, the concentration of 
free amino acids in the pool varied with the type of diet fed and the 
effect tended to be somewhat different in different parts of the brain.
Rajala/fitshmi et aL (1965) reported low concentrations of glutamic 
acid, aspartic acid and GABA in the cerebrum of young and adult rats* 
fed a 9% protein diet for 1* months. In the present investigation no 
significant change was found in the concentration of glutamic acid or 
aspartic acid in the forebrain, cerebellum and brainstem, and a 
lower concentration of GABA was found in the brainstem only. The
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difference between the present results and those of these workers may 
be due to the different composition of the diet and duration of restriction, 
although differences due to time of insult and the technique used for 
the amino acid determinations cannot be excluded.
The enzyme phenylalanine hydroxylase is necessary for the 
conversion of phenylalanine to tyrosine and this enzyme is absent from 
the brain (Guroff and Abramdwitz, 1967)* The increase in the 
concentration of phenylalanine found in the brainstem of protein 
deficient rats cannot therefore be due to diminished conversion to 
tyrosine and must be the result of a diminished incorporation into 
brain protein or to an increased uptake.
The relationship between brain and plasma amino acids is determined 
by uptake, extrusion and exchange (Baxter, 1968). It appears that the 
concentration of certain free amino acids in the plasma reflects that in 
the brain. This was particularly true of histidine which was similarly 
raised in both plasma and brain. The concentration of methionine, however, 
was within normal range in the plasma, but significantly increased in 
the brain, whereas that of tyrosine was lower than normal in the plasma 
and within the normal range in the brain. These findings are consistent 
with the general concept of the operation of a 'blood-brain barrier' 
in minimising cerebral reflection of plasma amino acid alterations 
(Waelch and Lajtha, 1961).
A disturbance of histidine metabolism occurs in children with 
kwashiorkor and results in the urinary excretion of urocanic acid 
(Whitehead, 196k ,) .. . In rats fed a low protein diet the ability
to metabolise histidine is also impaired and this impairment is associated 
with reduced activities of hepatic urocanase and histidase (Rajagopal Rao
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Deodhar and Hariharam, 1965). The raised plasma levels of histidine 
found in the rats fed low protein diet in the present experiments may 
thus he due to a failure to metabolise this amino acid.
w.- • - - The plasma concentrations
of insulin -were lover and those of cortiCXDSterone vere higher in the 
animals fed a LP diet for 56 d vhen compared vith concentrations in 
controls of the same age (Chapter 6). The changes in the free amino- 
acid pattern in the plasma and in the brain of LP rats cannot be 
attributed to an elevated level of plasma corticosterone only since 
it vas not reproduced by injection of corticoisterone in the normal rats. 
A severe protein-calorie deficiency leads to a deficiency of insulin and 
of thyroid and grovth hormones and a consequent relative excess of 
adrenocortical hormones (Heard, 1966). It is probable that the changes 
in free amino acid pattern in the plasma and brain of the LP animals 
vere a result of an imbalance of several hormones vhich vere affected by 
the dietary restriction.
Ilf . ■ 3 . . .The increased uptake of C -methionine and H -histidine into the
three brain parts in animals fed the LP diet may be the primary cause of
the higher concentrations of these amino acids in the three parts of the
brain. The present results are in agreement vith those of Lajtha and
Toth (1968) vho shoved that the exchange of free amino acids betveen
blood and brain changed in the same direction as the composition of the
free amino acid pool in the brains of animals fed a protein free diet
• . . llf . . . . .for 30 days. The incorporation of C -methionine into brain protein
vas also increased in the three brain parts of the animals fed the lov 
protein diet. This may indicate an alteration in protein synthesis in 
the brain in these animals, and this vas associated vith elevated brain 
concentration and increased uptake of these amino acids into the
lTlf
intracerebral pool. These results suggest that the alteration in 
protein synthesis induced by the low protein diet were secondary to 
changes in the uptake of amino acids. Since there was no change 
in the concentration of protein, there was a change in the rate of 
protein turnover. However, the changes in incorporation may also 
reflect the utilization of amino acid via other metabolic pathways, 
such as in the provision of energy required for.active transport 
processes., in possible replacement reaction of amino acids within 
the protein molecules, and in membrane permeability and compartment at ion 
of amino acids in the brain (Waelsch, I960; Lajtha, I96U). From the 
functional point of view, alterations in protein synthesis may 
result in changes in mental activity which are associated with the 
specialised function of the protein affected.
The biosynthesis of serotonin is dependent on the availability 
of its precursor, tryptophan (Mior and Eccleston, 1970; Wurtman and 
Femstrom, 1971) • The low concentrations of serotonin found in the 
forebrain and brainstem of the protein deficient rats may therefore be 
the result of a reduced intake of tryptophan and/or an alteration in 
the bioavailability of tryptophan through the serotonin pathway. The 
protein intake of the animals receiving restricted amounts of the high 
protein diet was apparently sufficient to maintain a normal concentration 
of serotonin in the brain. The inter-relationships of tryptophan and 
serotonin were further investigated and the results are described in 
the next chapter.
Rehabilitation
When transferred to the 25% casein diet, the previously retarded 
animals grew well and showed the expected growth spurt . The period of
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rapid growth vas maintained for about JO d and this brought the 
body weight and the weight of three brain parts up to. those of the 
controls of the same age by 200 d. The results are in agreement 
with Dobbing and Widdowson (1965)9 Dickerson and Walmsley (1967)*
The weight of different parts of the brain also recover on 
rehabilitation (Table 5^ 6)- The concentrations of free amino acids 
in the plasma and the three brain parts were within the normal range 
after 120 d of rehabilitation and were therefore not permanently 
affected by the previous period of malnutrition. Indeed, the 
concentration of tryptophan returned to normal levels after only 
7 d of rehabilitation (Chapter 6). The growth curve of the rats 
in this experiment was similar to that described previously in 
undernourished weanling rats (Dobbing and Widdowson, 1965; WTinick and 
Noble, 1966; Dickerson and Walmsley, 1967) for the body weight almost 
doubled during the period of restriction. Under these circumstances, 
the previous work showed, that the brain as a. whole was capable of 
complete rehabilitation with respect to cholesterol, phospholipids and 
DNA. If, however, increase in body weight and brain weight is 
completely prevented by more severe dietary restriction, complete 
rehabilitation may not be possible with respect to cholesterol and 
DNA in some parts of the brain (Dickerson, et al, 1972).
Recently, Baird, Widdowson and Cowley (1971) have reported a 
lower performance in the Hebb-Williams test in protein-energy malnourished ‘ 
rats as compared with controls of the same age, and this effect persisted 
after 5 weeks rehabilitation. Although the free amino acid pool in the 
present study returned to normal on rehabilitation, the possibility still 
remains, however, that the synthesis of some proteins may be more
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permanently affected and that this may account for some of the defects 
in learning capacity reported by some workers (Barnes, et al, 1966;
Baird, et al, 1971)•
Protein restriction for 120 d.
The body weight of the prolonged protein restricted rats showed 
r . little increase as compared to the rats on LP diet for 56 d. The 
growth of the forebrain and cerebellum was stopped by the prolonged 
protein restriction whereas the brainstem continued to grow. The 
increase in weight of the brain during restricted growth was probably 
due to growth in thickness of the medulla, since growth in thickness 
of spinal cord has been found to be related to chronological ..age 
(Dickerson, et al, 1967a Dickerson and Walmsley, 1967) •
The free amino acid pool in all three brain parts of prolonged 
protein restricted animals differed from those of the animals 
malnourished for 56 d. Thus, whereas at 56 d high concentrations of 
methionine was found in all three brain parts and a high concentration
of phenylalanine in the brainstem, these differences were not found in
© . . . .the animals on the protein restricted diet for a longer time. The
concentration of histidine in the three brain parts and that of glycine 
in the forebrain and cerebellum, on the other hand, did show a consistent 
increase during prolonged protein restriction.
On this evidence, it is tempting to suggest that the changes in 
some of the amino acids e.g. methionine and phenylalanine are transient 
and that they disappear as the animal adapts to prolonged protein 
restriction. It would clearly be of interest to follow these changes 
by measurements at shorter time intervals, and then to investigate 
the effects of protein restriction on various amino acid transport 
mechanisms.
The concentration of tyrosine in the forebrain and brainstem 
■was significantly lower than the control values only after the 
prolonged protein restriction. This can be explained by the 
utilization of this amino acid in the synthesis of DOPA and NE without 
an adequate replacement into the free amino acid pool from the blood.
The concentration of tyrosine in the plasma was markedly lower.
The plasma concentrations of valine, leucine and isoleucine, on the 
other hand, were significantly decreased whereas they were within 
normal range in the three brain parts .suggesting the existence of 
homeostatic mechanism in brain for these amino acids. These results 
are in agreement with Mendle and Marks (I965) who showed that 
feeding rats a protein-free diet for 6 to 11 weeks did not affect the 
concentrations of valine, leucine and isoleucine. These workers, however, 
did not measure the amino acids in the plasma.
There is strong support for the view that glycine may act as 
an inhibitory transmitter in the spinal cord. Distribution studies 
suggest that glycine might also function as a transmitter in other 
regions of the CNS (Aprison, Davidoff and Werman, 1970). It is 
tempting, therefore, to suggest that the consistent increase in the 
concentration of glycine in the forebrain andcerebellum ctn .1 the prolonged 
low protein animals may be of physiological significance.
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Chapter VI
Effects of lov protein and restricted high 
protein diet of equal energy content on rat 
train tryptophan metabolism.
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Introduction
•
The essential amino acid tryptophan appears to have a limiting 
role in ribosomalajgregation (Sidransky and Sarma, 19&5) and in protein 
•synthesis (Munro, 1970). It is also involved in a number of important 
biochemical processes, including the synthesis of nicotinic acid and 
of the putative neurotransmitter serotonin.
In recent years tryptophan and its respective metabolites have 
received increasing attention in connection with biochemical changes in 
mental illness. Behavioural disturbances have been associated with 
tryptophan itself (Smith and Prokop, 1962); with its indolic metabolites, 
tryptamine and indoleacetic acid (Brune and Himwich, 1962a) and 6-hydroxy 
skatole sulfate (Sprince, Houser, Jameson and Dohan, i960); with its 
5-hydroxyindole metabolites, 5-hydroxytryptophan, serotonin and 5H1AA 
(Himwich and Costa, i960; Woolley, 1962; Olson, Gursey and Vester, i960).
Psychoses and derangements of tryptophan metabolism have also been 
observed in various clinical syndromes, i.e. in inborn errors of metabolism 
such as Hartup disease, Wilson’s disease and porphyria, as well as in 
the disease pellagra caused by nicotinic acid deficiency.
Fernstrom and Wurtman (1970) reported that rats fed a corn diet 
for five weeks had a low concentration of serotonin in their brains.
Fasting rats for 2k hours enhances the turnover of brain serotonin with­
out changing its concentration (Perez-Cruet, Tagliamente and Gessa, 1972). 
It also increases the concentration of tryptophan and of 5HlAAin the brain 
(Curzon, Joseph and Knott, 1972). In a previous chapter (Chapter 5)» 
we have shown that giving rats a diet containing 3% casein caused a
1B0 ■
fall in the concentration of serotonin in the forebrain and brainstem, 
•whereas giving them a restricted amount of high protein diet of equal 
energy value did not cause any change in the concentration of serotonin 
in any of the three parts studied. It was therefore of interest to 
study the metabolism of tryptophan and of serotonin and its metabolite, 
5H1AA, in the brains, of rats subjected to the same two dietary regimes.
Animals and Diets
The animals used in these studies, their diets and the preliminary 
treatment of the brain were similar to those described in Chapter5.
Tryptophan was determined in the brain samples by the method described 
by Denckla and Dewey (1967) an(l serotonin and 5K1AA. as described by 
Curzon and Green (1970). Blood was collected from the cervical wound 
into heparinised tubes and plasma was obtained by centrifugation. Plasma 
tryptophan was determined by the same method as that used for the 
brain. The plasma levels of insulin and corticosterone were measured 
as described by Samols and Bilkus (196U) and Mattingly (1962) respectively.
3 . .
For the study of the uptake of H -tryptophan, groups of.animals given.'.-
the different diets were injected intraperitoneally with O.lyCi (H^-tryptophan) 
per g body weight and the animals killed at 10, 30 and 60 minutes after
injection. In further groups, the effect of giving insulin on the uptake
3 . . . . . .  ■
of H -tryptophan was investigated. Five of the low protein animals were
injected intramuscularly with two doses of insulin (0.5 IU per kg body 
weight with 0.1 g per kg body weight of glucose solution) at U0 and
l8l
. 3
10 minutes prior to the injection of the H -tryptophan. All animals
3were injected intraperitoneally with H -tryptophan (0.15 yCi per g body 
weight) and were killed after 60 minutes. Brain and plasma were obtained 
and analysed as described above.
For the study of the effects of rehabilitation, a further group of
rats maintained on the low-protein diet for 56 d was transferred to the
HP diet for 7 d before killing. The brains of these animals were then
compared with those of other animals maintained on the high protein diet 
for 63 d.
Results
The effect of the two dietary regimes on body and brain weight 
was similar to that previously described (Table 6.1). The concentration 
of tryptophan in the plasma of the animals given the low protein diet 
was about 80% lower than that in the animals given either an unrestricted 
or a restricted amount of the high protein diet. The concentration of 
tryptophan was also lower in each part of the brain of the animals on 
the low protein diet, although the differences were smaller than those 
found in plasma. The concentrations of serotonin and 5H1AA were lower 
in the forebrains and brainstems, but not in the cerebellums of the 
low protein animals, and again these parameters were not significantly 
different from the controls in the animals given the restricted high 
protein diet.
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Table 6.1 Effect of giving low protein (LP) and restricted high protein
diet of equal energy content (RHP) on the body weight, brain 
•weight, concentrations of tryptophan, serotonin and 5H1AA in 
the forebrain, cerebellum and brainstem and plasma tryptophan 
in rats
Each value represents average ± S.E.M. of determinations on 
five rats *
HP CONTROL LP RHP
Bodyweight (g) 320 ±10
Brain weight (g)
Forebrain 1.20 ±0.01
Cerebellum 0.29-0.02
Brainstem 0.1*2-0.01
Plasma tryptophan ik 8 ±0 1*6
(yig/100 ml ulasma)
Brain tryptophan 
(lig/g brain tissue)
Forebrain 1*.50 - 0.29
Cerebellum 10.80 ± 0.38
Brainstem 7*20■- 0.53
Brain serotonin 
(yig/g brain tissue)
Forebrain 0.50 - 0.002
Cerebellum 0.23 ± 0.01
Brainstem l.ll* - 0.0l*
Brain 5H1AA 
(llg/g brain tissue)
Forebrain 0.37 -.0.01
Cerebellum 0.13 - 0.01
Brainstem 0.63 ± 0.0l*
75 ± 3*** 225 ± 1 2 * * *
0.990 ±0.012*** 1.11 ±0.01
0.2l*0 ± 0.006* * 0.28 ± 0.01
0.3^0 ± 0.005*** 0.37 ± 0.02
3.10 ± 0.1+1**** 13.80 ±1.90
3.20 ± 0.15** 3.77±0.1+2
7.80 ± 1.00* 12.1+8 ± 1.30
5.2V ± 0.39* 7.38 ± 0.3I+
0 . 1*1 ± 0 . 01** 0 . 1+5 ± o.oi*
0.23 ±0.02 0.22 ± 0.03
0.93 ± 0.Q1+** 1.15 ± 0.03
0.11 ±0.01** 0.3U ± 0.02
O.ll* ± 0.02 0.15 ± 0.01
0.39 ± O.Ql*** 0.5^  ± 0.01
Statistical significance between controls and the experimental animals 
shown * where p < 0.05, ** where p< 0.01 and *** where p < 0.001.
183
Table 6.2 Effect of rehabilitation-for 7 d on the brain tryptophan, 
serotonin, 5H1AA and plasma tryptophan in the previously 
protein malnourished rats
Each value represents average ± S.E.M. of determinations 
on five animals
HP CONTROL
Brain weight (g)
Eorebrain
Cerebellum
Brainstem
Plasma tryptophan (yg/100 ml)
Tryptophan (yg/g wet tissue)
Forebrain
Cerebellum
Brainstem
1.21 ± 0.01 
0.29 ± 0.01 
0.43 ± 0.02
15.2 ±0.70
5.8 ± 0.2 
10.2 ± 1.0 
8.9 ± 0.4
LOW PROTEIN REHABILITATED 
FOR 7 a
1.04 ± 0.02*** 
0.25 ± 0.01* 
0.36 ± 0.02*
12.5 ±1.70
5.9 ± 0.20 
12.0 ± 1.1
8.5 ± 0.4
Serotonin (yg/g wet tissue)
Forebrain
Cerebellum
Brainstem
5HLAA (yg/g wet tissue)
Forebrain
Cerebellum
Brainstem
0.53 ± 0.02 
0.20 ± 0.02 
1.05 ± 0.04
0.35 ± 0.01 
0.16 ± 0.01 
0.52 ± 0.07
0.50 ± 0.04 
0.25 ±0.01 
1.09 ± 0.03
0.35 ± 0.03 
0.15 ± 0.02 
0.53 ± 0.01
Statistical significance between experimental and controls shown
* where p'< 0.059 *** where p < 0.001
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Table 6.3
Interval
(minutes)
Forebrain
Cerebellum
Brainstem
Statistical 
and controls
Effect of-giving a low protein (LP) and restricted high
protein diet of equal energy content (RHP) to rats on the 
3uptake of H -tryptophan into forebrain, cerebellum and 
brainstem in rats
Each value represents the average ± S.E.M. on five
. . . -3animals and is given cpm- per g weight x 10
10 30
HP CONTROL 67.2 ± 1.8 llit.l ± 6.1
LP 20.0 ± 1.3*** 2V.3 ± 0.8***
RHP T1*.1* ± 7.6 125.7 ± 7.6
62.6 ± 2.0 133.9 ± 3.2 157.9 ± 8
17.3 ± 1.7*** 30.9 ± 1.5*** 78.9 ±11
62.3 ± U.l ■ lUU.U ±20.9 166.1 ± 6
HP CONTROL 81.7 ± 5.1
LP 20.6 ±1.5***
RHP 68.1 ± 6.2
significance of differences between experimental animals 
shown * where p < 0.01, ** where p < 0.002, *** where p < 0
115.7 ± ^.6 
25.3*5^ 2 95”
128.8 +17 ..U
190.6 ± 12, 
IOU.-U ± 19.
190.9 ± 8,
HP CONTROL
LP
RHP
60
206.6 ± 17 
100.3 ± 1^  
199.9 ± 6
9
1^**
.8
5
,7**
,8
0
3*
0
001.
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Table 6.1* Effect of giving a low protein (LP) and restricted high
protein diet of equal energy content (RHP) to rats on
3 . .the uptake of H -tryptophan into protein m  the forebram,
cerebellum and brainstem
Each value represents average ± S.E.M. of determinations 
on five animals and is given as count per ten minutes 
per mg protein
Interval 10 30 60
(minutes)
HP CONTROL 208.k ± 13.5 366.8 ± 39.8 601.0 ±53.5
Forebrain LP ll*2.0 ± 39.1 21*8.7 ± 8.70* 319-6 ± 21.9***
RHP 213.1* ± 19.6 362.5 ± 62.6 511.3 ±23.1*
HP CONTROL 352.6 ± 5^ .0. 81*2.3 ± 72.0 989.1 ± 1*2 .1* .
Cerebellum' LP 1*55.1 ± 1*8.1 513.8 ± 1*1*.0*** 733.2 ± 67-9**
RHP . 1*89.0 ± 86.3 696.I ± 13.9 889.O ± 5l*.2
HP CONTROL 280.7 ± 17.2 606.0 ± 82.3 1086.5 ±59.0
Brainstem LP 229.9 ± 8.1 282.9 ±55.2* 756.5 ± 99-9**
RHP 261.9 ± 3.5 1*1*9.1* ± 96.6 959.6 ± 1*7.9
Statistical significance of differences between experimental animals
and controls shown * where p< 0.059 ** where p< 0.02, *** where p< 0.01.
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3 •Table 6.5 Effect of insulin on the uptake of H -tryptophan into
forebrain, cerebellum and brainstem and its incorporation 
in the brain protein of rats fed a low protein diet 
(For details see text)
Each value represents average ± S.E.M. of determinations 
on five animals
HIGH PROTEIN LOW PROTEIN LOW PROTEIN
CONTROL INSULIN INJECTED
Plasma insulin .
(iU/ml plasma) 50.5 ± 3-5 8.0 ± 3.0** 35.0 ± 3.3*** +
Plasma tryptophan
(pg/100 ml plasma) 12.8 ± 0.50 U.O ± 0.35*** 3.5 ± 0.25***
Uptake into the brain 
(cpm/g vet tissue x 10 )
Forebrain 66.1* ± 1.8 33.2 ± 1.9*** 1*8.9 ± 5.8** +
Cerebellum 62.6 ± 5-9 2l*.l ± 2.1*** 1*1.5 ± 3.2*++
Brainstem 71.6 ± 5.6 2l*.8 ± 2.2*** 37-7 ± 1*.0***++
Incorporation in protein 
(count/10 min/mg protein)
Forebrain 228.1* ±15-3 85.6 ±11.2*** 115-6 ± l*.3***f
Cerebellum 362.61 1*5-0 92.1111.9*** 165.OI 26.1*** f
Brainstem 290.7l 27.2 10l*,l± 1.1* ll*0.01 17.b+1* . '
Statistical significance of differences between high protein controls and
the experimentals shown * where p< 0.05s ** where p< 0.01, *** where p< 0.001
Statistical significance of differences between low protein controls and the 
low protein insulin injected animals shown + where p< 0.05y++ where p < 0.01, 
++f where.p < 0.01.
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Table 6.6 Plasma insulin and cortigEOSterone levels of animals 
fed a high protein, low protein and restricted high 
protein diet of equal energy content for 56 d
Each value represents average ± S.E.M. of determinations 
on five animals
Plasma insulin 
(iU/ml plasma)
HIGH PROTEIN 
CONTROL
53.3 ± 6.7
LOW PROTEIN RESTRICTED 
HIGH PROTEIN
8.8 ± 2.0*** 19.0 ±
Plasma corticosterone ^  g + ^  ^
(pg/100 ml plasma)
19.6 ± 0.9* 16.5 ± ^.7
Statistical significance of differences between high protein controls 
and the experimental * where p< 0.059 *** where p< 0.001.
Statistical significance of differences between restricted high protein 
group and the low protein group t where p< 0.05.
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After receiving the high protein diet ad lib for 7 the weights 
of the brains of the low protein animals were not significantly greater 
than those of the animals killed after 56 d on the low protein diet and 
therefore they remained lower than those of the controls (Table 6.2).
The biochemical differences had, however, disappeared.
3 # ^
The uptake of H -tryptophan into the brain (Table 6.3) increased
with time. At each time interval the uptake was significantly lower 
in each part of the brain of the animals receiving the low protein diet
than it was in those receiving either restricted or unrestricted amounts ,
. . : ' 3
of the high protein diet. The incorporation of H -tryptophan into
proteins of each part of the brain of the low protein animals was also
significantly lower at 30 and 60 minutes after injection (Table 6.1+),
3
Effect of insulin on H -tryptophan uptake
The concentration of insulin was lower in the plasma of the animals 
given the low protein diet than in those given the high protein diet,
(Table 6.5) and this low level was raised significantly by the injection 
of insulin. It was not, however, raised to the level found in the controls. 
The injection of insulin had no effect on the low level of tryptophan 
found in the plasma of the low protein animals, but it did increase both 
the uptake of H -tryptophan into the brain, and its incorporation into 
brain protein although it did not raise them to the levels found in the 
ad lib fed controls. \
The plasma insulin level was markedly decreased in the animals 
fed a low protein diet for 56 d (Table 6.6). The plasma insulin level 
in the restricted high protein animals was significantly lowered as
Table 6.7 Plasma insulin and corticosterone levels of animals
fed a high protein diet of equal energy content for 
63 d and animals on a low protein diet for 56 d and 
rehabilitated for 7 d
Each value represents average ± S.E.M. of determinations 
on five animals '
HIGH PROTEIN 
CONTROL 63 d
LOW PROTEIN 
REHABILITATED FOR 7 d
Plasma insulin 
(iU/ml)
50.5 ± 3.5 13.2 ± 3.1**
Plasma cortic:erSterone 
(Vg/100 ml plasma)
15' .h0± 1.0 16.9 ± 1.5
Statistical significance of differences between high protein control 
and the experimental ** where p < 0.002
Table 6.8 The effect of low protein diet (for 56 d) with (id) and
without rehabilitation on brain weight, concentration of 
plasma tryptophan and forebrain, cerebellum, brainstem 
concentration of tryptophan, serotonin and 5H1AA in rats
Each value represents average ± S.E.M. of determinations 
on five rats
Brain weight (g)
Forebrain 
.Cerebellum ' 
Brainstem
Plasma tryptophan 
(yg/100 ml plasma)
Brain tryptophan 
(pg/g wet tissue)
Forebrain
Cerebellum
Brainstem
Brain serotonin 
(yg/g wet tissue)
Forebrain
Cerebellum
Brainstem
Brain 5H1AA 
(yg/g wet tissue)
Forebrain
Cerebellum
Brainstem
HIGH PROTEIN 
CONTROL 56 d
1.21 ± 0.01 
0.29 ± 0.01 
0.k2 ±0.01
U..'50 ± 0.29 
10.20 ± 1.01
8.9O ± 0.1*2
0.50 ± 0.01 
0.23 ±0.01 
l.lk ± 0.0k
0.37 ± 0.03 
0.13 ± 0.01 
0.63 ± 0.0U
LOW PROTEIN 
FOR 56 d
0.99 ± 0.02++++ 
0.2k ± 0.06f 
0.31* ± 0.01++++
LOW PROTEIN RE­
HABILITATED FOR 7 a
l.Ok ± 0.02§§§
0.25 ± 0.01§§ 
0.36 ± 0.02§§
lk.80 ± O.kG 3.10 ± O.^ffff 12.50 ± 1.70**** N.S.
3.20 ± 0.15tff
7.80 ± 1.00+ 
5.2U ± 0.39+
O.Ul ± 0.01+++ 
0.23 ± 0.02 
0.93 ± 0.0^++
0.11 ± 0.01+++ 
0.1k ±0.02 
0.39 ± 0.0^++
5.90 ± 0.15**** N.S, 
12.0 ± 1.13* N.S.
8.50 ± 0.39****'N.S,
0.50 ± O.Olf*** N.S. 
0.25 ± 0.01 N.S. 
1.09 ± 0.03** N.S.
0.35 ± 0.03*** N.S. 
0.15 ± 0.02 N.S. 
0.53 ± 0.01*** N.S.
Statistical significance of differences between high protein control and
the low protein diet without rehabilitation f where p< 0.05, ++ where p< 0.02,
+++ p < 0.01, ftff p < 0.001.
Statistical significance of differences between control and rehabilitated 
animals where N.S. = not significant, §§ where p< 0.02, §§§ where p < 0.01.
Statistical significance of differences between animals fed a low protein diet 
and the rehabilitated animals fed the same diet * where p < 0.059 ** where 
p < 0.02, *** where p < 0.01, **** where p < 0.001.
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compared to the high protein controls but higher than those on the 
low protein diet. On rehabilitation for 7 &, the plasma insulin level 
was still significantly lower as compared to the high protein controls 
(Table 6.7).
The level of plasma corticpsterorie was significantly increased in 
the animals fed a low protein diet (Table 6.6). In the restricted high 
protein and rehabilitated animals no change in corticosterone level 
in the plasma was found (Table 6.7).
Giving the low protein animals free access to a high protein diet 
resulted in a rise in the concentration of tryptophan in the plasma to 
a level which was not significantly below that of'the controls (Table 
6.8). It had a similar effect on the concentrations of tryptophan, 
serotonin and 5H1AA in those parts of the brain in which the concentration 
had been previously low. Rehabilitation for this short time, however, 
had no significant effect on the weight of the brain.
Discussion
Large parent eral doses of tryptophan rapidly increased the 
concentration of serotonin in the brain (Ashcrofts Eccleston and Crawford, 1965; 
Moir and Eccleston, 1968), and changes in the dietary intake of 
tryptophan are accompanied by parallel changes in brain serotonin if 
given over a few weeks (Zbinden et al, 1958; Gal, Drewes and Barraclough,
1961; Wang, Harwalker and Waisman, 1962; Culley et al, 1963). The 
dependence of serotonin biosynthesis on tryptophan availability is 
probably due to the unusually high substrate K of the key enzyme, 
tryptophan hydroxylase (Moir and Eccleston, 1968).
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Fernstrom and Wurtman (1971) showed that chronic corn consumption 
m  the rat reduced, the serotonin content of the brain, although no> 
attempt was made in this work to study different parts of the brain.
In the present studies (Chapter 5) we have shown that feeding weanling 
rats a diet containing 3% casein for 56 d resulted in lower concentration 
of tryptophan in the plasma and in each part of the brain studied. The 
concentration of serotonin was also reduced in the forebrain and brainstem 
though not in the cerebellum. In animals that received a high protein 
diet of equal energy content, the values for all these parameters were 
not significantly different from the controls. Thus, in agreement with 
the work quoted above, the differences in brain tryptophan and serotonin 
in the animals on the low protein diet reflected the plasma concentration 
of tryptophan and were probably due to the low intake of this amino acid.
The omission of tryptophan from the diet of adult rats causes a 
decrease in the number of small polyribosomes during the first 3 hours 
of the post’-absorptive period (Wienner, 1967) and this is indicative 
of changes in the structural integrity of the polysomes which would
probably affect protein synthesis. Sidransky et_ al (1965) also reported that
. . ■ ■ ■ 3tryptophan regulates polyribosome aggregation .The uptake o f H -tryptophan
into the forebrain, cerebellum and brain stem was significantly depressed 
in rats fed the low protein diet, and this was probably the primary
cause of the significant reduction in the overall rate of uptake of
3 ■ ' ' . ■ ■ . ' .H -tryptophan into brain protein.
There is evidence, however, that the relationship of food intake 
to brain tryptophan metabolism is not simply a question of the effect of 
the tryptophan content of the diet on plasma tryptophan concentration.
Thus, Fernstrom and Wurtman (1971L) showed that ingestion of a high
carbohydrate diet, or the injection of insulin, both increased the 
concentration of tryptophan in the plasma, and of tryptophan and 
serotonin in the brain. Green and Curzon (1968) on the other hand, found a 
decrease in the concentration of serotonin in the brain after the 
injection of corticosterone. In the animals fed the low protein diet, 
the plasma concentration of corticosterone was raised, and the plasma 
insulin level greatly reduced. It is concievable therefore that the 
changes in the circulating levels of these hormones may be a contributory 
factor in causing the changes in brain tryptophan and serotonin.
The possibility that insulin plays such a role is strengthened
by the finding that the injection of insulin increased the uptake and
. . 3 ■ . ■'.'■■■
incorporation of H -tryptophan into the brain. Although the plasma 
insulin level of the low protein animals injected with insulin was
significantly elevated to near high protein controls level, the uptake
3 . . . . . - . .
of H -tryptophan and its incorporation into brain protein was still
lower compared with those of high protein control animals and this 
suggests that the plasma tryptophan concentration may also be an 
important factor in the regulation of the uptake of this amino acid 
into the brain under these conditions.
A major fraction of plasma tryptophan is normally bound to albumin 
(McMenamy and Oncley, 1958) and thus not available for uptake into the 
brain. The method used in this experiment for the measurement of plasma 
tryptophan measured both free and albumin-bound fractions of the amino
acid. Since the plasma concentration was not significantly increased in
■ ' . ■ - : . ■ . . 3the insulin-treated animals the increased uptake of H -tryptophan could
reflect a selective increase by insulin of the "free11 plasma tryptophan
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pool or an effect of insulin on the uptake mechanism by which tryptophan 
passes into the brain from the plasma.
Injection of tryptophan into rats in amounts such that plasma 
tryptophan changed only within the range of normal daily variation, was 
found to cause increased brain tryptophan and serotonin (Fernstrom and 
Wurtman, 1971a). Furthermore, various drugs known to' stimulate brain 
serotonin synthesis were reported to cause increased brain tryptophan 
concentration (Tagliamonte et al, 1971) • Curzon et al (1972) found that 
serotonin turnover is highly correlated with brain tryptophan concentrations. 
These findings indicate that the concentration of tryptophan in the brain 
is an important factor in determining the rate of serotonin synthesis 
in the brain.
On rehabilitation for 7 & the concentration of tryptophan in the 
plasma and in the three brain parts of the low protein animals and also 
the concentrations of serotonin and 5H1AA in the forebrain and brainstem, 
returned to the normal range. Thus, the lower concentration of '
these constituents are probably dependent, directly or indirectly, on 
the diet at the time of killing the animals and in terms of rehabilitation 
is only transient.
The change in brain serotonin induced by the low protein diet
raises the possibility that certain brain functions such as sleep, mood
and body temperature which have been shown to be associated with the
serotonin concentration in the brain, might be significantly impaired.
•
In view of the involvement of protein synthesis in the learning 
process (Flexner, Flexner and Roberts, I96U; Flexner, Flexner .and 
de la Haba and Roberts, 1963; Davis and Agranoff, 1966; Flexner and
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Flexner, 1966; Zemp et al, 1966), it is tempting to suggest that
factors affecting protein synthesis could impede brain functions.
3The decreased uptake of H -tryptophan into the brain protein m  the 
low protein animals may indicate a partial inhibition of protein 
synthesis and this may have deleterious effects on brain development 
and learning capacity. ' •
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Chapter VII .
GENERAL DISCUSSION AND SUGGESTIONS 
FOR FURTHER WORK
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General Discussion
It has heen shown that malnutrition during early life stunts 
physical growth in experimental animals and produces subsequent impair­
ment in behaviour, memory and learning ability (Scrimshaw,196?; Dobbing* . 
1968; Baird et al, 1971)* There is increasing evidence that some of the 
findings in experimental animals may be applicable to malnourished 
children (Cravioto et al, 1962; Scrimshaw, 1967; Winick and Rosso, 1969; 
Chase and Martin, 1970) although Frich (1970) has emphasised the need 
for caution in the interpretation of behavioural observations in children 
since nutritional deprivation in human populations often interacts in 
a complex manner with other environmental and socio-cultural factors to 
produce behavioural changes. Cravioto et al (1967) have drawn attention 
to .the complexity of the biosocial factors that are associated with low 
weight gain (FigJ-.i).
Malnutrition is clearly one of the factors responsible for low 
weight gain, and if this is accompanied by a decreased capacity for 
intellectual improvement it will result in a vicious circle of factors 
that will perpetuate the poor social conditions and this is certainly 
of great social importance.
It is very difficult to isolate the contributions of nutritional 
and non-nutritional factors that might be responsible for abnormal 
behavioural characteristics observed in children following early mal­
nutrition, and this has necessitated the use of a wide range of 
experimental animal models in an attempt to evaluate and define the
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sequence of events that might occur in the human. In animal studies 
it is possible to design experiments, in which the dietary aspect is the 
only variable in the production of the syndrome. However, the 
difficulties associated with the use of animals in the study of 
problems of human malnutrition are many, and some of these have been 
discussed by Widdowson (1968). Although the rat is a useful animal 
for nutritional experiments because of its short life-span and rapid 
growth rate, this pattern of development makes inferences uncertain 
when applied to the situation in the human. Furthermore, studies on 
the brain involve even greater uncertainties since different brain parts 
develop and mature at different rates (Dickerson et al,1967) and so too 
is the proportion of the brain associated with, different-physiological 
functions is different in different species. When development is 
considered, a further dimension is added ‘for there are differences 
in the timing of the growth spurt of the brain with respect to birth 
in different species (Davison and Dobbing, 1966).
It has been suggested that the brain is most vulnerable to 
nutritional deprivation at the time when it is growing most rapidly 
(Davison and Dobbing, 1966). The peak rate of growth of the rat brain 
occurs about 10 days after birth (Davison and Dobbing, 1966). Under- 
nutrition during the first 21 days of postnatal life in the rat results 
in brains that are small for their chronological age, contain lower 
concentrations of; myelin lipids (Dobbing, I96U; Culley and Mertz, I96U; 
Benton et al, 1966; Culley et al, 1966) and smaller amounts of DNA 
(Winick and Noble, 1966). Undernutrition after 21 days of age results 
in brains that are small for their chronological age, but contain 
normal concentrations of cholesterol and amounts of DNA (Dobbing and
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Widdowson, 1965; Dickerson and Walmsley, 1967). However, Dickerson 
et al (1972) have shown that when increase in body weight was prevented 
for four weeks from weaning by dietary restriction there was a permanent 
retardation of cholesterol deposition in the forebrain and brainstem, and 
of DNA in the cerebellum. These results further emphasize the complexity 
of the relationship between timing and severity when considering 
the effect of malnutrition on the structural constituents of the brain.
The importance of the metabolic constituents such as the free 
amino acids and amines in normal brain function has been described 
(Chapter l). It would clearly be preferable to study the effect of 
protein-energy malnutrition upon these in man but-this is impossible 
due to the known postmortem changes of certain free amino acids in the 
mammalian brain. Animal experiments therefore assume an importance that 
they do not have in considering stable constituents.
The composition of the free amino acid pool of the brain is fairly 
stable under normal conditions. Furthermore, the amino acid composition 
of several species (mouse, rat, guinea pig, hen and frog), shows striking 
similarities when the amino acids are arranged in the sequence of their 
concentrations (Levi, Kandera and Lajtha, 1967) and this indicates that 
they are controlled by mechanisms with high selectivity. Evidence has 
been found that psychotropic and neurotropic drugs, as well as neural 
excitation or depression induced by other means, appear to affect protein 
synthesis in specific areas of the brain (Waelsch and Lajtha, I96I;
Piha et al, 1963). The alterations in protein metabolism may be associated 
with changes in the permeability of the blood-brain barrier and consequent 
variations in the transport of amino and other metabolites into cerebral
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tissue. More recently, evidence was also found that alteration in the 
cerebral amino acid pool results in alterations of cerebral amino acid 
and protein metabolism (Roberts and Zomzely., 1965). These findings 
provide . support for the hypothesis that protein synthesis in the 
brain of the adult animal may be acutely dependent on the availability 
of free amino acids. However, changes may also reflect the utilization 
of amino acids via other metabolic pathways such as in the provision of 
energy required for active transport processes, in possible replacement 
reactions of amino acids within the protein molecules, and in membrane 
permeability and compartmentation of amino acids in the brain (Waelsch,
I960; Lajtha, 196*0.
The current investigations have shown that prenatal maternal protein
deficiency does not change the concentrations of glutamic acid, aspartic
acid and GABA in the whole brain of the offspring at birth. Changes in
the concentrations of these amino acids were however, induced by pre-
and post-natal maternal protein deficiency. Thus, at 21 d the concentration
of aspartic acid was increased in the forebrain and cerebellum whereas
the concentration of glutamic acid was decreased in the forebrain and
that of GABA was increased in the cerebellum. These changes were accompanied
lU .by a lower uptake of C -D-glucose into the brain. In animals reared to 
2k d on a normal diet and then subsequently fed a low protein diet there 
was no change in glutamic acid, aspartic acid and GABA in the forebrain 
and cerebellum, and a decrease in the concentration of GABA was found in 
the brainstem only. In animals given a restricted amount of the high 
protein diet, the concentrations of these amino acids were not affected 
and neither was the weight of the brain.
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As mentioned previously, glutamic, aspartic and y-aminob.utyric acid 
are present in relatively large concentrations in the brain and are believed, 
to have neurotransmitter functions, participate in protein synthesis and 
control the rate of operation of the TCA cycle. It appears from the results 
that nutritional deprivation during the three different periods of life 
have different effects on the concentrations of these amino acids in 
different parts of the brain, and that the different parts respond 
differently to the same kind of nutritional deprivation. Moreover, the 
concentrations of these amino acids seem to be more susceptible in the 
brain of the offspring of mothers given a protein deficient diet during the 
suckling period, a period which coincides with the brain’s growth spurt.
It would be interesting to know if the same changes would result from a 
primary deficiency of energy of similar severity.
In male weanling rats fed a low protein diet, the plasma concentrations
of some free amino acids were altered. The concentrations of certain free
amino acids in the brain were also affected. These alterations may. be
associated with the alterations in the plasma concentrations of free amino
acids in general. The primary abnormality in amino acid metabolism may
however, occur in the brain or elsewhere in the body. For instance, the
metabolism of histidine has been found to be impaired in the liver resulting
in a marked increase in the concentration of histidine in the plasma and
in the brain. The increase in plasma histidine may then lead to competition
with other amino acids for transport sites into the brain. These changes vary
in the three brain parts and they also differ from the changes in rats fed
a diet of equal energy content but of high protein content. This seems to
indicate that the protein content of the diet may be of paramount importance.
In order to prove this conclusively, however, it would seem to be necessary
to compare the brains of animals of similar body weight reared on the
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different regimes. In the present studies the structural components 
such as cell number and protein concentration did not differ significantly 
on the two dietary regimes. These findings were in contrast to those 
produced by perinatal malnutrition.' , '
3 . . . Ilf .The uptake of H -histidine and C -methionine -in vivo into the brain was
significantly higher in the animals on the low protein diet. The incorporation
ill . . . . . . . .
of C -methionine into brain protein was increased m  the brain of low 
protein animals indicating that the uptake of free amino acids and protein 
synthesis in the brain is affected by feeding a low protein diet. It has 
been reported that protein synthesis in the brain is dependent upon the 
presence of amino acids in adequate amounts and in the proper proportions. 
Thus, alteration of the amino acid pool in the brain may be responsible for
the alteration in the incorporation of amino acid into brain proteins.
Since there was no change in protein concentration there was an alteration 
in the rate of protein turnover. From a functional point of view, alteration 
of protein turnover in the brain may affect certain brain functions. •
Nevertheless, it must be pointed out that in the current isotope studies, 
'the labelled amino acids were administered intraperitoneally. It does not, 
therefore, exclude the physiological restriction of the blood-brain barrier 
of these amino acids into the brain and also their metabolism before they 
enter • the brain. The intracisternal administration of the labelled amino 
acids would certainly be preferable under the circumstances, but it proved 
impossible to do this on the malnourished animals due to their small size.
On rehabilitation for 120 djthe body weight and weights of the forebrain, 
cerebellum and brainstem returned to normal in the animals previously fed a 
low protein and restricted high protein diet of equal energy content. On 
the contrary, the body weight and weights of the three brain parts of rats
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malnourished perinatally remained lower after 120 d of rehabilitation.
The fact that the free amino acid pattern in the three brain parts in
these animals returned to normal on rehabilitation indicates that the
* • • • * •alteration is reversible and is related to the period of dietary
restriction.
Apart from the problem that was initially in mind in the work 
described, namely that of protein-energy malnutrition, it is possible that 
there is also some relevance of our studies to the widespread problem of 
psychiatric disease in man. In depressive illness there is evidence of 
defective serotonin metabolism (Coppen, 1971) and of a low tryptophan 
concentration in the cerebrospinal fluid (Copper and Brookbank, 1972).
The hypothesis that a defect in tryptophan metabolism may be involved 
at the onset of some forms of depression has been formulated by Dewhurst 
(1968). Lapin and Oxenkrug (1969) stated that depression may be due to 
a decrease in the serotonin content of the limbic system. The clinical 
observation that tryptophan potentiates the antidepressant effect of MAO 
inhibitors (Coppen, Shaw and Farrell, 1963) and that when administered as 
a large daily dosage it induces a definite improvement in depressed 
patients (Coppen, Shaw, Herzberg and Maggs, 1967)9 further supports the 
hypothesis that depressive states are due to a derangement in the metabolism 
of tryptophan or that of its metabolite, serotonin.
The decrease in concentration of tryptophan in the different parts 
of the brain and of serotonin and 5HIAA in the forebrain and brainstem of 
animals fed a low protein diet may therefore have some physiological 
significance. Some specific functions have been shown to be associated 
with serotonin-containing neurons, these include the control of sleep(H6ry,Pujol, 
Lopez, Macon and Glowinski# 1970), . mood (Bowers, 1970)9 body temperature
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(Beckman and Ei-senman, 1970), and the secretion of the anterior pituitary 
gland (Wurtman, 1971)* The decrease^in serotonin raises the possibility 
that certain brain functions might be significantly impaired. Malnourished 
animals and infants usually have subnormal body temperatures (Widdowson, 
1968), and this may perhaps correlate with the present findings of low 
serotonin concentrations in the brain.
A large number of genetic disorders of amino acid metabolism are 
also coupled with neurologic symptons, and most commonly with mental 
retardation. Abnormalities in the central nervous system in man have been 
demonstrated in the presence of defects in metabolism of phenylalanine, 
branch chain amino acids, tryptophan, histidine, cystathionine, homocystine, 
3-alanine, etc. In most of these conditions, notably phenylketonuria and 
maple syrup disease, the enzyme implicated is mostly absent from the brain. 
Evidence was found that excessive tissue levels of a given amino acid may 
inhibit transport of other amino acids into the brain and their utilization 
for protein synthesis (Chirigos, Greengard and Udenfriend, 1969; Lowden 
and LaRamec, 1969)9 cellular respiration (Barbato and Barbato, I969;
Swaiman and Lamieux, 1969) 9 synthesis of neurotransmitter- substances 
(Hansen, 1959; Tashian, I96I; Culley, Saunders, Mertz and Jolly, 1962), 
myelination (Menkes, 1968; Shah, Peterson and McKean, 1968), and cell 
replication (Clarke and Lowden, 1969). A possible relationship between 
the observations in brain changes in protein-energy malnutrition and 
naturally-occurring derangement in cerebral function which accompany 
the amino acidurias remains to be demonstrated. However, the basic 
biochemical mechanisms underlying certain changes in genetic disorders 
of amino acid metabolism would appear to have common characteristics which 
are found in severe protein-energy malnutrition.
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Suggestions for further work
The current investigation has shown intricate changes in the free 
amino acid pool in different parts of the brain of rats fed a low protein 
or restricted high protein diet of equal energy content. The uptake of 
certain free amino acids in vivo and their incorporation into brain 
protein were also affected. Studies on the effect of protein-energy 
malnutrition on the activity bf different brain proteins at subcellular 
level in terms of changes occurring in polysomal andoligosomal patterns, 
free ribosomes and ribosomal sub-units, and also in terms of amino acid 
incorporating activity of polysomes, have not been investigated and these 
might provide a further link between structure and function. On this 
basis, it is also necessary to carry out further investigations to test 
whether these effects are irreversible upon subsequent rehabilitation.
This approach will make it meaningful to correlate the effects of P.E.M. 
at various stages of development, in terms of protein biosynthetic 
activity, with the related findings of changes in intellectual or behavioural 
development as observed by other workers.
The present investigation has also shown low concentrations of 
serotonin and 5HIAA in the forebrain and brainstem of rats fed a low 
protein diet for 56 d. It was further shown that the lower concentration 
of serotonin in the two brain parts may be due to low tryptophan intake 
resulting in a low plasma concentration of tryptophan and also a low 
concentration of tryptophan in the brain. It would therefore be of 
interest to extend the present work to investigate the effect of supplementing 
an extra amount of tryptophan to the low protein diet to animals and observe 
the effect on the serotonin metabolism in the brain of these animals.
Knott and Curzon (1972) showed that changes of free tryptophan concentration
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in plasma may influence brain tryptophan and hence brain 5HT turnover in many 
circumstances. Since free tryptophan but not albumin-bound tryptophan in 
plasma can gain access to the brain for serotonin synthesis in the brain, 
it is necessary to measure the free plasma tryptophan concentration in 
these rats.
Corticosterone has been shown to induce the activity of tryptophan 
pyrrolase in rat liver and hence reduce the availability of tryptophan 
for brain serotonin synthesis. Severe P.E.M. leads to a deficiency of 
insulin and thyroid and growth hormones and a consequent relative excess 
of adrenocortical hormones (Heard, 1966). The present investigation also 
showed that the plasma corticosterone level in animals fed a low. protein 
diet was increased. It would be of great interest, therefore, to look at 
the activity of tryptophan pyrrolase in the liver of these rats.
Intraperitoneal injection of insulin into the animals on low protein
. . . . 3 . . ’
diet resulted m  an increase in an uptake of H -tryptophan into the brain
and also the subsequent incorporation of this amino acid into brain 
protein although the level of tryptophan in the plasma did not change.
These results indicate that insulin might increase the uptake or flux 
of free tryptophan into the brain. However, further studies on the effect 
of various hormones, e.g. thyroxine, ACTH, growth hormones :on brain free 
amino acids and their transport across the blood-brain barrier are 
required to elucidate the underlying mechanisms of the changes observed 
in the brain of animals subjected to protein-energy malnutrition.
Attempts to' link the changes in the biochemistry of the brain that 
result from malnutrition with behavioural differences in animals or
207
intellectual differences in man must at present "be largely speculative. 
However, there is increasing evidence*that some of the findings in 
experimental animals may be applicable to malnourished children.
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